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1 
ABSTRACT 
Cervical cancer remains the third most commonly diagnosed gynecological malignancy in the 
United States and throughout the world despite being potentially preventable. Patients diagnosed 
with cervical cancer may develop local recurrence in the cervix and surrounding structures 
(vaginal apex, parametrial, or paracervical), regional recurrence in pelvic lymph nodes, distant 
metastasis, or a combination of all. The management of such treatment outcomes has not been 
subject to rigorous investigation. Therefore, there is a need for studies and clinical trials that focus 
on decision making to support the choice of the best treatment modality that leads to the minimal 
number of adverse treatment outcomes.  
Medical imaging plays a vital role in the initial diagnosis, staging, and guiding treatment 
decisions for cancer patients. Positron Emission Tomography-Computed Tomography (PET/CT) 
hybrid scanner has proven to be a primary functional imaging modality in the oncology clinic. A 
typical oncological application of PET/CT aims to examine the whole body for high tracer uptake 
as a sign of tumorous lesions or metastasis using 18F-Fluoro-2-deoxy-D-glucose (18F-FDG). This 
radiopharmaceutical has been proven to be useful for the quantitative determination of regional 
glucose metabolism localized in the brain, heart, bladder, and, fortunately, in tumors.  Currently, 
18F-FDG measured on PET is the prominent radiotracer in cancer staging and follow-up imaging. 
In the –omics1 era, mining data to derive inherent information about a system has influenced 
the medical field, especially oncological imaging. The process of radiomics involves high 
1 The suffix –omics is often used to describe life sciences studies, which focuses on the extraction of large-
scale data/information to understand the object of interest (e.g., genomics, proteomics, and 
metabolomics). 
2 
throughput analysis of medical images to extract a large number of quantified features that are 
presented as a decision supporting tool for clinicians in terms of various clinical tasks such as 
staging, prediction, and prognosis. In recent studies, the focus of radiomics has exceeded the 
whole-tumor analysis to include the quantification of habitats, sub-regions within the tumor 
volume defined based on specific criteria, with the intent to investigate the diversity extent of the 
intratumor heterogeneity as robust descriptors and predictors of clinicopathological factors. 
The presented work is a retrospective analysis of a cohort consisting of pretreatment Positron 
Emission Tomography and Computed Tomography (PET/CT) hybrid scans of cervical cancer 
patients consecutively treated with radiochemotherapy. We extracted radiomic features from the 
primary cervical tumor volumes, and voxel intensity-based features from tumor habitats to 
analyze the tumors’ heterogeneity based on 18Flourodeoxyglocuse (18F-FDG) uptake of PET, and 
Hounsfield Units (HU) of CT to obtain useful tumor information, which might be associated with 
treatment outcomes. To our knowledge, a limited number of studies have focused on investigating 
the potential role of radiomic features on cervical cancer PET/CT images.  
Briefly, the workflow of this study consisted of investigating parameters that might affect 
radiomic features predictive performance by evaluating the reproducibility of radiomic features 
extracted from 18F-FDG PET images for segmentation methods, gray levels discretization, and 
PET reconstruction algorithms. Afterward, we used these features to predict cervical treatment 
outcomes after radiochemotherapy. Due to the use of human data, this research study acquired 
the approval of the institutional review board (IRB) at the University of South Florida.  
3 
1 CHAPTER 1: INTRODUCTION 
1.1 Overview 
Based on the 2017 estimates of the American Cancer Society (ACS), cervical cancer is the third 
most commonly diagnosed gynecological malignancy in the United States with an estimated 
incidence of 12,820 new cases and with estimated deaths of 4,210 per year [1]. The widespread 
implementation of early detection screening with the Pap smear test and subsequent treatment 
of precancerous lesions played a vital role in decreasing the cervical cancer incidence rate by half 
between 1975 (14.8 per 100,000) and 2012 (6.7 per 100,000). Subsequently, mortality rate also 
declined by half between 1975 (5.6 per 100,000) in comparison to 2012 (2.3 per 100,000). 
However, in less developed countries where screening is less prevalent or non-existent, the 
burden of cervical cancer is much higher. These statistical indices lead to cervical cancer being the 
fourth most common cancer in women worldwide, with an estimated global incidence of 528,000 
new cases and 266,000 deaths in 2012 with the vast majority of these cases in less developed 
countries [2]. Therefore, the ability to predict treatment outcome for patients, especially those at 
high risk of responding poorly to standard therapies, is of vital interest. Such ability could help 
clinicians modify their treatment plan, or modality, to improve patient’s response to treatment. 
Accordingly, recent research in the expanding field of functional imaging has put a high emphasis 
on the investigation and development of quantitative noninvasive biomarkers given the 
increasing need for robust treatment outcome predictors. 
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1.2 Literature Review 
Several studies have demonstrated promising results on the potential of radiomic features 
extracted from either PET or CT images to predict treatment outcomes for different cancer types. 
For PET, 18Flourine–fluorodeoxyglucose (18F-FDG) PET has been widely used in oncology as a 
functional imaging technique to define the gross tumor volume as well as to assess the cancer 
stage and response. One of the most common biomarkers for FDG-PET uptake semi-
quantification is the standardized uptake value (SUV). The maximum SUV (SUVMAX) is defined 
based on identifying one or group of voxels with the highest FDG uptake within the tumor volume.  
SUVMAX has been reportedly predicted for overall survival [3], treatment response [4], and lymph 
node involvement [5] in different cancer types. On the other hand, several studies questioned 
utilizing SUVMAX as an independent prognostic metric due to several measurement uncertainties 
[6, 7] that might be attributable to its sensitivity to variation in tumor volume, initial FDG uptake 
kinetics and distribution, inter-observer variability, and human body metabolism.  
Therefore, one of the goals of this project was to examine the accuracy of the prediction of 
cervical cancer treatment outcomes based on observed differences in the SUVMAX within the 
primary tumor volume. In addition to SUVMAX, several studies proposed SUVPEAK (defined as the 
maximum of all the mean values computed from placing a spherical kernel of approximately 1.2 
cm in diameter to yield a ~1 cm3 sphere centered at each voxel within the tumor volume) as a 
potential robust alternative to SUVMAX due to its minimum variability over time,  and relative 
insensitivity to image noise [8-10]. The predictive performance of SUVPEAK was also investigated 
in this study.  
In recent years, the high-throughput extraction of large amounts of features from medical 
images has been presented as a developmental process, called “radiomics” [11, 12].  The output of 
this process is sets of radiomic features that describe textural and shape patterns of the tumor 
volume of interest. Interestingly, radiomic features are reported by numerous studies to be 
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associated with treatment outcomes, tumor stage, as well as to have the ability to classify and 
segment cancerous versus normal tissue. El Naqa et al. [13] reported several logistic regression 
models of radiomic features with good prediction power for treatment outcomes in cervical cancer 
patients treated with radiochemotherapy.  However, the study suggested that further testing and 
validation using larger patient datasets was required. Reuzé et al. [14] defined a four-feature 
signature model consisting of both radiomic features and SUV measurements, which  predicted 
local recurrence in a cohort consisting of 118 locally advanced cervical cancer patients. The study 
also evaluated the reproducibility of the features as a function of several voxel size values and PET 
scanners of different vendors. The study emphasized on the challenging task of merging images 
from different PET scanners without introducing bias due to image acquisition protocols. Tixier 
et al. [15] demonstrated that analysis of intratumor FDG uptake heterogeneity of baseline PET 
scans using radiomics differentiated, with higher sensitivity than SUV measurements, between 
esophageal cancer patients who showed partial- and no-response to radiochemotherapy. 
However, it was encouraged to apply the same study using different radiotracers in the same or 
different tumor type to facilitate stronger association between imaging and inherent tumor 
biology characteristics.  Wei et al. [16] found a high association between radiomic features 
extracted from baseline PET images and tumor staging in cervical cancer. This study focused on 
primary tumor volumes because of the limited resolution of PET images, which did not reproduce 
significant heterogeneity in the smaller lymph nodes volumes. The preceding studies, and several 
others [17, 18], concluded that radiomic features have shown to have superior performance in 
comparison to SUV measurements regarding clinical outcome assessment and tumor 
heterogeneity description based on FDG uptake.  
Similarly, several studies used CT-based radiomics for predicting outcomes after 
radiotherapy treatment, especially for lung cancer patients. For example, Coroller et al. [19] 
demonstrated a strong association between CT-based radiomic signature and the development of 
distance metastasis for locally advanced lung adenocarcinoma. The authors also indicated 
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improved prediction when combining the radiomic-signature with clinical relevant factors. 
Hawkins et al. [20] extracted radiomic features from CT images of patients diagnosed with 
adenocarcinoma non-small cell lung cancer (NSCLC) tumors. Afterwards, they predicted survival 
time based on machine learning classifiers such as decision tree and support vector machine 
(SVM).  To our knowledge, a limited number of studies reported radiomic studies based on 
combined PET/CT scans. For example, Vaidya et al. [21] obtained multi-radiomic-feature models 
consisting of combined intensity-volume histogram (IVH) based features extracted from both 
PET/CT scans. The models significantly predicted local failure following radiotherapy for patients 
with NSCLC.  
As seen from the mentioned studies, the efforts of the majority of radiomic features studies 
have been focused on several cancer sites other than the uterine cervix. Accordingly, our 
motivation was to facilitate a comparison between our experience and the few previous studies 
that focused on the assessment of cervical tumor heterogeneity based on baseline PET and CT 
scans. Moreover, we aimed to investigate the ability of multi-radiomic regression models to 
predict the development of two primary treatment outcomes: development of distant metastases 
(DM) and loco-regional Recurrence (LRR). Also, we examined the possibility of generating 
multimodality PET/CT radiomic feature models to enhance the prediction of the mentioned 
treatment outcomes. To our knowledge, we will be the first to apply this approach on the site of 
cervical cancer. 
All the findings mentioned above indicate that quantitative assessment of tumor uptake 
heterogeneity derived from 18F–FDG PET is a promising method to investigate intra- and inter-
tumor characteristics. With such encouraging results, the focus is rationally turned toward 
examining the reproducibility of radiomic features due to various factors that may potentially 
affect their performance. Numerous three image-related factors such as tumor segmentation 
methods, gray level discretization of voxel values within tumor volumes, and PET reconstruction 
algorithms might cause large variation in radiomic features. Several PET segmentation methods 
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have been proposed in literature over the past years [22]. However, there is no consensus of one 
acceptable PET image segmentation method over the other. Also, aided by modern computational 
abilities, varying reconstruction techniques have evolved into sophisticated algorithms with 
various image qualities. The effect of such algorithms on radiomic features has not been widely 
studied. However, it was shown in a recent study [23] that different acquisition modes and image 
reconstruction settings caused variation in radiomic features.  Similarly, the gray-level 
discretization of PET and CT images has been shown to have a significant impact on some 
radiomic features [9].  
1.3 Dissertation Outline and Objectives 
 
     Since the reproducibility of radiomic features extracted from cervical cancer tumors has not 
been widely reported, the aim of Chapter 3 was to investigate the sensitivity of radiomic features 
for three critical parameters: tumor segmentation methods, gray-level discretization, and PET 
reconstruction algorithms. Also, we evaluated the application of correction factors for voxel size 
and gray-levels discretization reported by Shafiq et al.  using CT scans to the PET scans of this 
study. The rationale was to develop a set of radiomic features that are insenstives, or corrected, to 
the mentiond factors to be safely used as potential predictors for cervical cancer outcome 
assessment.  
     After identifying such set, the aim of Chapter 4 was to investigate the ability of radiomic 
features extracted from 18F-FDG PET uptake to predict for two major treatment outcomes: distant 
metastases (DM) and loco-regional Recurrence (LRR). 
        After successfully combining PET radiomic features into predictive models, we aimed in 
Chapter 5 to generate a model using radiomic features that incorporate tumors functional and 
anatomical information provided by PET and CT images, and to investigate the ability of support 
vector machine (SVM) classifiers to improve such prediction in comparison to the conventional 
method of fitting radiomic features into multiple logistic regression (MLR) models. 
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       In chapter 6, we proposed a method, which focuses on spatially distinct tumor sub-
regions (habitats) that are identified based on voxel intensity thresholds of the pretreatment 
PET/CT imaging data of cervical cancer patients. In other words, we divided the tumor 
volume voxel intensity maps into habitats of high and low PET and CT intensities based on the 
corresponding measure’s median threshold value. The identification of such subregional 
variations could potentially provide clinically relevant information to aid in designing a 
more patient-specific radiation therapy plan. 
 Chapter 7 concludes and summarizes the work done in this dissertation. Also, the 
chapter presents a discussion on the future directions of functional imaging research with an 
emphasis on recent technologies related to radiomic features, radiogenomics, and habitats. 
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2 CHAPTER 2: MATERIALS AND METHODS 
Due to the use of human data, this project acquired the approval of the institutional review 
board (IRB) at the University of South Florida Research compliance office.  In this chapter, the 
principles of the experimental techniques used in this dissertation are presented. First, we will 
briefly explain the physics and characteristics of PET/CT scan. Afterwards, we will describe the 
method used to calculate and extract the radiomic features.  
2.1 Patient Characteristics 
We retrospectively included 124 patients diagnosed with cervical cancer (Table 2.1) with an 
age range, at the time of diagnosis, of 24-86 years (median = 50 years). All patients were treated 
with definitive radiochemotherapy between 2009 and 2017. Radiotherapy consisted of external 
beam radiation therapy (EBRT) to a dose range between 43.2–50.4 Gy (median = 45 Gy), 
concurrent cisplatin chemotherapy and MRI-planned brachytherapy to 20–30 Gy (median = 28 
Gy). The patients’ disease was staged according to the classification of International Federation 
of Gynecology and Obstetrics (FIGO) [1]. The number of patients for FIGO stages IB, IIA, IIB, 
IIIA, IIIB, IVA, and IVB were 32, 7, 46, 2, 31, 3, and 3, respectively. The mean follow-up time at 
the start of the study was twenty-eight months.  
12 
 
Table 2.1. Patient demographics and clinical characteristics 
Characteristic Value (percentage) 
Age at initial biopsy (diagnosis) 
     Median 
     Range 
 
50 
24-86 
Histology 
Squamous cell carcinoma 
      Adenocarcinoma 
      both 
 
102 (82.3) 
17 (13.7) 
5 (4.0) 
FIGO stage 
      IB 
      IIA 
      IIB 
      IIIA 
      IIIB 
      IVA 
      IVB 
 
32 (25.8) 
7 (5.6) 
46 (37.1) 
2 (1.6) 
31 (25.0) 
3 (2.4) 
3 (2.4) 
Overall survival (OS) 
      Deceased 
      Survived 
Time to survival (months) 
      Mean 
      Median 
 
25 (20.2) 
99 (79.8) 
 
31.5 
27.0 
Disease-free survival (DFS) 
      Disease progressed 
      Disease-free 
Time to DFS (months) 
      Mean 
      Median 
 
38 (30.6) 
86 (69.4) 
 
28.2 
22.0 
Distant metastasis (DM) 
      DM developed 
      No DM developed 
 
37 (29.8) 
87 (70.1) 
Disease recurrence 
      Local recurrence 
      Regional recurrence 
      No recurrence 
 
3 (2.4) 
6 (4.8) 
115 (92.7) 
                      FIGO: Fédération Internationale de Gynécologie et d'Obstétrique 
                                  (International Federation of Gynecology and Obstetrics)  
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2.2 PET/CT Hybrid Imaging 
Positron emission tomography (PET) is a gamma imaging technique that uses compounds 
labeled with a positron, the antimatter counterparts of electrons, emitting radioisotopes as 
molecular probes to image functional and morphological processes in-vivo. In PET imaging, when 
a positron collides with an electron inside the patient’s body, both particles annihilate and 
produces two gamma rays traveling in a straight line and in opposite directions (Figure 2.1).  
Figure 2.1. After traveling about 1 mm, the emitted positron slows down and interacts with an electron 
inside the patient’s body. Annihilation of both electron and positron produces two gamma rays with energy 
equal to 0.511 MeV for each photon.  
Positron emitting isotopes of biologically active elements such as fluorine, carbon, and 
oxygen are all widely available in the industry. Fluorine-18, in particular, can be used to make a 
radioactive analog of glucose named 18F-fluorodeoxyglucose (18F-FDG) (Figure 2.2), which is 
preferentially taken up by brain and cancer cells, making a remarkable tool for detecting tumors. 
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Figure 2.2. Comparison between glucose (left) and 18F-FDG (right) molecules. The 18F molecule replaces an 
oxygen molecule resulting in fluorodeoxyglucose. 
Since the development of Computed Tomography (CT) in the early 1970s, manufacturers 
competed to enhance the capabilities of this sophisticated scanner. From the first CT developed, 
in England, in 1971 by Dr. G. N. Hounsfield, as an instrument to scan the brain, to the helical 
imaging CT developed by Kalender et al. [2], five scanner generations were designed with 
manufacturing evolutions in scanning configuration, scanning motions, and detector 
arrangement. Currently, CT is a well-established imaging technology that provides cross-sectional 
x-ray images with a clear anatomical description for all body sites.  The x-ray system of CT consists
of the x-ray source, detector arc, and a data-acquisition system. In clinical setup, the x-ray tube 
produces bremsstrahlung x-rays by accelerating a beam of electrons onto a target anode. The 
process of CT image acquisition starts by measuring projection data of x-ray transmission profiles 
through the patient in multiple angles.  The profile from each angle is detected by the detector 
arc, which consists of hundreds to thousands of detector elements (dels). Both the x-ray tube and 
the detector arc rapidly rotate around the patient to obtain the largest number of views. In general, 
the intensity of the x-ray beam is attenuated by absorption and scattering processes as it passes 
through the patient. The degree of such attenuation depends on the energy spectrum of the x-
rays, the average atomic number, and mass density of the patient tissues.  
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(2.2) 
If assumed monoenergetic,  the transmitted intensity through a homogenous patient body is 
given by equation (2.1) 
𝐼𝐼(𝑥𝑥) = 𝐼𝐼0𝑒𝑒−µ𝑥𝑥 
I(x) is the transmitted beam intensity after passing through thickness x, I0 is the intensity of the 
incident beam, and µ is the x-ray linear attenuation coefficient, which varies with tissue type and 
hence is a function of the distance x through the patient. For polyergic x-ray energies, penetrating 
heterogenous mediums (i.e., different patient organs) the equation becomes equation (2.2) 
𝐼𝐼(𝑑𝑑) =  𝐼𝐼0𝑒𝑒−∫ 𝜇𝜇(𝑥𝑥)𝑑𝑑𝑥𝑥𝑑𝑑0  
where µ(x) represents the linear attenuation coefficient at each point on the x-ray path from a 
distance zero to d. Finally, The CT image is reconstructed from the resulting transmission profile 
in the form of a matrix of small picture elements better known as pixels, and the volumetric 
patient body can be thought of a matrix of different linear attenuation coefficient volume elements 
(voxels). After CT reconstruction, the values of µ(x) within the pixel/voxel matrix are transformed 
into a corresponding matrix of CT numbers, which describes the optical density of the image. Due 
to Dr. Hounsfield’s pioneering efforts, CT numbers are called Hounsfield Units (HU). The scale 
of HU is expressed relative to the linear attenuation coefficient of water at room temperature 
(µwater), so the HU for any medium is expressed by equation (2.3), and the different HU values for 
body tissue are stated in table 2.2  
𝐻𝐻𝐻𝐻𝑚𝑚𝑚𝑚𝑑𝑑𝑚𝑚𝑚𝑚𝑚𝑚 =  𝜇𝜇𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤− 𝜇𝜇𝑚𝑚𝑤𝑤𝑑𝑑𝑚𝑚𝑚𝑚𝑚𝑚𝜇𝜇𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤 × 1000 
    Accordingly, CT images are described as density distributions due to the gray-scale 
display of linear attenuation coefficients that are closely related to the physical density of 
tissues, which makes this scanning technique the gold standard in radiation therapy simulation 
and planning. 
   (2.3)
(2.1)
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Table 2.2. Tissue densities on CT scan in Hounsfield units (HU). 
Tissue HU Scale on CT 
Bone +1000
Fat -30 to -100
Water 0
Muscle +40
Gray matter +38 (32-42)
White matter +30 (22-32)
Air -1000
2.3 Procedure of PET/CT Imaging 
    We performed all of the baseline (pretreatment) PET/CT patient scans in our diagnostic 
radiology department using the same Discovery STE® hybrid PET/CT scanner (General Electric 
Medical Systems, Milwaukee, WI, USA) (Figure 2.3) [3] and institutional radiopharmaceutical 
administration protocol. All patients had to be fasting for an average of six hours before being 
injected with an administered average dose of 363 MBq of 18F-FDG. Sixty minutes after the 
injection, a whole-body PET/CT scan in the supine position was acquired for the purpose of cancer 
staging. Patient’s weight, (average weight: 87 Kg), and blood glucose levels were recorded.  The 
PET static emission images were acquired after an average of 60 minutes post-injection. Images 
slice thickness 3.27 mm, row spacing 5.46 mm, column spacing 5.46 mm with a slice number of 
263. The PET images were reconstructed using 3D maximum likelihood ordered subset 
expectation maximization (ML-OSEM) with two iterations and 28 subsets. All images were 
corrected for attenuation. Consequently, we converted the image intensity values to SUV units 
(Bq/ml). CT scans were acquired in a helical mode with a slice thickness of 3.27 mm and spatial 
resolution of 1.38 × 1.38 mm/pixel at 120 kVp and 79 mAs tube current. The PET/CT scanning 
acquisition parameters are summarized in table 2.3.
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Table 2.3. PET/CT scanning acquisition parameters. 
PET 
Parameter Value 
Image type Static emission images obtained after an average of 60 minutes post F18- FDG injection 
Voxel dimensions (mm3) 3.27×5.47 × 5.47 
Reconstruction algorithm 3D maximum likelihood ordered subset expectation maximization (ML- OSEM) with two iterations and twenty-eight 
 Image intensity values conversion Standardized Uptake Values SUV units 
CT 
Parameter Value 
Image type Helical low dose CT scan 
Tube voltage 120 kVp 
Tube current Depending on BMI*, maximum value = 100 mAs 
Reconstruction algorithm Standard filtered back projection (FBP) algorithm 
Voxel dimensions (mm3) 3.27×1.37 × 1.37 
Image intensity values conversion Hounsfield units HU 
*BMI: body mass index.
Figure 2.3. The General Electric Discovery STE® hybrid Positron Emission/Computed Tomography 
(PET/CT) scanner. 
2.4 Tumor Segmentation
    The ability to differentiate between patterns of pathological from physiologic uptakes is 
highly dependent on the clinician’s experience. Therefore, two board-certified radiation 
oncologists 
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manually delineated the metabolic tumor volume (MTV1, MTV2) in the uterus and cervix regions 
based on the F–18 FDG uptake in pretreatment PET scans. The oncologists utilized CT scans and 
patient-specific histopathological reports for guidance to differentiate between cervix, bladder, 
and other surrounding organs. Both MTVs were generated using Mirada software (Mirada 
Medical DBx®, Oxford, UK.) Due to the lack of a ground truth for tumors definition, we chose 
MTV1 to be the reference, gold standard, tumor volume due to the physician’s experience. 
Subsequently, we generated semi-automated graphical-based volumes (GBSV) based on the 
method reported by Beichel et al. [4]. For further information about this method, the reader is 
encouraged to review the cited article. This approach is implemented as an extension for 3D Slicer 
software2, an open-source software package to visualize and analyze medical images.  
2.5 Radiomics Analysis 
We developed in-house software to process and quantify any three-dimensional helical 
modality images and to calculate the five commonly implemented methods of feature extraction. 
In total,  we extracted seventy radiomic features. The original mathematical formulation of each 
feature based on its method of extraction can be found in the cited references in the following 
subsection. In addition, Zwanenburg, A. et al. [5], on behalf of the image biomarker 
standardization initiative (IBSI),  presented a detailed formulation and nomenclature for 
hundreds of radiomic features, which covers the definition and formulations for the features we 
used in this study.  
2.5.1 Feature Extraction using Gray Level Co-Occurrence Matrix (GLCM) 
The GLCM (also known as Spatial Gray Level Sensitivity Matrix) is a second-order statistical 
method that characterizes the local information of gray levels between pairs of voxels; hence the 
extracted features are considered local features. GLCM features have become one of the most 
2 3D-Slicer is readily available at (https://www.slicer.org/) 
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well-known and widely used texture features.  In this study, the relationships between consecutive 
neighboring voxels in thirteen directions in a three–dimensional space were quantified. Twenty-
six features were calculated using this method [6]. Examples of this GLCM are Second-order 
Entropy, Difference Entropy, Inverse Difference (ID), Inverse Difference Moment (IDM), and 
Information Measure of Correlation (IMC). 
2.5.2 Feature Extraction using Gray Level Run-Length Matrix (GLRLM) 
GLRLM were used to extract eleven regional features, which captures the coarseness 
characteristics of image textures in specific directions within the predefined segmented volume 
[7]. A run is defined as the length of consecutive voxels that share the same gray-level intensity 
along a specific linear direction. This method was mainly applied to generate features based on 
fine textures that tend to contain more short runs with similar gray-level intensities; and coarse 
textures, which tend to have more long runs with significantly different gray intensities level. 
Examples of this method are Short Run Emphasis SRE (measures the distribution of short runs 
in the image), Long Run Emphasis LRE (measures the distribution of long runs in the image) and 
Run Percentage RPC (measures the homogeneity and the distribution of runs of an image in a 
specific direction). 
2.5.3 Feature Extraction using Gray Level Size Zone Matrix (GLSZM) 
GLSZM also extract regional features. However, the method of extraction takes place by 
quantifying the clusters of homogeneous intensity regions within the tumor [8]. Examples of this 
approach are High-Intensity Emphasis (HIE), Low-Intensity Emphasis (LIE), Size Zone 
Variability (SZV), Small Area Emphasis (SAE), and Large Area Emphasis (LAE). 
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2.5.4 Feature Extraction using Neighborhood Gray Tone Difference Matrix 
(NGTDM) 
These features were calculated using the neighborhood gray-tone-difference matrix 
(NGTDM) initially proposed by Amadasm and King [9]. These features are thought to correlate 
with human visual impressions. The neighborhood of a pixel used was 7x7 pixels for both CT and 
PET. Note that the original NGTDM feature equations were defined only for square ROIs. 
However, the calculations were modified slightly to apply them to irregularly shaped, and multiple 
slice ROIs. The five higher-order features were coarseness, contrast, complexity, busyness, and 
texture strength. 
2.5.5 Feature Extraction based on Shape Aspects 
Shape-based features (SF) were extracted to describe morphological and geometrical aspects 
of tumor volumes. Examples of this method are convexity (a measure of tumors solidity), 
eccentricity (a measure of non-circularity of tumors), tumor surface area, and the ratio of surface 
area to tumor volume (Surf/Vol) [10, 11]. 
2.5.6 Feature Extraction using Intensity Histogram (IH) and Intensity–Volume 
Histogram (IVH) 
Analysis of intensity histograms (IH) presents first-order features that describe global 
measurements of the tumor based on the information provided by the distribution of voxel 
intensities within the tumor volume [12]. However, they do not provide information about voxel-
to-voxel relation or dependency within the volume of interest. Thus, intensity histogram features 
(IHFs) describe the range of voxel intensity values within the segmented tumor volume. In other 
words, we plotted tumor volume as a function of the image intensity to calculate global features, 
which are described by common first-order metrics such as the mean, standard deviation, 
maximum and minimum intensities, skewness, kurtosis, intensity entropy, and uniformity of 
voxel intensity. We also studied other IVH-based features reported by Elnaqa et al. [13]. Examples 
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of such features are V90 (volume percentage having at least intensity of 90%) and I90 (minimum 
intensity of 90% of the highest intensity volume). We will present in chapter four a method to 
divide the tumor volume into sub-regions (habitats) based on the median of voxel intensity values. 
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3 CHAPTER 3: REPRODUCIBILITY OF F18-FDG PET RADIOMIC FEATURES 
FOR DIFFERENT CERVICAL TUMOR SEGMENTATION METHODS, GRAY-
LEVEL DISCRETIZATION, AND RECONSTRUCTION ALGORITHMS 
Note to Reader 
Portions of this chapter have been previously published in Journal of Applied Clinical 
Medical Physics, 2017, and have been reproduced with permission from Wiley Publishing. 
3.1 Introduction 
Several institutes have reported quantitative analysis studies, with a focus on radiomic 
features, for different imaging modalities such as Computed Tomography (CT) [1-3], and 
Magnetic Resonance Imaging (MRI) [4-6]. The investigation of Positron Emission Tomography 
(PET) radiomics was first reported in 2009. In recent years, Fluorine-18-labeled Fluoro-2-deoxy-
D-glucose positron emission tomography-computed tomography, 18F–FDG (PET/CT) has
become a major functional imaging technique in oncology due to its ability to evaluate tumor stage 
and metabolic characteristics with high specificity and sensitivity [7, 8].  
Since the start of 18F–FDG PET clinical application, there has been a rapid growth in the 
number of studies that employed Standardized Uptake Values (SUV) as a primary imaging 
biomarker for uptake heterogeneity quantification. Such studies employed maximum, mean and 
peak SUVs (SUVMAX, SUVMEAN, and SUVPEAK, respectively) as biomarkers for prediction [9], 
diagnosis, and monitoring of treatment response [10].  
In addition to SUV measurements, Metabolic Tumor Volume (MTV) is another biomarker 
that has been reportedly shown to have predictive significance for clinical outcomes. Some studies 
have demonstrated the ability of MTV to quantify heterogeneity of PET uptake in the detection of 
pelvic lymph nodes in cervical cancer [11, 12] as well as in the association with treatment response 
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[13] within the same site. Other studies focused on investigating the performance of SUV to 
predict for survival endpoints or treatment outcomes of cervical cancer, and head and neck 
tumors [14]. However, relying solely on semi-quantitative measurements such as SUV or MTV 
has been shown to run into several pitfalls. For example, in addition to radiotracer dose 
sensitivity, SUV measurements are profoundly influenced by the distribution of radiotracer 
uptake, delayed time of injection, and imaging acquisition and reconstruction parameters [15]. 
These factors can potentially cause substantial treatment assessment uncertainty. 
As an alternative, several studies [16] proposed quantitative imaging features, such as 
radiomic features, as a surrogate to overcome such pitfalls. Textural features, a type of radiomic 
features, are extracted from statistical matrices based on local intensity spatial distribution 
relationships. They are thought to be independent of tumor size, position, and time of imaging 
[17]. These characteristics made textural features superior to SUV measurements regarding tumor 
heterogeneity characterization. Also, shape features (SF), which describe geometrical 
characteristics of tumors, have shown to provide a morphological characterization of PET uptake 
heterogeneity within a specified volume of interest [18, 19].   
Recent studies have emphasized the higher discriminatory power of several radiomic features 
in comparison to SUV measurements regarding classification of tumor versus benign regions in 
the lung, and head-and-neck patients [20], as well as for the prediction of cervical cancer 
treatment outcomes [21]. Radiomic features were also reported as a significant tool to stage 
cervical cancer based on tumor heterogeneity information [22].  Along the same line, Cheng et al. 
[23] reported that uniformity, a GLCM feature, might serve as an independent prognostic 
predictor as well as risk stratification descriptor for patients with oropharyngeal squamous cell 
carcinoma. Another study investigated the physiologic reproducibility of textural features by 
characterizing the tumor F18-FDG uptake heterogeneity in the PET scans of forty-one esophageal 
cancer patients [24].  
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All the findings mentioned above indicates that quantitative assessment of tumor uptake 
heterogeneity based on PET 18F–FDG images is a promising method to investigate intra- and 
inter-tumor characteristics. With such encouraging results, the focus is shifting toward examining 
the reproducibility of radiomic features due to various factors that might potentially affect their 
performance. The most challenging of these factors is the definition of tumor volume. An 
extensive review study by Foster et al. [25] identified five sophisticated procedures of PET tumor 
segmentation, namely manual segmentation, thresholding-based methods, learning methods and 
stochastic modeling-based techniques, region-based (graphical-based) segmentation methods, 
and boundary-based methods. The study concluded that there is no notion of one acceptable PET 
image segmentation method over the other. Also, it was suggested that further research is needed 
to come to a conclusion of an optimal method for PET segmentation. For more studies with efforts 
to enhance methods of tumor segmentation on PET scans, the reader is encouraged to review 
these articles [26-29]. 
In this study, we explored the differences between using graphical- and boundary-based 
methods in comparison to the manual method for segmenting the cervical tumor volumes on PET 
scans. Since the introduction of tomographic reconstruction application to medical imaging in the 
late 1960s, research work has progressed to enhance image formation. In recent years, varying 
reconstruction methods have evolved into sophisticated algorithms with various image qualities 
due to modern computing. A study by Galavis et al. [30] showed that different acquisition modes 
and image reconstruction settings might cause variation in radiomic features.  Similarly, the gray-
level discretization of PET/CT images has been shown to have a high impact on some radiomic 
features [31].  
All the mentioned studies investigated the reproducibly of radiomic features in different body 
sites. To our knowledge, the reproducibility of radiomic features in cervical cancer tumors has not 
been widely reported.  Thus, the purpose of this work was to investigate the sensitivity of radiomic 
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features with regard to three critical parameters: segmentation methods, gray-levels 
discretization, and PET reconstruction algorithms. The rationale was to develop a group of 
radiomic features that might serve as robust biomarkers for cervical cancer outcome assessment. 
3.2 Materials and Methods 
Details of PET image acquisition technique have been provided previously in chapter 2 
(section 2.2; Table 2.3). 
3.2.1 Patient Demographics 
Our dataset consisted of pretreatment PET/CT scans of eighty-eight patients (age range: 31-
76 years) from the original cohort (Table 2.1). We used eighty patients for segmentation methods, 
and gray-level testing and eight for reconstruction algorithm testing. All patients were treated, 
and FIGO staged [32] according to the method explained in section 2.1.  
This research study acquired the approval of our institutional review board (IRB) at the 
University of South Florida. All of the patients’ pretreatment PET/CT scans were performed in 
the Radiology Department of Moffitt Cancer Center on the same Discovery STE® hybrid PET/CT 
scanner (General Electric Medical Systems, Milwaukee, WI, USA) [33] and under the same 
institutional F18-FDG administration protocol.  
PET images had a slice thickness of 3.30 mm and spatial resolution of 5.47 × 5.47 mm/pixel 
and were acquired after 60 minutes of injection with 6 MBq/kg of 18F-FDG. The PET images were 
reconstructed using 3D maximum likelihood ordered subsets expectation maximization (ML–
OSEM) with two iterations and 28 subsets. All of PET images were corrected for attenuation and 
then converted to SUV units (g/ml). 
3.2.2 Method of Tumor Segmentation 
In a measurement error study, we often consider the observers as a random sample from a 
larger population of potential observers who may be used in future studies or clinical practice 
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[34]. In the present study, we treated each segmentation method as a different observer of the 
tumor volume. In this case, we were not interested in drawing conclusions about the performance 
of a particular segmentation method, the observer, but only in the information provided by the 
effect of their variation on radiomic features. For the purpose of segmentation methods and gray-
level effect analysis, two board-certified radiation oncologist manually delineated the metabolic 
tumor volume (MTV1, MTV2) in the uterus and cervix regions based on the F–18 FDG uptake in 
pretreatment PET scans.  
The oncologists utilized CT scans and patient-specific histopathological reports for guidance 
to differentiate between cervix, bladder, and other surrounding organs. Both MTVs were 
generated using Mirada Medical DBx®, Oxford, UK. Due to the lack of a ground truth for tumors, 
we chose MTV1 to be the reference, gold standard, tumor volume due to the physician’s 
experience. Subsequently, we generated semi-automated graphical-based volumes (GBSV) based 
on the method reported by Beichel et al. [35]. For further information about this method, the 
reader is encouraged to review the cited article. This approach is implemented as an extension for 
3D Slicer software, an open-source software package to visualize and analyze medical images. We 
studied the effects of RA variation on radiomic features extracted from the GBSVs. 
3.2.3 Method of Gray Intensity Level Discretization 
This preprocessing step is essential since the value of the extracted radiomic features varies 
widely from each other. Also, it helps to reduce image noise by normalizing intensities across all 
patients’ images or tumor volumes. Therefore, it allows for a direct comparison of all calculated 
radiomic features among patients.  
To investigate the effect of gray-level, image intensity values, discretization on radiomic 
features, we down-sampled the tumor volumes for each patient into three gray-levels 32, 64, and 
128 in addition to the original 256. Using such fixed numbers of discrete resampled values, a 
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3.1) 
number of bins divide the image SUV range into equally spaced intervals. Therefore, the bin sizes, 
intensity resolutions, of the discretized volumes depended on the SUV range (i.e., four bin sizes 
for each gray-level) as indicated by equation  ) 3.1): 
 minmaxSizeBin 
Ng
SUVSUV −
=
where Ng is the number of gray-level bins. 
3.2.4 PET Reconstruction Algorithms 
One of the goals of this study was to focus on the effect of common PET reconstruction 
algorithms on radiomic features, but not to discuss the difference between them. For references 
on medical image reconstruction, the interested reader is encouraged to read [36, 37]. In addition 
to ML-OSEM, the conventional iterative reconstruction (IR) algorithm in GE Discovery STE 
scanners, we explored the impact of three additional reconstruction settings (Figure 3.1) on 
radiomic features: Fourier rebinned FORE-IR, FORE-filtered backprojection reconstruction 
(FORE-FBP), and three-dimensional reprojection algorithm (3DRP). 
3.2.5 Radiomics Analysis 
In a recent study, Kumar et al. defined radiomics as [38] “the extraction and analysis of large 
amounts of advanced high throughput of imaging features with high throughput from medical 
images obtained with computed tomography, positron emission tomography or magnetic 
resonance imaging. Importantly, these data are designed to be extracted from standard-of-care 
images, leading to a considerable potential subject pool”.  
Radiomic features can be divided into different categories according to their method of 
feature extraction. The most common ones are textural and shape features. The intensity 
arrangements found in a region of interest (ROI) within an image can have various patterns, 
which can hold valuable information about the ROI (e.g., tumor volume).  
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Figure 3.1. PET image variations due to different reconstruction algorithms (RA): (a) Maximum 
Likelihood-Ordered Subset Expectation Maximization Iterative (IR) Method (ML-OSEM), (b) Fourier 
Rebinning- ML-OSEM (FOREIR), (c) FORE-Filtered Back Projection (FORE FBP), and (d) Three-
Dimensional Reprojection (3DRP). The slice position, field of view and viewing contrast level were 
fixed for all RAs before acquiring the images. 
    These patterns are often called a texture.  A textural feature of a radiological image 
describes the spatial relationships among the gray intensity levels of voxels; textural analysis is, 
therefore, the mathematical extraction of textural features and their subsequent correlation of 
biological or clinical variables. On the other hand, shape-based features are calculated to 
describe the morphological characteristics of ROIs. Recently, all the mentioned quantitative 
imaging features are referred to as radiomic features. We developed in-house software to 
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GL (64-32) GL (64-128) GL (64-256)
IDM (GLCM) 0.997 0.996 0.822
Diff. Entropy(GLCM) 0.956 0.910 0.838
SRE (GLRLM) 0.948 0.920 0.892
RPC (GLRLM) 0.951 0.945 0.884
SAE (GLSZM) 0.799 0.695 0.638
0.00
0.09
0.18
0.27
0.36
0.45
0.54
0.63
0.72
0.81
0.90
0.99
1.08
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process and quantify PET scans, and to calculate the five commonly implemented methods of 
feature extraction. In total,  we extracted seventy-five radiomic features according to the 
methods described in chapter 2 (section 2.5). 
3.2.6 Statistical Analysis 
As previously mentioned, MTV1 was chosen as the reference volume. To assess 
segmentation accuracy, we computed the Dice coefficient between the semi-automatic 
and manual segmentations. For the segmented volumes MTV1, MTV2, and GBSV, the Dice 
coefficient is given by the following equation:  
DC = (2|MTV1 OR 2 ∩ GBSV|) / (| MTV1 OR 2|+|GBSV|) 
To assess the level of agreement between both experts; we reported the Dice coefficient 
based on their observation of the same tumor. We generated matrices of inter-item 
correlation coefficients (IIC) [39-41] to determine the reference gray-level. Since gray-level 64 
demonstrated the highest IIC in comparison with all gray-levels (Figure 3.2).  
Figure 3.2. Inter-item correlation coefficient (IIC) among Reference gray-level 64 (GL-64) relative to GL-
32,128,256. The plots show IIC of several radiomic features extracted from the metabolic tumor volume 
(MTV) after down-sampling. It is noticed that IIC is minimum between GL 64 and GL 256. GLCM, Gray 
Level Co-occurrence Matrix; GLRLM, Gray Level Run Length Matrix; GLSZM, Gray Level Size Zone Matrix; 
IDM, Inverse Difference Moment; Diff. Entropy, Difference Entropy; SRE, Short Run Emphasis; RPC, Run 
Percentage; SAE, Size Area Emphasis. 
(3.2) 
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(3.3) 
(3.4) 
      We investigated the reproducibility of each feature through the first parameter by 
pairing the reference tumor volume with the other two volumes (MTV1 – MTV2 and MTV1-
GBSV). For the second parameter, we paired each of the three distinct gray-levels with the 
reference (64–32, 64–128, and 64–256) and for the third, we paired ML-OSEM with FORE-
OSEM, FORE-FBP, and  3DRP.  We studied and reported each test separately.  
We expressed the difference between radiomic feature values measured from each element 
of the testing parameters by the mean percentage difference | d | by the equation (3.3) below:  
%100
2)(
d ×
+
−
=
nm
nm
ff
ff
where fm and fn represent features extracted from first and second segmentation methods, gray-
level or reconstruction algorithms. Bland–Altman analysis is a graphical method to quantify the 
agreement between two quantitative measurements by studying the mean difference within which 
95% of the difference between the second measure in comparison to the first measure fall [42]. 
We used the Bland-Altman analysis to evaluate the mean, standard deviation (SD), and upper/
lower reproducibility limits  (URL/LRL), equation (3.4) and (3.5),  for radiomic features in 
response to variation in each testing parameter [43-45].   
 SD)(1.96  -Mean    LRL
)96.1(MeanURL
×=
×+= SD
(3.5) 
     The bias between measurements is often estimated by the mean difference |d| and its 
associated standard deviation (SD).  In this study, we used |d| as an indicator for radiomic 
feature reproducibility level, where any feature scored |d|±SD |25|±35% was considered 
reproducible. Furthermore, we proposed the use of U/LRL as criteria to classify the levelof 
reproducibility: High— ±1% ≤ U/LRL ≤ ±30%; Intermediate— ±30% < U/LRL ≤ ±45%; Low—
±45 < U/LRL ≤ ±50%.
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(3.6) 
       We considered any feature below the low level as non-reproducible (NR).  We based this 
approach on methods reported in several clinical studies [34, 42-44]. Also, Galavis et al. [30] 
used a similar scale to categorize the features based on their variation, and Tixier et al. [31] 
indicated that such limits were referenced to previously defined reproducibility limits for 
standard uptake values.  
Finally, we calculated the Interclass Correlation Coefficient (ICC) to evaluate the reliability 
of radiomic feature measurements from each parameter. A perfect agreement is indicated by an 
ICC value of 1.0. The 95% confidence intervals were also calculated. The precision of ICC (Eq. 3.6) 
served as a basis for evaluating the reproducibility of measurements in each case [39]. 
𝑃𝑃𝑃𝑃𝑒𝑒𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 = ℎ𝑎𝑎𝑎𝑎𝑎𝑎 𝑤𝑤𝑃𝑃𝑤𝑤𝑤𝑤ℎ 𝑃𝑃𝑎𝑎 𝐶𝐶𝐼𝐼 × 100 = �(95% 𝐶𝐶𝐶𝐶 𝑈𝑈𝑈𝑈−95% 𝐶𝐶𝐶𝐶 𝐿𝐿𝑈𝑈)
2
� × 100 
Where CI represents Confidence Interval; UB and LB represent upper and lower bounds, 
respectively. We considered a p-value of less than 0.05 as statistically significant for all the tests 
in this study.  
Finally, we explored the method used in Shafiq et al. [46] to correct for the dependency of 
radiomic features on voxel size (volume) and gray-level discretization. All statistical analyses were 
performed using SPSS (Version 22; IBM Corporation; Armonk, New York, U.S.) and MedCalc 
Statistical Software version 17.6 (MedCalc Software, Ostend, Belgium).  
3.3 Results 
The GBSVs of sixty-five patients (81.25% of the cohort) scored Dice coefficients > 0.75 when 
associated with both manual segmentation, yet the association with MTV1 was slightly higher (4% 
higher on average). Supplementary table S.1. (Page 120) shows the detailed segmentation 
accuracies categorized based on increasing values of MTV1.  As noticed from table S.1, Dice 
coefficients were low for both small (volume ≤ ~ 15 cm3) and large tumors (volume ≥ 160 cm3). 
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For a fair comparison, we only included highly accurate tumor volumes (DC> 0.75, n = 65). 
Finally, we reported the results of gray-level discretization based on resampling the GBSVs. The 
following subsections, we will report the reproducibility of radiomic features through each testing 
parameter separately.   
3.3.1 Reproducibility of Radiomic Features through Segmentation Methods
       Among the 26 local heterogeneity features extracted using GLCM (Table S.2a, page 122), 
eight features (31%) showed high reproducibility, two (7%) showed intermediate reproducibility, 
and two (7%) showed low reproducibility. The rest of GLCM features (55%) were not 
reproducible. We also found that IDM holds the highest reproducibility among all methods 
(Table 3.1, Figure 3.3 a-b). IDM scored an ICC of 0.90 with a precision of 5%.
The ICCs, associated 95% CIs, and precision for the rest of the features are summarized in 
table 3.2. Out of the 11 regional features extracted using GLRLM (Table S.2b, page 122), only three 
features (27%) were reproducible. Short run emphasis (SRE) (Figure 3.3 c-d) had the highest 
reproducibility and ICC (Table 3.2) of 0.89 with a precision 6.5%. 
Table 3.1. Bland Altman table for the highest reproducible radiomic features as a function of 
segmentation methods (SM). 
MTV1 – GBSV MTV2 – GBSV 
Feature | d |% ± SD% LRL URL | d |% ± SD% LRL URL 
IDM 0.03 ± 2.11 -2.76 2.69 1.20 ± 2.18 -2.89 1.57 
ID 0.10 ± 2.49 -5.17 4.97 2.20 ± 5.41 -5.29 2.89 
Summation Entropy* 0.54 ± 25.15 -23.16 21.56 1.08 ± 14.52 -11.01 9.92 
Entropy* (2nd order) 0.03 ± 18.43 -24.14 22.93 0.79 ± 15.01 -10.87 10.41 
Mean** (2nd order) 2.08 ± 3.57 -13.35 9.18 3.85 ± 2.54 -17.45 9.75 
IMC2  3.37 ± 6.61 18.31 16.91 3.02 ± 10.21 -20.06 14.03
SRE 0.17 ± 2.89 -1.45 1.79 0.42 ± 2.24 -1.33 2.18 
RPC 1.16 ± 10.43 -10.01 7.69 1.84 ± 8.09 -9.14 10.96 
Sph. D 6.31 ± 3.89 -13.53 26.15 5.01 ± 3.50 -15.80 25.81 
LRL and URL = lower and upper reproducibility limits, respectively; ID, IDM: Inverse Difference, and 
Inverse Difference Moment; IMC.1, 2: Information Correlation Method 1, and 2 (GLCM); SRE: Short Run 
Emphasis (GLRLM); RPC: Run Percentage (GLRLM); Sph. D.: Spherical Disproportion (SF); 
*Corrected for volume and gray-level dependence; ** Corrected for volume and gray-level dependence.
34 
Among the seven shape-based Radiomic features (Table S.2e, page 122), four (57%) had 
high reproducibility, while one (14%) showed low reproducibility. Tumor volume asphericity 
showed high reproducibility through segmentation methods. Spherical disproportion was also 
reproducible with test outputs close to the one for tumor volume asphericity. All the 11 regional 
features extracted using GLSZM showed high sensitivity to variation in segmentation methods. 
However, High- Intensity Emphasis HIE and Zone Percentage ZP (Table S.2c, page 122) 
were the only features to show intermediate reproducibility after correction for gray-level 
dependence. Only one IVH features (Table S.2f-g, page 122), Intensity entropy, showed high 
reproducibility. Finally, all the NGTDM features showed high sensitivity to segmentation 
methods. 
Table 3.2. Reliability of radiomic features through segmentation methods (SM) using ICC. 
Type Feature ICC 95% UCI 95% LCI Precision 
Entropy* 0.97 0.95 0.98 ±1.5% 
Summation entropy* 0.81 0.70 0.88 ±9% 
Information correlation method 2 0.73 0.67 0.82 ±7.5% 
Local Mean** 0.91 0.86 0.94 ±4% 
Inverse difference moment 0.90 0.84 0.94 ±5% 
Inverse difference 0.85 0.72 0.92 ±10% 
Difference entropy* 0.84 0.75 0.89 ±7% 
Run percentage 0.92 0.84 0.92 ±4% 
Regional Short run emphasis 0.93 0.80 0.93 ±6.5% 
High intensity emphasis 0.73 0.58 0.81 ±11.5% 
Shape & Spherical disproportion 0.92 0.86 0.95 ±4.5% 
Intensity Asphericity 0.91 0.85 0.94 ±4.5% 
Intensity entropy 0.85 0.79 0.92 ±6.5% 
3.3.2 Reproducibility of Radiomic Features for Different Nnumbers of Gray-Levels 
       The goal of this part was to measure reproducibility limits and absolute agreement between 
radiomic features extracted from multiple gray-levels of the down-sampled GBSVs. We did not 
test shape-based features or intensity histogram features for gray-level dependence since the 
down-sampled tumor volume was fixed and, therefore, the shape and geometrical aspects were 
not affected. In general, radiomic features have small mean percentage difference (Figure 3.4),  
SD, and L/URL among gray-level pairs 64–32 and 64–128 in contrast to 64–256. 
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Figure 3.3. Bland–Altman plots for two of the most reproducible radiomic features through manual vs. 
the semiautomatic segmentation graphical-based methods (GBSV). Bland–Altman plots for: (a-b) Inverse 
Difference Moment IDM (MTV1 – GBSV) and (MTV2 – GBSV). (c–d) Short Run Emphasis SRE (MTV1 – 
GBSV) and (MTV2 – GBSV). 
Following the same approach in the previous subsection, fewer features passed this testing 
parameter in contrast to the first one. Among GLCM features, two (18%) were highly reproducible 
through all gray intensity levels. IDM (Table 3.3, Figure 3.5 a-c) was the highest reproducible GLCM 
feature with a mean difference (|d|±SD) equals to 0.1±2.7 and L/URL range below 6% (ICC 0.98; 
precision < 6%).  Entropy, difference entropy and summation entropy (Supplementary Table 
S3.a) showed  high reproducible levels among gray-level pairs of 64-32 and 64-128 but 
intermediate reproducibility for gray-level pair 64-256.  
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2nd-order-mean showed intermediate reproducibility after correction for volume and 
gray-level dependence. Dissimilarity was the only feature to show low reproducibility. The rest of 
GLCM features (69%) were not reproducible. The ICCs, associated 95% CIs, and precision are 
summarized in Table 3.4. Among GLRLM features, two (18%) were highly reproducible. In 
concordance with the result from the previous test, SRE and RPC (Supplementary Table 3.B) were 
the highest reproducible GLRLM features. The rest of GLRLM features (54.5%) were not 
reproducible. None of the GLSZM or NGTDM features showed reproducibility limits range 
compared to other calculation methods, and therefore all the features under these two methods 
were considered sensitive to the discretization of gray-level. 
Table 3.3. Bland Altman table for the highest radiomic features as a function of gray intensity levels (GL) 
for the graph-based segmented volume (GBSV). 
LRL and URL = lower and upper reproducibility limits, respectively, * Corrected for GL dependence. 
** Corrected for volume and gray-level dependence 
Feature GL pairs |d|% ± SD% LRL URL Level of Reproducibility 
Inverse difference 
moment
64 – 32 
64 – 128 
0.01 ± 0.04 
0.12 ± 0.29 
-1.22 
-1.92 
1.23 
2.15 High 
64 – 256 0.15 ± 0.02 -1.78 1.94
Inverse difference 
64 – 32 
64 – 128 
0.04 ± 0.230 
0.2 ± 0.144 
-1.22 
-1.92 
1.23 
2.15 High 
64 – 256 0.15 ± 0.07 -1.78 1.94 
Short run emphasis 
64 – 32 
64 – 128 
2.38 ± 4.03 
1.19 ± 3.32 
-0.01 
-2.67 
4.78 
0.29 High 
64 – 256 1.87 ± 4.40 -3.53 -0.22 
64 – 32 0.93 ± 15.35 -34.58 36.45 
Intermediate Mean** 64 – 128 3.58 ± 6.50 -39.32 41.48 
64 – 256 6.08 ± 10.73 -42.00 45.06 
64 – 32 3.62 ± 7.14 0.09 7.14 
High 
High 
Run percentage 64 – 128 1.49 ± 7.01 -5.02 2.02 
64 – 256 2.30 ± 10.20 -6.92 2.31 
64 – 32 0.63 ± 0.08 -10.57 11.82 
Entropy* 64 – 128 9.82 ± 0.03 -9.19 28.84 
64 – 256 5.78 ± 1.81 -30.62 42.17 Intermediate 
64 – 32 18.43 ± 5.50 7.84 29.44 
High Summation entropy* 64 – 128 13.50 ± 8.57 -30.44 3.43 
64 – 256 21.97 ± 10.74 -43.16 -0.80 Intermediate 
64 – 32 0.69 ± 6.03 -8.87 7.48 
High Difference entropy* 64 – 128 9.82 ± 8.76 9.19 28.84 
64 – 256 5.80 ± 12.20 -30.97 42.58 Intermediate 
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Table 3.4. Reliability of radiomic features through gray intensity levels (GL) using ICC. 
Type Feature ICC 95% UCI 95% LCI Precision
Inverse difference moment 0.96 0.93 0.98 ±2.5% 
Inverse difference 0.92 0.90 0.94 ±2% 
Local Information correlation method 2 0.72 0.65 0.90 ±12.5% 
Mean** 0.85 0.82 0.94 ±6% 
Entropy* 0.72 0.75 0.83 ±4% 
Summation entropy* 0.70 0.67 0.79 ±6% 
Difference entropy* 0.81 0.67 0.86 ±9.5% 
Regional Run percentage 0.89 0.73 0.91 ±9% 
Short run emphasis 0.72 0.64 0.87 ±11.5% 
Long run emphasis 0.80 0.70 0.83 ±6.5% 
* Corrected for GL dependence. ** Corrected for volume and gray-level dependence
Figure 3.4. A plot of the standard deviation (SD) of the mean percentage difference (d) for the 
top seven reproducible radiomic features as a function of discretization IDM, Inverse Difference 
Moment; ID, Inverse Difference; SRE, Short Run Emphasis; RPC, Run Percentage; LRE, Long Run 
Emphasis. 
GL64-32 GL64-128 GL64-256 
IDM 0.04 0.14 0.01
ID 0.05 0.29 0.02
SRE 0.44 0.36 0.48
RPC 0.77 0.76 1.10
Entropy 0.56 0.93 1.19
Summation Entropy 0.49 2.16 0.60
Difference Entropy 0.67 0.98 1.36
LRE 1.63 2.10 2.12
SD
 o
f |
d
| (
%
) 
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Figure 3.5. Demonstration of the reproducibility of radiomics through different gray levels (GL). Bland–Altman plot of 
Inverse Difference Moment (IDM), which is extracted from the resampled semiautomatic graphical-based segmentation 
volumes (GBSV) to: (a) GL 64-32, (b) GL 64-128, and (c) GL 64-256. 
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3.3.3 Reproducibility of Radiomic Features through Different PET Reconstruction 
Algorithms 
In comparison to the segmentation methods and gray-levels, radiomic features showed 
highest variations as a function of reconstruction settings. Following this approach mentioned 
above, some of the features that presented small variations for this parameter (Supplementary 
Table S.4a-d) are the entropy, 2nd-order-mean, and some NGTDM features such as coarseness, 
complexity, and contrast.  
Figure 3.6 shows 2nd-order-mean as an example of such performance. More than twenty 
features showed a large range of variations, some of these include HIE, GLNU, texture strength 
and busyness, which have been commonly used in previous clinical studies.  
Most of the radiomic feature within the scope of this study showed high sensitivity to 3DRP 
reconstruction algorithm; the highest reproducible features are listed in Table 3.5. The reliability 
of radiomic features through reconstruction algorithms RA using ICC are found in Table 3.6. The 
nine reproducible radiomic features through all parameters are summarized in the colored-coded 
map in Figure 3.7 (a). Also, the six-reproducible shape feature through segmentation methods 
and reconstruction algorithms are summarized in Figure 3.7 (b). 
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Table 3.5. Bland Altman table for the highest radiomic features as a function of PET image reconstruction 
algorithms (RA).  
Feature RA pairs Mean ± SD LRL URL Level of Reproducibility 
Inverse difference 
moment 
OSEM-FOREIR -0.04 ± 15.67 -0.34 0.37 High OSEM-FOREFBP -0.31 ± 10.34 -0.26 0.26 
OSEM-3DRP -1.02 ± 10.17 -0.14 0.014 Intermediate 
Inverse difference 
OSEM-FOREIR 0.15 ± 0.99 -0.44 0.76 High 
OSEM-FOREFBP -0.31 ± 0.97 -0.54 0.52 
OSEM-3DRP 4.33 ± 1.42 -0.49 0.21 Intermediate 
Short run emphasis 
OSEM-FOREIR -0.09 ± 0.48 -4.25 11.46 High 
OSEM-FOREFBP 0.83 ± 3.37 -8.76 4.10 
OSEM-3DRP -23.04 ± 8.18 -12.42 4.82 NR 
Run percentage 
OSEM-FOREIR -0.30 ± 8.24 -7.88 19.94 High 
OSEM-FOREFBP -0.22 ± 20.25 -17.77 9.70 
OSEM-3DRP -25.61 ± 31.60 -26.45 13.56 Intermediate 
Mean** 
OSEM-FOREIR -0.29 + 8.87 -1.30 0.73 High OSEM-FOREFBP -4.92 + 8.45 -15.36 5.52 
OSEM-3DRP 1.96 + 8.08 -28.55 32.47 Intermediate 
Entropy* 
OSEM-FOREIR -1.44 ± 16.66 8.90 28.65 High OSEM-FOREFBP -0.39 ± 17.22 -30.28 3.19
OSEM-3DRP -29.47 ± 17.99 -43.05 -1.17 NR 
Summation entropy 
OSEM-FOREIR -9.06 ± 14.29 7.84 29.44 High OSEM-FOREFBP -10.61 ± 14.55 -30.44 3.43
OSEM-3DRP -19.35 ± 10.74 -43.16 -0.80 Intermediate 
Difference entropy* 
OSEM-FOREIR 5.31 ± 10.01 6.00 30.06 High 
OSEM-FOREFBP 8.93 ± 10.62 -30.72 4.42
OSEM-3DRP 10.72 ± 19.07 -45.84 2.75 Intermediate 
Information 
correlation method 2 
OSEM-FOREIR -1.41 ± 2.01 -5.44 32.48 High OSEM-FOREFBP -1.29 ± 2.47 -31.98 3.31 
OSEM-3DRP 4.96 ± 3.82 -51.87 3.15 Intermediate 
Long run emphasis 
OSEM-FOREIR 1.21 ± 0.48 -54.19 21.87 High OSEM-FOREFBP 0.83 ± 3.37 -19.52 39.58
OSEM-3DRP -23.04 ± 8.18 -22.01 54.70 NR 
* Corrected for GL dependence. ** Corrected for volume and gray-level dependence
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Figure 3.6. Bland–Altman plots for second-order mean (GLCM) as a function of reconstruction algorithms (RA). The plots demonstrate 
the trend of high reproducibility between RA pairs OSEM-FOREIR and OSEM-FOREFBP, but low reproducibility for the RA pair 
OSEM-3DRP. This trend was noticed for the majority of radiomic features. ML-OSEM, Maximum Likelihood-Ordered Subset 
Expectation Maximization Iterative (IR) Method; FOREIR, Fourier Rebinning-ML-OSEM; FORE FBP, FORE-Filtered Back Projection; 
3DRP, Three-Dimensional Reprojection. 
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Table 3.6. Reliability of radiomic features through reconstruction algorithms RA using ICC. (3DRP is 
excluded) 
Type Feature ICC 95% UCI 95% LCI Precision 
Inverse difference moment 0.94 0.80 0.98 ±9% 
Inverse difference 0.97 0.90 0.99 ±4.5% 
Local Information correlation method 2 0.77 0.45 0.89 
±22% 
Mean** 0.83 0.79 0.94 ±6.5% 
Entropy* 0.84 0.68 0.96 ±14% 
Summation Entropy* 0.84 0.70 0.96 ±13% 
Difference Entropy* 0.78 0.76 0.95 ±9.5% 
Regional Run percentage 0.90 0.74 0.97 ±11.5% 
Long run emphasis 0.73 0.65 0.80 ±7.5% 
Short run emphasis 0.82 0.73 0.94 ±10.5% 
* Corrected for GL dependence. ** Corrected for volume and gray-level dependence
3.4 Discussion 
The promise of radiomics, as with other –omics, is the provision of robust markers for 
personalized medicine applications. One of its potential applications might be in predicting and 
tracking clinical outcomes for various therapy modalities. Mu et al. [22] observed a high 
association between textural features on baseline 18F–FDG PET and tumor staging in cervical 
cancer. The study focused on primary tumor volumes because of the limited resolution of PET 
images, which did not reproduce significant heterogeneity in small lymph nodes. On a similar 
note, Elnaqa et al. [21] reported several logistic regression models of radiomic features, with good 
prediction power, for cervical cancer treatment outcomes. However, it was suggested that further 
testing and validation using large datasets is required. Although the use of radiomic features as 
markers for prediction of treatment outcomes, tumor staging, or monitoring response is a rising 
application of F18-FDG PET; investigating the reproducibility, reliability, and robustness of such 
markers through physiological or physical parameters have shown to be a step of great 
importance. Several image parameters pose unique challenges in the process of quantifying and 
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(a) 
(b) 
extracting useful information from the tumor’s FDG uptake [47]. In the present study, we 
explored the effect of three of these challenging parameters, segmentation methods, gray intensity 
levels, and reconstruction algorithms, on radiomic features extracted from pretreatment 18F-FDG 
PET scans of cervical cancer patients.  
 
 
 
 
 
 
 
 
 
 
Figure 3.7. (a) Local (second order) and regional (higher order) radiomic features that showed 
reproducibility through all testing parameter (SM: Segmentation Method, GL: Gray Level and RA: 
Reconstruction Algorithm). IDM, Inverse Difference Moment; ID, Inverse Difference; IMC2, Information 
Measure of Correlation II; SRE, Short Run Emphasis; RPC, Run Percentage; RLNU, Run Length Non-
Uniformity; LRE, Long Run Emphasis; HIE, High-Intensity Emphasis; Zp, Zone Percentage. (b) Shape-
based radiomic features (SF) that showed reproducibility through SM and RA. GL was not included because 
it does not affect shape-based features. Sph. Disprop, Spherical disproportion. *Corrected for grey-level 
discretization with (a) for GL dependence. **Corrected for gray-level discretization and voxel size with (b) 
corrected for GL and volume dependence. 
According to our results, we found that segmentation of cervical tumors revealed challenges 
due to difficulty in isolating the tumor from adjacent organs, such as bladder and rectum, with 
similar signal intensities on PET and CT scans. This finding is concordant with another study by 
Wei et al. [48].  To examine the impact of cervical tumor volume variations on radiomic features, 
we employed two manual volumes segmented by two expert radiation oncologists and one semi-
automatic segmented volume. The Just-Enough-Interaction (JEI) graphical-based semi-
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automatic segmentation approach offered minimal operator interaction and a high degree of 
automation. To measure the accuracy of tumor segmentation, we overlapped the voxel intensity 
maps of each tumor pair and calculated the Dice coefficient as a measure of segmentation 
similarity. Since MTV1 was closer to GBSV in most cases, the majority of radiomic features showed 
slightly higher (4%) reproducibility between MTV1-GBSV than MTV2-GBSV. The detailed 
comparison is found in supplementary table S.1.  In addition to graphical-based methods, we also 
explored the performance of a boundary-based method called the geodesic active contours, which 
was first introduced by Caselles et al. [49].  We implemented this approach using an open source 
software called ITK-SNAP [50].  A major challenge of such method is to set several equation 
parameters, primarily the speed function. We tested all four methods available for forming speed 
functions, which are thresholding, classification, clustering, and edge detection methods. 
Threshold-based method, as the name implies, utilize the intensities probabilities based on the 
intensity histogram of the image. For more information about calculating the probabilities for this 
method, the reader is encouraged to read Zhu et al. [51] and Yushkevich et al. [52]. A major 
disadvantage of thresholding method is that the intensity histogram does not provide spatial 
information about the ROIs. Also, there is no consensus on the selection of an optimum threshold 
level because of the large variability of pathologies, low resolution, inherent noise, and high 
uncertainties in fuzzy object boundaries [25]. Moreover, defining tumor volumes based on SUV 
thresholds has been widely challenged [53, 54]. As a requirement for the supervised classification 
based method, we trained three labels based on image intensity (1: tumor volume, 2: bladder, and 
3: other surrounding tissue) on a training set and applied the resulted classifier on a test set. A 
disadvantage of using classification methods is that they do not incorporate spatial information 
into the decision of label generation.  Also, this method required much manual interaction to 
obtain a training data. Therefore, it is both labor-intensive and time-consuming. Nonetheless, the 
segmentation using this speed function for patients with volumes between 49 ~ 100 cm3 was 
acceptable (DC>0.75). Otherwise, the volumes highly varied when compared with manual 
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volumes.   In contrast to classification method, the clustering method is an unsupervised method 
that does not require training labels (classes). Edge detection speed functions are given by the 
image grayscale gradient, where the volume of interest is separated from the surrounding object 
in the image by edges, i.e., strong intensity discontinuities. The main limitations of the edge based 
contours are its leakage past weak edges in proximity to surrounding organs and its long 
processing time. The tumor volumes generated using clustering and edge methods captured 
intensities from both bladder and rectum, which resulted in highly variant tumor volumes. Within 
the framework of this study, the only method with just enough interaction that showed high 
accuracy in comparison to the manual segmented volume was the graphical-based method. Also, 
it was the only method to show full separation between the tumor and the adjacent organ with 
minimum, if any, operator involvement (Figure 3.8). However, this method might need 
improvement for small tumor volume (≤ 16 cm3) with low uptake, and large volume (≥ 160 cm3) 
with very high uptake with proximity to surrounding organs. 
Figure 3.8. Comparison between (a) geodesic active contour method with a classification speed 
function (blue volume), and (b) semiautomatic graphical-based method (GBSV) for the same tumor volume 
(red volume). In contrast to GBSV, the geodesic active contour method often captures intensity signals from 
surrounding organs such as the bladder. 
Inverse difference moment IDM (Fig. 6 a, b and Fig. 8 a, b, c) and Inverse Difference ID were 
the most reproducible through all testing parameters. ID and IDM measure the level of local 
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homogeneity within the tumor volume. Their methods of calculation are based on assuming larger 
values for smaller gray tone differences in pair elements within the Gray Level Co-occurrence 
Matrices (GLCM) [17, 55]. Also, they are formulated to have a maximum value when all elements 
in the image are of equal values. Therefore, these features are characterized by high sensitivity to 
the presence of adjacent diagonal elements in the GLCM [55, 56]. These characteristics might lead 
to their remarkable insensitivity toward variation of the studied parameters. We noticed that the 
tumor heterogeneity patterns could be profoundly affected by choice of gray-level. We found 
higher reproducibility among small gray intensity levels pairs (64-32 and 64-128) in contrast to 
lower reproducibility for gray-level pair 64–256 (Supplementary Table S.2) in local features 
(GLCM) and regional features (GLRLM and GLSZM). We noticed that excluding GL-256 would 
increase the precision of ICC by ~ 35%. Also, when resampling the voxel values within the 
segmented tumor volume to a high gray-level value, the elements on the GLCM, GLRLM, GLSZM, 
and NTGDM would read small voxel intensity values relative to the values measured from the 
reference gray-level. This trend is consistent with the one reported by Sassi et al. [57]. 
Consequently, this trend yields large mean percentage differences between feature values 
measured based on different gray-levels, which, in turn, will translate into sensitivity toward this 
parameter (Fig. 5, Fig. 7 and Fig. 9).  
We investigated the reproducibility of several subtypes of GLCM entropy feature since they 
were reported as one the highest reproducible and predictive radiomic features [15, 21, 24]. We 
included: Entropy, Summation Entropy, Difference Entropy in addition to 1st order Entropy 
(Intensity Histogram Entropy). GLCM entropy-based features were strongly affected by the high 
heterogeneity of cervical cancer tumors since they measure the degree of non-uniformity within 
a given region of interest.  
SRE and RPC, GLRLM regional features, showed the highest reproducibility through all 
testing parameters. This result can be explained by the fact that SRE only measures the 
distribution of short runs in the image (region) texture without taking into account gray-level 
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intensity [58]. The high reproducibility of RPC (measures the homogeneity and the distribution 
of runs of an image in a specific direction) can be explained by the fact that gray-level 
discretization does not highly impact the homogeneity of the run. 
On the contrary, most of the regional features calculated based on GLSZM showed sensitivity 
to all testing parameters. These features may be categorized into different subsets. Features that 
focus on small homogenous and low-intensity areas within the tumor volume, SAE, LIE, and 
LISAE, showed high sensitivity to variation in gray-levels. This subset was the lowest reproducible 
among all features within the scope of this study (L/URL: ±100-200%).  
On the other hand, GLSZM features subset that characterizes large homogeneous and high-
intensity areas had a slightly better reproducibility range (L/URL: ±55-90%). However, it was still 
lower than our proposed acceptable reproducibility limits. As previously mentioned, cervical 
tumors are associated with high regional FDG uptake, which might be the reason they perform 
slightly better than the other subset. Also, Tixier et al. [31] reported that high-intensity areas 
correspond to aggressive tumor regions associated with high 18F-FDG uptake while the large 
homogeneous area is thought to be less likely affected by statistical noise or partial-volume effects. 
NGDTM features performed similarly to GLSZM features even after correction for volume and 
gray-level dependency.  
On a similar note, all of the IVH global features tested in this study (e.g., mean, SD, and 
kurtosis) showed a sensitivity toward all testing parameters. This outcome was expected because, 
on the one hand, they have large variations due to their lack of measuring significant information 
of uptake heterogeneity within the given tumor volume, and on the other hand,  because of the 
delicate method used to calculate such features.  We extracted shape-based features (SF) to 
illustrate the morphological characteristics describing the voxel intensity distribution within the 
segmented tumor volumes without taking into consideration spatial relationships between 
neighboring voxels. Since we fixed the volume tested for discretization, all SF showed insensitivity 
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toward gray-level discretization. Finally, the method described by Shafiq et al. did not reflect 
similar results on PET images for most of the corrected radiomic features. However, GLCM 
features showed higher reproducibility after correction for volume and gray-level dependence 
(Supplementary Table 2.A).  
Variations introduced by reconstruction algorithms are different for each scanner vendor. 
These differences add difficulties in comparing results across institutions with different scanners. 
Along the same vein, it creates challenges to generate large patient cohort with similar clinical 
setups. Fortunately, despite this variation, different vendors produced reconstruction algorithms 
that are similar enough to be quantitatively comparable. According to our results, most of the 
radiomic features rely heavily on the choice of image reconstruction algorithm, whereas, 3DRP 
had the least reproducible outputs.  
Standardization and robustness are of utmost importance in this field; we suggest that 
features characterized by insensitivity toward segmentation methods, gray intensity level, and 
reconstruction algorithms (Fig. 12) may contribute as a robust characterizing descriptor of 18F-
FDG uptake heterogeneity and, therefore, might have promising clinical potential. However, such 
features might not demonstrate the same reproducibility in other tumor sites. This site-specific 
study underlines the need for a profound analysis of radiomic features as descriptors of 18F-FDG 
PET heterogeneity in cervical cancer patients treated with definitive radiochemotherapy. 
Accordingly, other site-specific radiomic studies are required to examine the reproducibility of 
the mentioned features in a different tumor site. 
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Figure 3.9. A diagram presenting the number of reproducible radiomic features per testing parameter and 
the common reproducible featured among all tests. The features are categorized into textural and shape 
features (TF and SF, respectively). The reproducibility through the three-dimensional reprojection (3DRP) 
reconstruction algorithm is excluded. SM: Segmentation Method, GL: Gray Level, and RA: Reconstruction 
Algorithm. 
The relatively small cohort of patients might be a limitation of the current study. However, 
this cohort is about the same size, or larger, in comparison to samples in previously published 
reproducibility studies. Finally, although it is a challenging task, we support multi-center 
collaborative efforts that aim to standardize the process of radiomic analysis. 
3.5 Conclusion  
 
This study examined the reproducibility of several radiomic features extracted from 18F-FDG 
PET images of cervical cancer patients in response to the variation of three parameters: 
segmentation methods, gray intensity levels, and reconstruction algorithms. According to our 
results, most of the radiomic features within the scope of this study were highly affected by 
variations of such parameters. Therefore, we suggest that testing the reproducibility of radiomic 
features is essential before proceeding to employ them in any clinical applications.  
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4 CHAPTER 4: INVESTIGATING MULTI-RADIOMIC MODELS FOR ENHANCING 
PREDICTION POWER OF CERVICAL CANCER TREATMENT OUTCOMES 
Note to Reader 
Portions of this chapter have been previously published in the European Journal of Medical 
Physics, 2017, and have been reproduced with permission from Elsevier Publishing. 
4.1 Introduction 
At present, recent research in the expanding field of functional imaging has put a high 
emphasis on the investigation and development of quantitative noninvasive biomarkers given the 
increasing need for robust treatment outcome predictors. 18Fluorine–fluorodeoxyglucose (18F-
FDG) PET imaging has been widely used in oncology as a functional imaging technique to define 
the gross tumor volume, assess its response, and for cancer staging. One of the most common 
semi-quantitative metrics for FDG-PET is the standardized uptake value (SUV) where the 
maximum SUV (SUVMAX) reportedly predicted for overall survival [1], treatment response [2], and 
lymph node involvement [3].  
On the other hand, several studies [4, 5] questioned utilizing SUVMAX as an independent 
prognostic metric due to several measurement uncertainties that might be attributable to its 
sensitivity to variation in tumor volume, initial FDG uptake kinetics and distribution, inter-
observer variability, and in-vivo metabolism.   Therefore, one of the goals of this study was to 
examine the accuracy of the prediction of treatment outcomes based on observed differences in 
the SUVMAX within the primary tumor volume. In addition to SUVMAX, several studies proposed 
SUVPEAK (defined as the maximum of all the mean values computed from placing a spherical 
kernel of approximately 1.2 cm in diameter to yield a ~1 cm3 sphere centered at each voxel within 
the tumor volume) as a potential robust alternative to SUVMAX due to its minimum variability over 
56 
time and relative insensitivity to image noise [6, 7]. The predictive performance of SUVPEAK was 
also investigated in this study.  
The extraction of underlying information from medical images based on quantitatively 
derived features (Radiomics) is presented as a developing process in the field of medical 
oncological imaging [8, 9].  The extracted radiomic features based on image textural and shape 
patterns have been used in tumor staging, the prediction for treatment outcome as well as in the 
process of classification and segmentation of tumor versus normal tissue. El Naqa et al. [10] 
reported several logistic regression models of radiomic features with good predictive power for 
treatment outcomes in cervical cancer patients treated with radiochemotherapy.  However, the 
study suggested that further testing and validation using larger patient datasets were required. 
Tixier et al. [11] demonstrated that analysis of intratumor FDG uptake heterogeneity of baseline 
PET scans using radiomics differentiated, with higher sensitivity than SUV measurements, 
between esophageal cancer patients who showed partial- and no-response to chemoradiotherapy. 
Wei et al. [12] found a strong association between radiomic features extracted from baseline 
FDG PET and tumor staging in cervical cancer. This study focused on primary tumor volumes 
because of the limited resolution of PET images, which did not reproduce significant 
heterogeneity in the smaller lymph nodes. The previous studies concluded that radiomic features 
have superior performance in comparison to SUV measurements regarding clinical outcome 
assessment and tumor heterogeneity description.  
Accordingly,  our motivation was to facilitate a comparison between our experience and 
previous studies in this field to analyze cervical cancer tumor heterogeneity on baseline FDG-PET 
scans retrospectively, and to investigate the ability of multi-radiomic regression models to predict 
for two major treatment outcomes, distant metastases (DM) and loco-regional recurrence (LRR). 
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4.2 Methods and Materials 
4.2.1 Patient Demographics 
This retrospective study consisted of eighty patients from the original cohort (Table 2.1) 
discussed in chapter 2.  We aimed to examine the correlation between radiomic features and two 
treatment outcomes: the development of distant metastasis (DM) and loco-regional recurrence 
(LRR) where both treatment outcomes were set as scalars and conventionally assigned values 0 
and 1. The event DM/LRR = 1 presents the complication after treatment and DM/LRR = 0 is the 
absence of that complication at the specific time point from the end of radiochemotherapy 
treatment. 
We set the start point of the follow-up time for each patient at the date of the initial 
pathological biopsy report, while the time to the clinical treatment outcome was reported based 
on the date of event occurrence.  We used the same imaging procedure and techniques in chapter 
2, section 2.2. 
4.2.2 Method of Metabolic Tumor Volume Segmentation 
We used the validated manual segmentation, named MTV1,(Figure 4.1.a)  discussed in section 
2.4, page 17, and tested for accuracy in section 3.2.2, page 26 for all eighty patients using Mirada 
Medical DBx® software (Mirada Medical DBx®, Oxford, UK).  
4.2.3 Radiomics Analysis 
We used our developed in-house software to process and quantify PET scans and to calculate the 
commonly implemented methods of feature extraction, which we explained in section 2.5. In total, 
we extracted seventy-five radiomic features from each MTV (Figure 4.1.b).  
In addition to the features mentioned above, we measured SUVMAX and SUVPEAK from each tumor 
volume to compare the predictive performances between radiomics and SUV measurements. 
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Figure 4.1. (a) Example of a delineated metabolic tumor volume (MTV) on 18F-FDG PET scans (axial view), 
and (b) an illustration of the heterogeneity pattern analysis of  the MTV using: (I) short and long runs of 
voxel intensities (GLRLM), (II) consecutive voxel directions (GLCM), and (III) size of voxel zones with the 
same intensity (GLSZM). 
4.2.4 Statistical Analysis 
The following subsections describe the method we followed to analyze the radiomic 
features as well as training and testing the resulted predictive models. The steps of this process 
are summarized in Figure 4.2. 
4.2.4.1 Preprocessing of Radiomic Features 
Prior to the extraction of texture features, we resampled all the MTVs to an isotropic voxel 
size using cubic interpolation. Accordingly, we isotropically resampled the FDG-PET based 
volumes with voxel size 5.47 × 5.47× 3.27 mm3 to a voxel size of 5 × 5× 5 mm3. We also tested the 
dependence of radiomic features on voxel size (volume) and gray level discretization (GL) 
according to the method described in Altazi et al. [13] and Shafiq et al. [14], where features were 
corrected for each parameter if necessary. As per the statistical analysis section of chapter 3 
(a) (b) 
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(Figure 3.2), the GL that scored highest among four gray levels (32, 64, 128, and 256) on the inter-
item correlation coefficient (IIC) [15, 16] was GL-64 (for more information about ICC results, the 
reader is referred to subsection 3.2.6, page 30) . Hence, it was selected as a reference GL. Also, 
similar studies [11, 17] reported the same value because it allowed for 0.25 SUV increments for a 
range of SUVs, which is similar to the SUV range of the presented group of patients (~4 – 35).  
Figure 4.2. Flowchart of the proposed approach to generate the final radiomic features multivariate 
logistic regression models. We extracted seventy-five radiomic features from each MTV (eighty patients) 
based on six feature calculation methods: Gray Level Co-occurrence Matrix (GLCM), Gray Level Run-
length matrix (GLRLM), Gray level Size Zone matrix (GLSZM), Neighborhood Gray Tone Difference 
Matrix Method (NGTDM), Shape features (SFs) and intensity-volume histogram (IVH) features.  The 
preprocessing steps included rescaling the features to a standard range [0, 1], investigating trends using 
Spearman’s Rho test, and univariate correlation with treatment outcomes using univariate logistic 
regression modeling. We applied backward feature selection method as part of Leave-One-Out Cross 
Validation (LOOCV) within a training set consisting of 70% of the original patient cohort.  The trained 
MLRs were tested on an independent set consisted of 30% of the original cohort. Finally, we evaluated 
the performance of the final models using the Area under the Receiver Operator Characteristic Curve 
(AUC). 
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4.2.5 Preliminary Analysis 
 In this supervised study, we grouped patients according to treatment outcome (DM–patients 
and LRR–patients) where the association of radiomic features with each outcome was carried out 
separately. We used the independent t-test to estimate the association level between radiomic 
features and treatment outcomes where the size of the effect was measured using Cohen’s-d 
conventions where the effect range cut-offs are: small (0.2), medium (0.5) and large (0.8) [18]. 
We used non-parametric Spearman’s Rho test to detect any trend of radiomic feature values 
in correspondence to the development of DM and LRR. We rescaled all radiomic features 
extracted from each patient’s MTV to a range [0, 1] by using:  
𝒓𝒓′ =  𝒓𝒓−𝒎𝒎𝒎𝒎𝒎𝒎(𝒓𝒓)
𝒎𝒎𝒎𝒎𝒎𝒎(𝒓𝒓)−𝒎𝒎𝒎𝒎𝒎𝒎(𝒓𝒓)
where r is the original value of any radiomic feature and r’ is the rescaled value. We tested the 
unconditional association between each treatment outcome and radiomic features, without 
consideration of any confounders association between features, using a univariate logistic 
regression model with a p-value at the 0.05 level for the association to be considered significant.  
4.2.6 Feature Selection 
Before proceeding to the modeling step explained below, we randomly split the positive and 
negative cases from our patient cohort into a training set consisting of fifty-six patients (70%) and 
a test set consisting of twenty-four patients (30%).  
To generate models consisting of highly predictive features, we applied the straightforward 
sensitivity analysis method of sequential backward feature selection (SBS) as part of Leave-One-
Out Cross Validation (LOOCV) within the training set. Due to complete separation for models 
combining all features, the selection was made within each feature calculation method category. 
For the feature to remain in a model, we set the stepwise selection to an entry and removal alpha 
of 0.05 at each model iteration and the model re-run containing the remaining variables. 
(4.1) 
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(4.3) 
4.2.7 Logistic Regression Modeling 
To improve the radiomic features’ predictive power for both outcomes (DM and LRR), we 
combined the selected features in multivariate models using multiple logistic regression (MLR). 
In this approach, we first consider a collection of p independent variables of the ith patient denoted 
by the vector 𝒎𝒎𝒎𝒎 = �𝑥𝑥𝑚𝑚𝑖𝑖 ∈ ℝ ∶ 𝑗𝑗 = 1,2, … ,𝑝𝑝�  for N number of patients. In our case, the variables are 
the selected PET features. Our interest is to generate an equation consist of a linear combination 
of p that takes the form:  
𝑔𝑔(𝑥𝑥𝑚𝑚) =  𝛽𝛽𝑜𝑜 +  ∑ 𝛽𝛽𝑖𝑖𝑥𝑥𝑚𝑚 ,𝑝𝑝𝑖𝑖=1   𝑎𝑎𝑃𝑃𝑃𝑃 𝑃𝑃 = 1, 2, … . ,𝑁𝑁, 𝑗𝑗 = 1, … ,𝑝𝑝 
where β is the set of regression coefficients of the model to be determined via maximum likelihood 
estimation (MLE) based on the given treatment outcomes. In which case, we use a logit 
transformation to generate the logistic regression model of the form: 
𝑎𝑎(𝑥𝑥𝑚𝑚) =  𝑒𝑒𝑔𝑔(𝑥𝑥𝑚𝑚)1 + 𝑒𝑒𝑔𝑔(𝑥𝑥𝑚𝑚) =  11 + 𝑒𝑒−𝑔𝑔(𝑥𝑥𝑚𝑚) 
4.2.8 Model Evaluation and Selection 
To evaluate the performance of our models, we plotted the area under the receiver operator 
curve (AUC) to graphically represent the association between the extracted features and each of 
the treatment outcomes. The p-values for both the MLRs and their associated AUC are two-sided 
and considered statistically significant at the 0.05 level (p<0.05).  
Accordingly, we removed any model with no statistical significance, scored AUC < 0.65, or 
had an AUC with a 95% confidence interval lower limit < 0.6. Finally, we applied the trained 
models on the independent test set and followed the same approach mention above to select the 
final models. We performed the statistical analysis using SPSS (Version 22; IBM Corporation; 
Armonk, New York, U.S.), and WEKA 3.6 (The University of Waikato, Machine Learning Group, 
Hamilton, New Zealand).  
 (4.2) 
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4.3 Results 
The group of patients who developed distant metastasis DM (N = 18) was associated with an 
average tumor volume = 105 cm3 (SD = ± 57.1 cm3).  By comparison, the patients with no distant 
metastasis (N = 62) were associated with a numerically smaller average tumor volume = 65 cm3 
(SD = ± 50.9 cm3). To test the hypothesis that both groups were associated with statistically 
significantly different average tumor volume, we performed an independent samples t-test (Table 
4.1 and Table 4.2) by comparing the mean consistency scores of patients diagnosed with either of 
the outcomes versus those with the absence of such outcomes. The distribution for both DM and 
No-DM patient groups were sufficiently normal for the purpose of conducting a student t-test 
(i.e., skewness < |2.0| and kurtosis < |0.9|). Also, the assumption of homogeneity of variances 
was tested and satisfied via Levene’s F–test, F (78) = 0.194, p= 0.66. The independent samples t-
test was associated with a statistically significant effect, t (78) = 2.12, p =0.037. Thus, the group 
of patients with DM was statistically significantly associated with larger average feature value 
(e.g., larger average tumor volume) than the group of patients with no DM. 
Table 4.1. Results of independent t-test and descriptive statistics for some of the highly predictive 
radiomic features in association with the development of distant metastasis (DM). Standardized 
maximum and peak uptake values (SUVMAX and SUVPEAK) are reported for comparison. 
Lavene's F-test* t-test for Equality of Means
F p > 0.05 t df p < 0.05 Mean Diff. 95% CI LB 95% CI UB 
2nd-order Mean 1.72 0.19 2.21 78 0.030 0.13 0.01 0.24 
SZV 3.60 0.06 2.08 78 0.040 0.08 0.04 0.17 
SAE 2.45 0.12 1.99 78 0.049 0.15 0.00 0.30 
Texture Strength 3.47 0.07 -2.97 78 0.004 0.17 0.07 0.25 
Tumor Vol. 1.86 0.18 2.12 78 0.037 0.11 0.01 0.22 
Surface Area 3.86 0.05 3.61 78 0.001 0.18 0.08 0.29 
SUVMAX 0.38 0.54 2.05 78 0.047 0.23 0.015 0.45 
SUVPEAK 0.20 0.90 2.31 78 0.028 0.13 0.015 0.25 
*Equal variances assumed.
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Along the same line, we found that the group of patients with LRR (N = 9) was statistically 
significantly associated with larger average radiomic feature value (an average tumor volume = 
127 cm3; SD = ± 70.9 cm3 while patients with no–LRR had an average tumor volume = 68 cm3; 
SD = ± 48.9 cm3). Following the same steps performed for the first group, the independent 
samples t-test was associated with a statistically significant effect t (78) = 3.23, p =0.002. 
Table 4.2. Results of independent t-test and descriptive statistics for some of the highly predictive 
radiomic features in association with the loco-regional recurrence (LRR) of the disease. Standardized 
maximum and peak uptake values (SUVMAX and SUVPEAK) are reported for comparison. 
Levene's F-test* t-test for Equality of Means
F p > 0.05 t df p < 0.05 Mean Diff. 95% CI LB 95% CI UB 
2nd order Mean 0.18 0.67 1.90 78 0.046 0.14 0.07 0.29 
Diff. Entropy 2.91 0.09 2.21 78 0.030 0.12 0.01 0.22 
SAE 0.19 0.67 -0.47 78 0.640 -0.05 -0.25 0.15 
SZV 6.43 0.01 2.56 78 0.012 0.22 0.05 0.39 
Tumor Vol. 2.47 0.12 3.23 78 0.002 0.25 0.10 0.41 
SUVMAX 0.04 0.08 2.09 78 0.047 0.30 0.01 0.60 
SUVPEAK 0.06 0.08 2.08 78 0.040 0.31 0.21 0.97 
The effect size for MTV to predict for DM was d = 0.74, which exceeds Cohen’s conventions for 
medium effect (d = 0.5) and for LRR was d = 0.98, which exceeds Cohen’s conventions for the 
large effect (d = 0.90).  The results of Cohen’s d for both outcomes are summarized in Table 4.3. 
Spearman’s Rho correlation revealed a trend of higher radiomic feature values for patients 
with event occurrence in comparison to lower radiomic feature values for patients with no event 
occurrence (Table 4.4; Figure 4.3a-b). The preliminary results mentioned above resulted in 
shortlisting radiomic features to twenty-four features (32% of the original number of features), 
namely five HIFs, four GLCMs, two GLRLMs, four GLSZMs, four NGTDM, and five SFs. 
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Table 4.3. Descriptive statistics and effect size (Cohen’s d) of Radiomic features and standardized uptake 
value (SUV) measurements in association with distant metastasis (DM) and loco-regional recurrence 
(LRR). Cohen’s d range cut-offs: small (0.2), medium (0.5) and large (0.8.). 
Figure 4.3. Box plot illustrates the trend of some radiomic features such as (a) surface area in response to 
patients with and without distant metastasis (DM) and (b) difference entropy area in response to patients 
with and without loco-regional recurrence (LRR). The higher median of the right box of each plot suggests 
that patients with DM or LRR are characterized by higher feature values in comparison with the other 
group (left box). Values of Radiomic features were rescaled on a range between [-3, 3]. 
We fitted each of these features in a univariate logistic regression model based on the data of 
the  training  set  to  assess  the  magnitude  of  their  association  with  treatment  outcomes. 
Subsequently, we combined the radiomic features that showed statistically significant univariate 
Feature Outcome Mean ± SD Cohen's d Feature Outcome Mean ± SD Cohen's d 
Mean* 
DM 0.65± 0.16 
0.68 DE 
LRR 0.11±0.078 
0.99 
No DM 0.78±0.22 No LRR 0.23±0.15 
SZV 
DM 0.54±0.24 
0.83 SZV 
LRR 0.05±0.06 
0.88 
No DM 0.73±0.22 No LRR 0.15±0.16 
MTV 
DM 0.57±0.24 
0.74 MTV 
LRR 0.54±0.36 
0.75 
No DM 0.80±0.21 No LRR 0.76±0.22 
TS 
DM 0.53±0.19 
0.81 RPC 
LRR 0.48±0.3 
0.98 
No DM 0.72±0.22 No LRR 0.73±0.21 
SUVMAX 
DM 0.52±0.43 
0.55 SUVMAX 
LRR 0.54±0.42 
0.66 
No DM 0.75±0.41 No LRR 0.84±0.48 
SUVPEAK 
DM 0.53±0.42 
0.60 SUVPEAK 
LRR 0.55±0.41 
0.99 
No DM 0.78±0.42 No LRR 0.86±0.47 
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(4.6) 
   (4.7) 
(4.8)
(4.9) 
associations with any of the two outcomes into MLR models according to their method of 
calculation.  The radiomic features were selected by the backward sequential selection method 
based on Leave-One-Out Cross-Validation within the training set as explained in the methods 
section.  
Table 4.4. Association between different radiomic features and standardized uptake value (SUV) 
measurements with distant metastasis (DM) and loco-regional recurrence (LRR) in a cohort of eighty 
cervical cancer patients measured by Spearman's rank correlation (rs). Correlation is significant at the alpha 
level of 0.05 (2-sided). 
Outcome 
Radiomic features 
2nd Mean DE RLNU SZV Surf Area MTV SUVMAX SUVPEAK
DM 0.33 0.20 0.32 0.27 0.38 0.31 0.25 0.27
LRR 0.25 0.26 0.28 0.23 0.34 0.28 0.22 0.23 
Six models highly predicted for both treatment outcomes (equations 4-9, Figure 4.4.a and b) 
according to the following linear combinations:  
G1 =1.223 × Difference Entropy + 0.223 × 2nd order mean - 13.568 
G2 = – 3.609 × SAE – 3.335 × SZV – 1.075 
G3 = – 4.609 × IV + 3.104 × LIE – 2.047 
G4 = – 2.081 × Texture Strength – 3.054 ×Coarseness – 1.075 
G5 = – 0.058 × Tumor Vol. + 0.046 × Surface Area – 3.630 
G6 = -0.072 × Asphericity + 0.127 Spherical Disproportion – 2.640 
Before generating the models mentioned above, we corrected coarseness for volume (voxel 
size) dependence, and 2nd order mean and difference entropy for GL discretization and texture 
strength for both volume and GL discretization using a method presented in a recent study [14].
Models G1 to G3 showed statistically significant association with LRR (Table 4.5), and 
models G2 to G6 showed statistically significant association with DM (Table 4.6). 
Regarding SUV measurements, both SUVMAX and SUVPEAK showed statistically significant 
association with DM 
(4.5) 
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and LRR through all preliminary tests, except for univariate logistic regression modeling.  Also, a 
multivariate logistic regression model of both SUVMAX and SUVPEAK was found to be statistically 
insignificant due to the removal of SUVMAX in the selection step at an alpha level of 0.05. We 
removed any model that scored an AUC < 0.60. Although model G3 was statistically significantly 
associated with LRR (AUC = 0.79, p<0.05), it was removed due to low 95%CI range (0.59 – 0.99).
Variables AUC SE p-value 95%CI LB 95%CI UB 
G1: Diff. Entropy, 2nd Mean 0.89 0.05 0.009 0.78 1.00 
G2: SAE, SZV 0.85 0.07 0.019 0.71 0.99 
G3: IV, LIE 0.79 0.10 0.049 0.59 0.99 
G4: Texture strength, Coarseness 0.73 0.13 0.115 0.47 1.00 
G5: Volume, Surface Area 0.59 0.19 0.525 0.21 0.98 
G6: Asphericity, Spherical Disp. 0.54 0.21 0.750 0.12 0.97 
SUVMAX* 0.76 0.10 0.077 0.56 0.97 
SUVPEAK* 0.77 0.10 0.070 0.57 0.97 
* AUC for both maximum standardized uptake value (SUVMAX) and peak standardized uptake value 
measurements (SUVPEAK) corresponds to their univariate logistic regression models.
Variables AUC SE p-value 95%CI LB 95%CI UB 
G1: DE, 2nd-order Mean 0.65 0.09 0.141 0.45 0.83 
G2: SAE, SZV 0.80 0.07 0.002 0.66 0.93 
G3: IV, LIE 0.79 0.07 0.003 0.65 0.93 
G4: Texture strength, Coarseness 0.75 0.07 0.011 0.62 0.89 
G5: Volume, Surface Area 0.82 0.06 0.001 0.69 0.93 
G6: Asphericity, Spherical Disp. 0.74 0.08 0.013 0.58 0.91 
SUVMAX* 0.67 0.07 0.086 0.51 0.82 
SUVPEAK* 0.69 0.08 0.047 0.54 0.85 
* AUC for both maximum standardized uptake value (SUVMAX) and peak standardized uptake value
measurements (SUVPEAK) corresponds to their univariate logistic regression models.
By evaluating the trained models using the independent test set (Table 4.7, Table 4.8, and 
figure 4.5. a and b), we found two models associated with LRR (G1, and G2), and four models 
associated with DM (G3, G4, G5, and G6).  
Table 4.5. Area Under the Characteristic Receiver Operator Curve (AUC) of the trained models for LRR 
prediction. 
Table 4.6. Area Under the Characteristic Receiver Operator Curve (AUC) of the fully trained and 
validated models for prediction of DM over the test set (N = 24). 
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Figure 4.4. (a) Area under the receiver operator characteristic curve (AUC) representing a comparison 
between the trained multivariate logistic regression models (MLR) versus SUV measurements for 
prediction of loco-regional recurrence (LRR), and (b) for prediction of distant metastasis DM. 
Table 4.7. Area Under the Characteristic Receiver Operator Curve (AUC) for the LRR predictive models 
based on the test set. 
Variables AUC SE p-value 95%CI LB 95%CI UB 
G1: DE, 2nd-order Mean 0.92 0.07 0.004 0.78 1.00 
G2: SAE, SZV 0.88 0.10 0.009 0.67 1.00 
SUVMAX* 0.74 0.09 0.095 0.55 0.94 
SUVPEAK* 0.76 0.09 0.070 0.58 0.95 
* AUC for both maximum standardized uptake value (SUVMAX) and peak standardized uptake value
measurements (SUVPEAK) corresponds to their univariate logistic regression models.
Table 4.8. Area Under the Characteristic Receiver Operator Curve (AUC) for the DM predictive 
models  based on the test set. 
Variables AUC SE p-value 95%CI LB 95%CI UB 
G3: IV, LIE 0.86 0.07 0.007 0.71 1.00 
G4: Texture strength, Coarseness 0.88 0.06 0.004 0.75 1.00 
G5: Volume, Surface Area 0.92 0.05 0.001 0.82 1.00 
G6: Asphericity, Spherical Disp. 0.89 0.06 0.003 0.76 1.00 
SUVMAX* 0.56 0.11 0.611 0.34 0.79 
SUVPEAK* 0.61 0.11 0.374 0.39 0.85 
* AUC for both maximum standardized uptake value (SUVMAX) and peak standardized uptake value
measurements (SUVPEAK) corresponds to their univariate logistic regression models.
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Figure 4.5. Area Under the Receiver Operator Characteristic Curve (AUC) representing a comparison 
between the final multivariate logistic regression models (MLR) versus SUV measurements for 
prediction of loco-regional recurrence (LRR), and (b) for prediction of distant metastasis DM. 
4.4 Discussion 
The presented supervised analysis study consisted of generating statistical learning models 
that inferred a high association with dichotomous outcomes. Accordingly, we aimed to determine 
the most efficient radiomic feature predictors of cervical cancer treatment outcomes. By 
performing univariate and multivariate logistic regression analysis on radiomic features and SUV 
measurements generated under the same conditions, conclusions were drawn regarding the 
predictive power of each metric. Characterizing and understanding the information extracted 
from the tumor FDG uptake poses unique challenges. Therefore, several preprocessing steps are 
required to maximize the benefit of the unique radiomic information derived from the 
heterogeneity patterns within the tumor image. Rescaling radiomic feature values to a 
standardized range is an essential pre-processing step as it makes the feature values directly 
comparable both inter- and intra-patient. Otherwise, the value of the extracted features data will 
vary widely, even within the same patient (equation 1). Another critical preprocessing step is to 
(a) (b)
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eliminate radiomic features that failed to show any statistically significant association between 
feature and treatment outcome under univariate analysis. These features are unlikely to be 
associated with the outcome after adjusting for other features (cofactors) in multivariate models. 
As previously mentioned, we noticed that some radiomic features displayed increasing trends 
corresponding to patients who developed either DM or LRR versus patients with absence of such 
events (Fig. 2-3). This result urged us to investigate the potential of such features to serve as 
robust quantitative predictors for the development of DM and LRR. The results of this study 
revealed that the geometrical aspects of tumors, interpreted by shape-based features (SF), showed 
the highest correlation with treatment outcomes. Thus, future research should focus more on 
ascertaining the predictive power of these radiomic features. For example, the size of the primary 
cervical tumor volume (Tumor Vol.) had the highest significant univariate prediction for DM. This 
finding is concordant with other studies in this field [19, 20]. The results also presented a 
prominent role of GLSZM features (IV and LIE) in univariate correlation with DM, while GLCM 
features (difference entropy, 2nd order mean) presented the highest correlation with LRR. It is 
worth to mention that GLSZM features extracted from FDG-PET were shown to have an 
association with physiological processes such as colorectal tumor vascularization [17] and a 
differentiation ability of esophageal patients based on their response [11].  
To our knowledge, we are the first to report a correlation between texture strength, 
coarseness, IV, LIE, and difference entropy to treatment outcomes. Meanwhile, IVH based 
features which characterize the distribution of voxel intensities without taking into account spatial 
relationships among voxels were all statistically uncorrelated with outcomes. In contrast to a 
similar study [10],  V90, percentage volume having at least 90% intensity value,  V10-90, the 
difference between V10 and V90, and I90, minimum intensity to the 90% highest intensity 
volume, did not show statistically significant association on any preliminary statistical test (p > 
0.05). This finding might be due to the relatively higher number of the patients between both 
studies. We also found that patient age did not have statistically significant correlation with any 
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of the outcomes. Racial disparity was out of the scope of this study [21]. Interestingly, although 
SUVPEAK and SUVMAX demonstrated preliminary correlation with both treatment outcomes, they 
failed to display any statistically significant correlation (p > 0.05) neither in the univariate nor 
multivariate logistic regression analysis. Therefore, within the scope of this study, radiomic 
features are considered superior to SUV measurements, especially to SUVMAX, regarding 
prediction for both DM and LRR (Table 7-10, Fig. 5-6).  This finding is thought to be attributed to 
the advanced calculation method of textual-based radiomic features, which better analyze the 
spatial resolution, and voxel-neighborhood information within the tumor volume. Such features 
might present enhanced understanding of tumor heterogeneity and behavior.  In agreement with 
related studies, multiple logistic regression modeling was shown to be a useful methodology that 
may enhance the predictive performance of radiomic features [22, 23]. In the case of LRR, logistic 
regression modeling significantly improved the predictive power by an increase of ~8%, whereas 
in the case of DM it increased by ~ 5%). Furthermore, using sequential backward selection 
followed by LOOCV served as a rigorous method to select features with the best performance 
within the training set. Finally, applying the multivariate models on the test set presented G1 as 
the best model to predict for LRR (AUC: 0.89 95%CI: 0.78-1.00) and G5 as the best model to 
predict for DM (AUC: 0.82. 95%CI: 0.693-0.94).  
On the other hand, quantitative analysis of 18F-FDG PET images presents several challenges 
[24].  From a clinical perspective, the metabolic tumor volume is shown to be highly dependent 
on both the scanning protocol and source-to-background ratio. Also, an anatomical restriction of 
the pelvic region requires a more sophisticated method of segmentation.  Several articles reported 
the use of fuzzy locally adaptive or fuzzy c-means algorithms have led to satisfactory results [12, 
25]. Therefore, to avoid variabilities due to tumor volume definitions, we assessed the 
segmentation accuracy, in a previous study, by computing the Dice coefficient of the overlap 
between two experts’ manual and a graphical-based semi-automatic segmentation method [26] 
for the same patient cohort [13]. Moreover, the relatively small patients’ cohort might be a 
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limitation of the current study. However, this cohort is about the same size, or larger, in 
comparison to samples in similar studies. From a technical perspective, the accurate 
determination of treatment response remains a challenging task owing to the limitations of 
current PET imaging technologies, specifically, their limitation of spatial resolution and high 
noise characteristics resulting from lower sensitivity [27, 28]. Hence, in this study, we adhered to 
the recommendation of the Society of Nuclear Medicine (SNM) and the European Association of 
Nuclear Medicine (EANM) by following one strict scanning and image acquisition protocol for 
our patient cohort.  
4.5 Conclusion 
Radiomics is an emerging process to extract more quantitative and predictive information 
from radiological images. We have selected twelve FDG-PET based radiomic features to fit into 
six distinct multivariable logistic regression models. These models had more predictive power in 
comparison to univariate radiomic features models and SUV measurements. Shape features such 
as the metabolic tumor volume and surface area in addition to NGTDM features such as texture 
strength and coarseness were shown to be valuable features for the predicting distant metastasis. 
On a similar note, GLSZM features such as SZV, SAE and GLCM features such as 2nd-order mean 
and different entropy were more predictive of loco-regional recurrence disease.   
The proposed multi-radiomic models might be used for correlation with clinical treatment 
outcomes for cervical cancer treated with definitive radiochemotherapy, and warrant further 
investigation. We also encourage intra-center studies with larger patient cohorts for validation of 
our results and those of other investigators in radiomics. This scope of research might lead to 
better tumor targeting, identification of response at an early stage, and provide a clearer 
understanding of the relation between radiomic features and tissue heterogeneity characteristics. 
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CHAPTER 5: FDG-PET/CT COMBINED RADIOMIC FEATURES MODELS FOR
PREDICTING THE DEVELOPMENT OF DISTANT METASTASIS AFTER 
CERVICAL CANCER RADIOCHEMOTHERAPY
5.1 Introduction 
The ability to predict treatment outcome for patients, especially those at high risk of 
responding poorly to standard therapies, is of prime interest. Such prediction could help clinicians 
modify their treatment plan, or modality, to improve patients response to treatment. Accordingly, 
recent research strategies focused on developing quantitative noninvasive tumor descriptors that 
might serve as robust treatment outcome predictors. Based on the well-established role of 18F-
FDG PET/CT in radiation oncology [1], recent studies have demonstrated separate results on the 
potential of FDG-PET or CT-HU to predict response in different body sites.  For PET, several 
studies compared the predictive performance of multi-metric radiomic features in comparison to 
Standardized Uptake Values (SUV).  
El Naqa et al. [2] reported several logistic regression models of radiomic features with good 
predictive power for treatment outcomes in cervical cancer patients treated with 
radiochemotherapy.  However, the study suggested further testing and validation using larger 
patient datasets. Similarly, Reuzé et al. [3] identified two multi-metric models consisting of a 
signature model of radiomic features and SUV measurements, extracted from baseline 18FDG-
PET,  that were predictive of local recurrence in a cohort of 118 locally advanced cervical cancer 
patients. The study also evaluated the reproducibility of the features as a function of PET/CT 
scanners and voxel size values. 
 Tixier et al. [4] demonstrated that radiomic features extracted from the intratumor FDG 
uptake of baseline PET scans differentiated esophageal cancer patients as partial- and non-
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responders to radiochemotherapy with higher sensitivity than SUV measurements. The studies 
mentioned above, and several others [5, 6], concluded that radiomic features have superior 
performance in comparison to SUV measurements regarding clinical outcome assessment and 
tumor heterogeneity description. Several studies used CT-based radiomics for predicting 
outcomes after radiotherapy treatment, especially in lung cancer. For example, Coroller et al. [7] 
demonstrated a strong association between CT-based radiomic signature and the development of 
distance metastasis (DM) for locally advanced lung adenocarcinoma. The authors also indicated 
improved prediction when combining the radiomic-signature with clinical relevant factors.  
Hawkins et al. [8] extracted CT radiomic features of patients diagnosed with adenocarcinoma 
non-small cell lung cancer (NSCLC) tumors. Afterwards, they predicted survival time based on 
machine learning classifiers such as decision tree and support vector machine (SVM). SVM is a 
supervised machine learning method based on the statistical learning theory developed by Cortes 
and Vapnik [9]. This approach has demonstrated high performancee in solving classification 
problems in numerous fields from text categorization [10], cancer classification by gene selection 
[11], to outcome prediction using radiomics [12-14].  
To our knowledge, a limited number of studies reported radiomic studies based on combined 
PET/CT scans. For example, Vaidya et al. [15] obtained multi-radiomic-feature models based on 
combined PET/CT scans that significantly predicted local failure for patients with NSCLC. Their 
model consisted of PET/CT intensity-volume histogram (IVH) features.  
This study aims to generate multiple radiomic features model that incorporates the PET 
functional and CT anatomical information of the tumor and to investigate the ability of SVM to 
improve such prediction in comparison to the conventional multiple logistic regression (MLR) 
approaches. 
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5.2 Material and Methods  
5.2.1 Patient Characteristics 
This study included 124 patients of the original cohort presented in chapter 2 (section 2.1, 
Table 2.1).  
5.2.2 PET/CT Scanner Characteristics 
We followed the same imaging protocol presented in section 2.2. The image acquisition 
parameters for PET and CT are summarized in Table 2.3. 
5.2.3 Tumor Segmentation 
A board-certified radiation oncologist manually delineated the tumor volumes, which 
contained both the cervical tumor and local direct extension in the uterus, parametrium, vagina, 
or other adjacent organs, based on FDG uptake findings on PET and guided by CT, MRI, clinical 
examination findings, and patient-specific histopathological reports. In a previous study, we 
assessed the segmentation accuracy by computing the Dice coefficient of the overlap  (Figure 5.1 
Demonstration of tumor segmentation based on combined PET/CT scan.) between two experts’ 
manual and a graphical-based semi-automatic segmentation method [16] for the same patient 
cohort [17]. We avoided using an SUV-based fixed threshold segmentation approach (e.g., 40% 
SUVMax) since this method has been widely challenged [18]. Tumor volumes were segmented 
using Mirada Medical DBx® software (Mirada Medical DBx®, Oxford, UK). 
5.2.4 PET/CT Image-based Radiomics Analysis 
We used the same methods presented in section 2.5 to extract radiomic features for each 
imaging modality independently. Therefore, we generated two sets of radiomic features 
corresponding to the voxel intensity and tumor heterogeneity as measured by SUV and HU 
distributions based on PET and CT images, respectively. The combination of features from both 
imaging modalities took place during the statistical modeling step only. 
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5.2.4.1 Correction for Voxel Size, Gray Intensity Level Dependence, and  
Reconstruction Algorithm 
In previous studies, we examined the reproducibility of radiomic features against image 
perturbations such as voxel size, gray intensity level (GL) dependence, and reconstruction 
algorithm (RA) for both PET [17] and CT [19]. Accordingly, we resampled all the delineated tumor 
volumes to an isotropic voxel size using cubic interpolation before the extraction of radiomic 
features. Thus, we isotropically resampled both FDG-PET and CT images to a voxel size of 3.27 × 
3.27 × 3.27 mm3. Furthermore, we removed the dependency on GLs and PET RAs by using the 
corrected feature formulas in addition to fixing the GL to a discrete value of 64 (matrix size: 64 × 
64) and the PET reconstruction algorithm to the standard ML-OSEM because they were shown
to provide the highest radiomic feature reproducibility. 
5.2.5 Statistical Analysis 
5.2.5.1 Preprocessing Analysis 
The development of distant metastasis (DM) was assigned conventional scalar values of 0 
and 1. The event DM=1 represents the occurrence of the complication after treatment, whereas 
DM = 0 is the absence of that complication; either one is recorded at the time of the last follow-
up from the end of radiochemotherapy treatment. We set the start point of the follow-up period 
for each patient at the date of the initial pathological biopsy report until the time when the clinical 
Figure 5.1. Demonstration of tumor segmentation based on combined PET/CT scan. 
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treatment outcome was reported based on the event occurrence or patient’s last follow-up. We 
used Spearman’s Rho (rs) test to detect inter-correlation between radiomic features. We removed 
features with inter-correlation of rs > .60. We used the Mann-Whitney U test to assess the 
differences in radiomic feature values between patients in different subgroups with a p-value < 
0.05 for the difference to be considered significant. Before proceeding to the modeling step 
explained below, we randomly split the positive and negative examples from our patient cohort 
into a training set = 87 (70%), and a test set = 34 (30%). Receiver operating characteristic curves 
(ROC) were compared within each group using the method of DeLong et al. [20]. A flowchart of 
study is summarized Figure 5.2. The statistical and machine learning analysis in this study was 
performed using SPSS (Version 24; IBM Corporation; Armonk, New York, U.S.), and WEKA 3.6 
(The University of Waikato, Machine Learning Group, Hamilton, New Zealand).  
5.2.5.2 Support Vector Machine (SVM) Classification 
SVM is a supervised machine learning algorithm that constructs an n-dimensional 
hyperplane that optimally segregates two classes by maximizing the margin between two input 
data clusters[9]. The distance between the hyperplane and the nearest data point on each side 
(known as support vectors) is maximized. After training the SVM on data from the training set, 
we subsequently use it as a classifier for data from an independent test set. Depending on the 
nature of the dataset, this algorithm achieves high discriminative power by using a linear function 
or kernels (special nonlinear functions) to separate instances in the input space that has been 
transformed into a multidimensional space. 
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Figure 5.2. Flowchart of the process followed to generate the final predictive models.  
We extracted a total of 158 radiomic features from PET and CT images of a training set of n = 87, 
DM =18 (20.6%). Then, we investigated the inter-feature dependence using Spearman’s Rho test. 
We only included features with rs < 0.60. We assessed the median differences between radiomic 
features based on DM outcome using Mann-Whitney U test. Radiomic features were shortlisted 
after above-mentioned preliminary tests. We used Relief-F with ranker search to select the top 5, 
10, 15, 20 features for SVM modeling and backward selection with entry and remaining alpha < 
0.05 to select features for MLR modeling. Both models were cross-validated using 10-folds 
technique. We selected the final models based on the highest area under the receiver operator 
characteristic curve (AUC) and lowest Akaike Information Criterion (AIC). Finally, we tested and 
reported the final trained and validated models on the independent set of n= 34, DM = 10 (29.4%). 
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In this work, we used different kernel functions such as linear, polynomial, radial basis 
function (RBF), and sigmoid to choose the kernel with the best performance. Two user-specified 
parameters for the kernels, soft margin or cost parameter C and Gaussian kernel parameter γ, 
need to be adjusted to generate an optimal SVM model. Parameter C controls over-fitting of the 
model by specifying a tolerance for misclassification. Parameter γ controls the degree of influence 
of a training example. We tuned the combination of parameters on the training data using the 
grid search method that chose the best (C, γ) pair from the exponentially growing sequences of C 
∈ [2-4, 2-3,...,214,215] and γ ∈ [2-15, 2-14,…, 21,23], and yielded the highest AUC under 10-fold cross-
validation during training.  
For this purpose, we used LibSVM developed by Chang and Lin [21], a freely available SVM 
software library3 to generate the SVM models and run the grid search while using default 
termination criteria. We used Relief-F[22] as a feature evaluator with ranker search method to 
assign ranks to the top five, ten, fifteen and twenty features during ten-fold cross-validation within 
the training set to choose features with high predictive power for DM in terms of AUC.  
5.2.5.3 Multiple Logistic Regression (MLR) Modeling 
We conducted an MLR analysis to predict the DM treatment outcomes while aiming to gain 
improvement of radiomic features predictive power using the SVM algorithm. We selected the 
best predictive features using backward selection based on Akaike Information Criterion 
(AIC)[23] and determined the best model using 10-fold cross-validation on the training set, with 
a removal alpha of 0.05. For comparison, we generated univariate logistic regression model, 
without consideration of any confounders association.  
5.2.5.4 Final Model Evaluation 
To evaluate the robustness of both modeling techniques, we examined the trained models on 
an independent test consisting of 34 patients.  We used 10-fold cross-validation to find the best 
3 SVM library can be found at: http://www.csie.ntu.edu.tw/~cjlin/libsvm/ 
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models on the training set. We selected the final models based on the largest AUC and applied 
those models to the test set.  
5.3 Results 
Only fifty-three radiomic features were shown to abide by the strict testing parameters of 
inter-feature correlations and corrections for volume and gray-level. Mann-Whitney U test 
showed a significant statistical difference of radiomic feature values between patients who had 
the event of treatment outcomes as opposed to patients who did not have the event (Figure 5.3). 
The detailed list of Mann Whitney U results is found in supplementary table S.5. GLCM 
features extracted from CT, NGTDM extracted from PET and SF had the highest correlation with 
DM. IVH-based features (e.g., V40, V90, I10, and I30) showed an insignificant association with 
the treatment outcome.  
Also, clinical markers such as FIGO stage and histology showed insignificant differences 
between both groups. Mann-Whitney U test contributed to further shortlist the radiomic features 
from fifty-three to thirty-nine.  By evaluating these features on the training set, we found that the 
best approach to predict for DM was the SVM classifier with RBF kernel, using top five features 
found by Relief-F and ranker search in comparison with the top 10, 15, and 20 (Figure 5.4). In 
general, the RBF kernel function, followed by the linear kernel, showed best accuracy and AUC in 
comparison to other kernels (Table 5.1).  
Table 5.1. Area under the curve (AUC) comparison of support vector machine (SVM) using different kernel 
functions as a predictor for the development of distance metastasis (DM). The output is based on the test 
set. 
Kernel 
Evaluator/Search Linear Polynomial Radial basis function Sigmoid 
Relief-F with ranker 
search top 5 features 0.75 67.8 0.80 0.48 
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Figure 5.3. Rank distribution for the occurrence and absence of the development of distance metastasis 
(DM) as a function of the highest performance features according to the results of Mann-Whitney U test. 
The polynomial and sigmoid kernels had low AUC and were not evaluated on the independent 
test set. As for the MLR method (Table 5.2), we found the best model scored AUC =0.77 (AIC 
=63.3). We applied the generated models, based on the training set, on the unseen independent 
test (n=34 patients). 
In this case, SVM with the RBF kernel showed superior performance in comparison with the 
traditional MLR model with higher classification accuracy and AUC. The comparison between the 
performance of MLR and SVM are summarized in Table 5.3 and Figure 5.5.  
Table 5.2. Radiomic features, coefficients, standard errors of coefficients, odds ratio, and Akaike 
Information Criterion (AIC) for the final multiple logistic regression models. 
Models Radiomic features Coefficient SE Odds Ratio AIC 
MLR1 
Difference Entropy+ 0.107 0.032 1.113 
63.3 
Texture strength* 0.132 0.015 1.141 
MLR2 
2nd order mean+ 0.171 0.079 1.186 
73.2 
Coarseness* 0.146 0.076 1.157 
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Table 5.3 Comparison between the performance of the final Support Vector Machine (SVM) classifier 
with radial basis kernel (RBF) and the multiple logistic regression model (MLR) as predictors of distant 
metastasis (DM). 
Method Radiomic features Sensitivity (%) 
Specificity 
(%) 
Accuracy 
(%) 
AUC 
SVM TS*, DE
+, 2nd Mean+, Coarseness*,
Asphericity 88.2 28.2 88.3 0.80 
MLR TS*, DE+ 86.5 42.9 86.5 0.77 
We also noticed from the aforementioned table that the ROC results of the SVM using RBF 
kernel slightly outperformed MLR for both outcomes. The SVM final model consisted of PET 
Texture Strength, CT-Difference Entropy, PET-Coarseness, CT- Mean, and Tumor Asphericity, 
while the MLR final model consisted of PET Texture Strength and CT-Difference Entropy. As 
noticed from these results, GLCM and NGTDM textural features, in comparison to feature derived 
from the GLSZM and GLRLM, played better roles in building the mentioned models.  
5.4 Discussion 
      The wealth of information provided by the clinical, imaging, and genetic data can be 
combined into signature-models to improve outcome prediction and to contribute to patient-
specific clinical decision support. However, most current predictive models consist of cutoff-
based biomarkers, simple univariate, or multivariate logistic regression models with features of 
a single image modality type.  The primary result of this study is the combined radiomic 
models that significantly predict cervical cancer distant metastasis (DM) based on PET 
functional and CT anatomical imaging information. Our study indicated two highly predictive 
PET/CT combined radiomic models for the development of distant metastases. NGTDM 
features from PET images and GLCM features from CT images combined had a higher 
association with DM relative to other feature extraction methods.  PET texture strength and CT 
Difference Entropy showed the highest correlation with DM.  This correlation warrants further 
investigation of the importance of the association between this set of radiomic features and the 
increased probability for the development of DM in cervical cancer patients. 
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Figure 5.4. The heatmap is describing the inter-correlation between top twenty radiomic features measured 
by Spearman’s Rho (rs) correlation. The features were selected using Relief –F with ranker search as part 
of generating the Support Vector Machine (SVM) classifier.  All features in the Heatmap have a (rs) score 
of the range: 0.07 < rs < 0.6. The heatmap does not reflect the statistical significance of Spearman’s Rho 
test; some features had inter-correlation with p-value>0.05. 
In concordance with similar studies, tumor geometrical and morphological features 
generated by the shape features were also shown to have promising potential for predicting DM. 
For instance, patients with larger tumor volume, and asphericity were shown to have a statistically 
significant association with the treatment outcome. 
RF101: Texture strength, NGTDM (PET); RF50: Difference entropy, GLCM (CT); RF38: 2nd order 
mean (CT);  RF97: Coarseness, NGTDM (PET); RF153: Asphericity, SF; RF63: Run percentage, 
GLRLM (PET); RF154: Compactness, SF; RF151: Surface Area, SF; RF150: Tumor Volume, SF; 
RF95: Size-zone variability, GLSZM, (CT); RF18: Inverse difference moment, GLCM (PET); RF100: 
Complexity, NGTDM (PET); RF62: Run length non-uniformity, GLRLM, (PET); RF28: Contrast, 
GLCM (CT); RF24:  Difference entropy, GLCM (PET); RF02: Contrast, GLCM (PET); RF155: 
Spherical disproportion, SF; RF106: Texture strength, NGTDM (CT); RF12: 2nd order Mean, GLCM 
(PET); RF105: Complexity, NGTDM (CT). 
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Figure 5.5. Receiver operator characteristic (ROC) curves for the final support vector machine (SVM) 
model with the radial-basis kernel (RBF) and the final multiple logistic regression models (MLR) for the 
prediction of distance metastasis (DM). 
On the other hand, low or insignificant association with DM characterized the majority of 
IVH-based features. We also found that clinical data such as age and FIGO stage were not 
statistically significant predictors of treatment outcomes within the scope of this study. However, 
we do not intend to evaluate the predictive performance of FIGO staging since it was outside the 
scope of this study.  In this work, we avoided generating predictive models that combine radiomic 
features with SUV measurements because the latter has proven to be vulnerable to several pitfalls, 
which were reported in related studies [24, 25].   
Within the scope of this study, PET radiomic features were slightly superior to CT regarding 
classifying patients into DM and non-DM as they scored higher ranks as part of the feature 
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selection process for SVM (Figure 5.5). This finding might be due to the functional nature of PET, 
which generates radiomic features presenting inherent functional tumor traits as opposed to the 
anatomical nature of CT that represents variations in electron density within tumor regions. 
Furthermore, tumors with high HU, dense tumors and FDG uptake were associated with the 
occurrence of DM. This trend might stem from the fact that the cervical tumors of this cohort are 
associated with high regional FDG uptake (i.e., aggressive tumors).  
In this study, we compared the performance of two common modeling approaches, MLR and 
SVM, which combined PET/CT radiomic features to predict the development of DM after cervical 
cancer radiochemotherapy.  Although we used the same training and test sets for both methods, 
the AUC results demonstrated that the discriminative performance of SVM with an RBF kernel 
function was higher compared to the method commonly used for this purpose, MLR.  This result 
might indicate that nonlinear function better classifies patients with and without the occurrence 
of the treatment outcome of interest, in such heterogeneous tumors. Moreover, the high 
sensitivity demonstrated by the SVM models for the existence of DM might contribute to a future 
method that aims for a patient-specific treatment regimen.  Although MLR is the most common 
algorithm for solving classification and predicting problems, it seems to be rapidly losing ground 
to machine learning techniques.  
The processes of SVM and MLR are very different. MLR assigns a probability to each 
outcome, trains to a specific maximum likelihood, and generates a linear decision boundary 
(plane) that separates each class. On the other hand, an SVM enforces a separation margin 
between classes, trains a model to find the maximum boundary using different kernels, then 
generates a decision boundary by maximizing the distance between the closest point to the margin 
(support vectors), which might be the reason SVM model tends to select fewer radiomic features 
that are significantly correlated with the treatment outcome in comparison with MLR modeling. 
Moreover, the SVM approach tended to classify data points without providing estimates of the 
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ratio of the probability of the response, which is a fundamental difference from MLR. The multi-
step nature of MLR modeling could be considered as one of its shortcomings. Although several 
studies, including this one, using radial-basis function (RBF) kernel with enhanced results for 
SVM, there is still no consensus on the optimal kernel choice since other studies reported the use 
of other kernels such as linear and polynomial [26, 27]. 
Using radiomic features that were corrected for several perturbations (volume dependence, 
gray level dependence, and reconstruction algorithm dependence) is one of the strong points of 
this study. Also, the performance of this set of features was thoroughly investigated and previously 
reported [17, 19, 28], and proved to be predictive for DM and LRR based on F18-FDG PET images 
[29]. The limited number of patients and the retrospective and single-center nature of this study 
might be considered as limitations, but it also warrants further investigation and validation of 
these models on a larger dataset of cervical cancer and other cancer sites. 
5.5 Conclusion 
We aim to generate sophisticated mathematical methods to identify a patient’s response to 
treatment by employing combinations of robust, tested, and validated radiomic feature models. 
The importance of radiomics lies in its potential as a robust quantitative tool to predict tumor 
response to treatment. Equipped with such quantitative tumor descriptors, clinicians may be able 
to personalize treatments by classifying patients based on the response, stage, or prognosis and, 
therefore, determine the course of treatment for each of their patients.  
Accordingly, this study presented predictive models, which combined anatomical and 
functional descriptors using MLR and SVM modeling. The predictive powers of both modeling 
techniques for cervical cancer post radiochemotherapy distant metastasis were significant. Our 
results indicated better performance of SVM over the commonly used MLR. This approach holds 
the promise for enhancing the predictive power of radiomic features. 
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6 CHAPTER 6: ASSESSING THE IMAGING HABITATS OF CERVICAL CANCER 
USING PET/CT IMAGES TO PREDICT TREATMENT OUTCOMES 
6.1 Introduction 
Because surgical options are limited in cervical cancer due to the proximity of the cervix to 
the bladder, uterus, and rectum, radiotherapy is often chosen as the optimal treatment modality. In 
fact, optimal radiotherapy treatment results can be achieved by a combination of external beam 
radiotherapy, concurrent chemotherapy, and brachytherapy. Staging of cervical cancer is 
performed according to the Federation International of Gynecological Oncology (FIGO) system, 
which was revised in 2009 [1]. In radiation oncology clinic, Baseline PET/CT scans provide useful 
information for staging, treatment design, and management of patients undergoing radiotherapy. 
PET functional imaging allows the detection of metabolically active tumor and assessment of 
response to radiochemotherapy while CT anatomical imaging offers the basis for radiotherapy 
treatment simulation and planning. Hence, both modalities are of similar importance in the 
application of radiotherapy.  At present, promising study efforts of quantifying heterogeneity 
patterns of tumor volumes based on PET/CT information are accumulating evidence of the 
importance of such approach.  
Application of tumor quantification has been focused on extracting several descriptors of the 
tumors in a process known as radiomics. Application of tumor quantification has been focused on 
extracting several descriptors of the tumors in a process known as radiomics. Several pioneering 
radiomic publications focused on prediction of treatment outcomes in various oncologic body-
sites such as cervix [2, 3], lungs [4], head and neck [5], and esophagus [6]. These studies shared 
relatively common methodology including segmenting and rendering tumor volumes, extraction 
and selection of radiomic features, and finally generating radiomic feature predictive models 
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using common statistical methods or by incorporating sophisticated machine learning 
techniques. Other uses for radiomics including cancer staging [7] and patient classification based 
on treatment response [8]. Quantitative tumor descriptors in general, and radiomics in particular 
hold promise to evaluate cancer diseases selectively and to personalize radiotherapy treatment 
plans and regimens [9, 10], yet successful clinical implementation of these strategies is still not 
yet available for two primary reasons. First, few studies have considered the dependence of a 
radiomic feature on several parameters. The focus on enhancing the reproducibility and reliability 
of radiomic feature and present a sub-group of features that are insensitive to imaging factors or 
parameters such as voxel size [11], respiratory gating [12], imaging reconstruction algorithms, 
gray intensity level discretization and tumor segmentation methods [13] are needed.  Second, 
presenting validated and precise radiomic models that are patient-group specific is essential. For 
example, studies taking into account the different heterogeneity and characteristic of tumor sub-
types based on clinical stage, histologic or genetic types. Such approach might help radiomics as 
a robust tool in the radiation oncology clinic. In other words, more studies should allow for the 
identification of radiomic features that could be eventually used as imaging biomarkers.  
Despite the monoclonal origin of cancer cells, tumors have high intratumor heterogeneity, at 
multiple scales, that has direct clinical implications for disease classification, targeting, and 
radiochemotherapy treatment efficacy. Another way of characterizing tumor heterogeneity is by 
dividing tumor volumes into sub-regions (habitats) based on distinct heterogeneity levels 
developed based on multimodality or multiparametric imaging data. Such approach might lead 
to better understanding of such essential tumor characteristics [14]. Here we present spatial 
heterogeneity descriptors as tools to provide new insights into cervical tumor functional and 
anatomical composition as well as to predict treatment outcomes in cervical cancer patients by 
analyzing the variation within the tumor habitats on pre-treatment PET/CT images. The clinical 
rationale of such approach lies in the fact that both radiologists and radiation oncologists would 
like to have non-invasive confirmation tool, in contrast to pathological biopsies, which 
93 
discriminates among high and low heterogeneous tumor regions. Introducing a robust tool with 
such potential will contribute to improvements and personalization of the radiation therapy plan 
to accommodate for smaller irradiated volume, which will spare more healthy organs at risk. To 
our knowledge, the literature lacks such studies [14, 15] on the site of cervical cancer especially 
using PET/CT. Therefore, in the present study, we sought to apply imaging habitats as an 
approach to address the distribution of PET and CT intensities within cervical cancer tumors. We 
aimed to combine information from Standardized Uptake Values (SUV) of F18-FDG uptake from 
PET images and Hounsfield Units (HU) from CT images to investigate the potential of habitat 
features as a non-invasive predictive tool for overall and disease-free survivals and the 
development of distant metastasis after radiochemotherapy of cervical cancer.  
6.2 Methods and Materials
6.2.1 Patient Demographics 
This study included the 124 patients of the original cohort presented in chapter 2 (section 2.1, 
Table 2.1).  
6.2.2 PET/CT Scanner Characteristics 
We followed the same imaging protocol presented in section 2.2. The image acquisition 
parameters for PET and CT are summarized in Table 2.3. 
6.2.3 Tumor Segmentation 
       We followed the same tumor segmentation method described in chapter 5 (section 5.2.3, 
page 76). 
94 
6.2.4 PET/CT Image-based Habitats Analysis 
To divide cervical tumors into habitats, we first developed an in-house program that evaluates 
the diversity extent of the intratumor heterogeneity within the tumor volume based on voxel 
intensity distribution in the form of Standardized Uptake Values (SUV) and Hounsfield Units 
(HU) of PET and CT images, respectively. We used the median value of voxel intensity within the 
overall tumor volume to categorize the habitats into high and low intensities. We extracted a total 
of sixty-five features, which are defined in Table 6.1. 
Table 6.1. Definitions of PET/CT based Habitat features 
Habitat Feature Definition 
Ref: Tumor volume  The total size of tumor volume 
Ref: Total Voxels total number of voxels within the tumor volume 
1. HL-1 NV Number of voxels within habitat volume at level-1 
2. HL-2 NV  Number of voxels within habitat volume at level-2 
3. HL-3 NV Number of voxels within habitat volume at level-3 
4. HL-4 NV Number of voxels within habitat volume at level-4 
5. HL-1% Percentage of number of voxels within the habitat at Level-1  (No. of voxels within HL-1/total voxels within the tumor volume)  
6. HL-2% Percentage of number of voxels within the habitat at Level-2  (No. of voxels within HL-2/total voxels within the tumor volume) 
7. HL-3% Percentage of number of voxels within the habitat at Level-3  (No. of voxels within HL-3/total voxels within the tumor volume) 
8. HL-4% Percentage of number of voxels within the habitat at Level-4  (No. of voxels within HL-4/total voxels within the tumor volume) 
9. HL-1 NIV Number of independent subregion (habitat) volumes of Level-1 
10. HL-2 NIV Number of independent subregion (habitat) volumes of Level-2 
11. HL-3 NIV Number of independent subregion (habitat) volumes of Level-3 
12. HL-4 NIV Number of independent subregion (habitat) volumes of Level-4 
13. HL-1 NMax Number of voxels within the largest subregion (habitat) volume of Level-1 
14. HL-2 NMax Number of voxels within the largest subregion (habitat) volume of Level-2 
15. HL-3 NMax Number of voxels within the largest subregion (habitat) volume of Level-3 
16. HL-4 NMax Number of voxels within the largest subregion (habitat) volume of Level-4 
17. HL-1 NMin Number of voxels within the smallest subregion (habitat) volume of Level-1 
18. HL-2 NMin Number of voxels within the smallest subregion (habitat) volume of Level-2 
19. HL-3 NMin Number of voxels within the smallest subregion (habitat) volume of Level-3 
20. HL-4 NMin Number of voxels within the smallest subregion (habitat) volume of Level-4 
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21. HL-1 loc. Hmg.+ Overall local homogeneity based on all habitats of Level-1 
22. HL-2 loc. Hmg.+ Overall local homogeneity based on all habitats of Level-2 
23. HL-3 loc. Hmg.+ Overall local homogeneity based on all habitats of Level-3 
24. HL-4 loc. Hmg.+ Overall local homogeneity based on all habitats of Level-4 
25. HL-1 contrast+ Overall contrast based on all habitats of Level-1 
26. HL-2 contrast+ Overall contrast based on all habitats of Level-2 
27. HL-3 contrast+ Overall contrast based on all habitats of Level-3 
28. HL-4 contrast+ Overall contrast based on all habitats of Level-4 
29. SD of voxels% SD of the mean for percentage voxels within each habitat level 
30. PT_HL-1 IMEAN
VMAX1
PET Mean intensity within the maximum (largest) habitat volume of level 
1 
31. PT_HL-1 IMEAN
VMAX1
PET Mean intensity within the maximum (largest) habitat volume of level 
2 
32. PT_HL-1 IMEAN
VMAX1
PET Mean intensity within the maximum (largest) habitat volume of level 
3 
33. PT_HL-1 IMEAN
VMAX1
PET Mean intensity within the maximum (largest) habitat volume of level 
4 
34. CT_HL-1 IMEAN
VMAX1 CT Mean intensity within the maximum (largest) habitat volume of level 1 
35. CT_HL-2 IMEAN
VMAX1
CT Mean intensity within the maximum (largest) habitat volume of level 
2 
36. CT_HL-3 IMEAN
VMAX1
CT Mean intensity within the maximum (largest) habitat volume of level 
3 
37. CT_HL-4 IMEAN
VMAX1
CT Mean intensity within the maximum (largest) habitat volume of level 
4 
38. PT_HL-1_SD VMAX1 SD of PT_level-1 IMEAN VMAX1
39. PT_HL-2_SD
VMAX1 SD of PT_level-2 IMEAN VMAX1 
40. PT_HL-3_SD
VMAX1 SD of PT_level-3 IMEAN VMAX1 
41. PT_HL-4_SD
VMAX1 SD of PT_level-4 IMEAN VMAX1 
42. CT_HL-1_SD VMAX1 SD of CT_level-1 IMEAN VMAX1
43. CT_HL-1_SD VMAX1 SD of CT_level-2 IMEAN VMAX1
44. CT_HL-1_SD VMAX1 SD of CT_level-3 IMEAN VMAX1
45. CT_HL-1_SD VMAX1 SD of CT_level-4 IMEAN VMAX1
46. PT_HL-1 IMEAN
VMAX2
PT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 1 
47. PT_HL-2 IMEAN
VMAX2
PT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 2 
48. PT_HL-3 IMEAN
VMAX2
PT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 3 
49. PT_HL-4 IMEAN
VMAX2
PT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 4 
50. CT_HL-1 IMEAN
VMAX2
CT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 1 
51. CT_HL-2 IMEAN
VMAX2
CT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 2 
52. CT_HL-3 IMEAN
VMAX2
CT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 3 
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53. CT_HL-4 IMEAN
VMAX2
CT Mean intensity within the 2nd maximum (largest) habitat volume of 
level 4 
54. PT_HL-1 SD IMEAN
VMAX2 SD of PT_level-1 IMEAN VMAX2 
55. PT_HL-2 SD IMEAN
VMAX2 SD of PT_level-2 IMEAN VMAX2 
56. PT_HL-3 SD IMEAN
VMAX2 SD of PT_level-3 IMEAN VMAX2 
57. PT_HL-1 SD IMEAN
VMAX2 SD of PT_level-4 IMEAN VMAX2 
58. CT_HL-1 SD IMEAN
VMAX2 SD of PT_level-1 IMEAN VMAX2 
59. CT_HL-2 SD IMEAN
VMAX2 SD of PT_level-2 IMEAN VMAX2 
60. CT_HL-3 SD IMEAN
VMAX2 SD of PT_level-3 IMEAN VMAX2 
61. CT_HL-4 SD IMEAN
VMAX2 SD of PT_level-4 IMEAN VMAX2 
62. DHL1 Distance between 1st and 2nd largest habitats at Level-1 (mm) 
63. DHL2 Distance between 1st and 2nd largest habitats at Level-2 (mm) 
64. DHL3 Distance between 1st and 2nd largest habitats at Level-3 (mm) 
65. DHL4 Distance between 1st and 2nd largest habitats at Level-4 (mm) 
Consequently, we generated spatial mapping structures from each imaging modality (Figure 
6-1). To eliminate features’ voxel size dependence, we isotropically resampled both PET and CT 
images using cubic interpolation to a joint resolution of 3.27 × 3.27 × 3.27 mm. We also extracted 
the features using a fixed gray level to a discrete value of 64. We also used the same PET and CT 
standard reconstruction algorithm for all patients as mentioned in Table 5.2.  
Figure 6.1. an example of PET/CT delineated tumor volume separated into four distinct sub-regions 
(habitats) based on the median of voxel intensities.  Blue (Level 1): both PET/CT images have low voxel 
Intensity values; Green (Level 2):  PET image has high-intensity values, and CT image has low-intensity 
values; Yellow (Level 3): is the opposite of the green sub-region; Red (Level 4): both PET/CT images 
have high voxel intensity values. 
HL-1: Low-SUV + Low-HU
 HL-2: High-SUV + Low-HU
 HL-3: Low-SUV + High-HU 
HL-4: High-SUV + High-HU 
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6.2.5 Statistical Analysis 
6.2.5.1 Survival Analysis 
The overall survival (OS), disease-free survival (DFS), and the development of distant 
metastasis (DM) were assigned conventional scalar values of 0 and 1. The value of one represented 
the event of death or complication after treatment, whereas the value of zero indicated survival or 
absence of complication.  Time to overall survival is defined as the time from initial biopsy until 
the date of death or last follow-up, and time to disease-free survival is defined as the time from 
the primary treatment until the time which patient survives without any signs of the treated 
disease. The incidence of DFS included local recurrence (LR), regional recurrence (RR) and 
distant metastasis (DM) with a screening of all death incidents. LR was defined as disease 
recurrence within the cervix region and surrounding structures such as vaginal apex, parametrial, 
or paracervical progression. RR was defined as any recurrence within the pelvic region including 
related lymph nodes. DM was defined as any recurrence outside the pelvic area, which might 
include peritoneal spread, the involvement of supraclavicular, mediastinal, para-aortic lymph 
nodes, lung, liver, or bone. We used the Mann-Whitney U test to analyze the differences in the 
values of habitat feature between patients in response to each treatment endpoint or outcome. 
For the purpose of fair comparison among patients, we divided the cohort into two groups based 
on the median to overall survival time of the group with the event of death. Hence,  we included 
patients with time to OS greater than fifteen months (total of 102 patients). Hereinafter, the 
twenty-five deceased patients will be referred to as Group-1, and the ninety-nine survivals will be 
referred to as Group-2. We identified the optimal cut-off point for each feature using receiver 
operating characteristic (ROC) curve. Also, we only selected habitat features with ROC > 0.6 and 
p-value < 0.05 for further analysis. We compared and plotted OS and DFS differences in response
to univariate habitat features using Kaplan-Meier method and analyzed the differences using the 
log-rank test. Consequently, we assessed the predictive significance of the habitat features using 
univariate and multivariate Cox proportional hazards regression analysis with backward selection 
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method to determine the association of habitat features with the mentioned treatment endpoints. 
Hazard ratios and 95% confidence interval are reported. Multiple testing corrections were 
performed using the Benjamini–Hochberg method [16] to estimate the false discovery rate (FDR) 
with q-value <0.1.  We used the concordance index (Harrell’s C) to assess the performance of the 
models where C-index of 1.0 is considered as the perfect prediction model. We validated the best 
predictive model using multiple logistic regression (MLR) modeling with backward selection as 
part of 10-folds cross-validation technique.   
6.2.5.2 Prediction of the Development of Distant Metastases (DM)
As previously mentioned, we dichotomized the DM status into 1= DM, and 0=No-DM. For 
this analysis, we only included features that showed statistical significance in Mann-Whitney U. 
Before proceeding to the modeling step explained below. We randomly split the positive and 
negative examples from our original 124 patient cohort into a training set = 75 (60%), and an 
independent test set = 49 (40%). The training set consisted of highly unbalanced positive and 
negative samples. This inconsistency between groups could lead to inaccurate results. Therefore, 
we used the synthetic minority oversampling technique (SMOTE) [17] algorithm within WEKA 
software to balance the negative and positive samples. SMOTE is based on the technique of 
generalization the minority class decision region by generating synthetic cases. This method has 
been reported several times in similar radiomics studies [18-20] the positive and negative samples 
before and after SMOTE balancing can be found and supplementary table S7.
For this analysis, we only included features that showed statistical significance in 
Mann-Whitney U. We used support vector machine (SVM) classifier with radial basis kernel 
function (RBF) to generate a predictive model for DM. We used Relief-F [21] as a feature 
evaluator with ranker search method to assign ranks to the top five, ten, fifteen and twenty 
features during ten-fold cross-validation within the training set to choose features with high 
predictive power for DM in terms of AUC.
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6.3 Results 
For deceased patients, the median follow-up time was 15 months (Mean = 15.2 months, range 
3-27 months) and the median time for survivals was 37 months (Mean = 36.8 months, range: 15 
– 100 months).  The median time for patients who developed the disease in the form of recurrence
or distance metastasis after radiochemotherapy was ten months (Mean = 15.7 months, range: 4 – 
63) and for the median time for patients without post-treatment diseases was 34 months (Mean
= 34.1, range: 8 – 80 months). The two-year OS and DFS were 75.5% and 67.6%, respectively. 
According to Mann-Whitney U test, we found twenty-three habitat features (Table 6.1) that 
showed statistically significant difference between OS, DFS and DM groups. FIGO stage was the 
only clinical biomarker with significant differences between groups but not age or 
histopathological type. We only included the features passed these initial test for the further 
analysis. As previously mentioned, we studied overall and disease-free survivals on group-1  
consisting of twenty-five patients in comparison to group-2 consisting of ninety-nine patients. 
4 SVM library can be found at: http://www.csie.ntu.edu.tw/~cjlin/libsvm/ 
Two user-specified parameters for the kernels, soft margin or cost parameter C and 
Gaussian kernel parameter γ, need to be adjusted to generate an optimal SVM model. 
Parameter C controls over-fitting of the model by specifying a tolerance for 
misclassification. Parameter γ controls the degree of influence of a training example. 
We tuned the combination of parameters on the training data using the grid search 
method using the LibSVM tool developed by Chang and Lin [22], a freely available 
SVM software library4 to generate the SVM models and run the grid search while using 
default termination criteria. Finally, we evaluated the trained models on the 
independent test set. We used the statistical software package (SPSS) 24.0 and WEKA 
3.6 (The University of Waikato, Machine Learning Group, Hamilton, New Zealand) for 
all statistical and machine learning analyses in this study.
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The first group showed a trend of increased tumor volume than the second group. Also, group-1 
tumors contained a higher number of independent volumes of level-2 and level-4 habitats than 
group-2. Kaplan-Meier analysis showed that patients with early FIGO stages (Figure 6.2) had an 
improved overall and disease-free survival. The correlations between FIGO stage and both OS and 
DFS were significant (HR = 1.39, p = 0.005 and HR = 1.33, p = 0.008, respectively ). In contrast, 
Kaplan-Meier analysis did not show a statistically significant association between other clinical 
factors, such as age and histology, with either OS or DFS. 
Univariate Cox proportional hazard modeling revealed that twenty habitat features 
significantly correlate with OS and nineteen correlated with DFS. The results indicate that the 
selected habitat features (Table 6.2) significantly predicted for OS and DSF using univariate Cox 
regression models.   
Table 6.2. Mann Whitney-U test results. The p-value is two-sided and chosen to be significant at the level 
of 0.05. 
Overall survival Disease-free survival 
Parameters U-score Z-score p-value U-score Z-score p-value
FIGO stage 660.0 -2.46 0.014 841.50 -2.217 0.014 
HL1 NV 600.5 -2.82 0.005 872.00 -1.906 0.005 
HL2 NV+ 550.5 -3.21 0.001 870.00 -2.513 0.001 
HL3 NV 558.0 -3.15 0.002 907.50 -1.911 0.002 
HL4 NV+ 612.5 -2.72 0.006 822.00 -2.622 0.006 
HL2 NIV* 606.0 -2.79 0.005 879.00 -1.923 0.005 
HL4 NIV* 614.0 -2.81 0.005 850.00 -2.064 0.005 
HL1 NMax 591.0 -2.89 0.004 890.00 -1.778 0.004 
HL2 NMax 570.5 -3.05 0.002 850.00 -2.064 0.002 
HL3 NMax 501.0 -3.59 0.000 858.00 -2.317 0.000 
HL4 NMax 629.5 -2.59 0.010 863.50 -1.967 0.010 
HL1 local homog. 540.5 -3.28 0.001 894.00 -2.026 0.001 
HL2 local homog. 520.0 -3.44 0.001 858.00 -2.317 0.001 
HL3 local homog. 569.5 -3.06 0.002 984.00 -0.962 0.002 
HL4 local homog. 674.0 -2.24 0.025 852.00 -2.049 0.025 
HL1 contrast 537.0 -3.31 0.001 918.00 -1.918 0.001 
HL2 contrast 539.0 -3.30 0.001 893.00 -1.756 0.001 
HL3 contrast 591.0 -2.89 0.004 904.50 -1.963 0.004 
HL4 contrast 624.0 -2.63 0.008 872.00 -1.906 0.008 
PT-HL4-IMean+ 638.0 -2.59 0.012 880.00 -2.014 0.012 
CT-HL4-IMean+ 641.0 -2.57 0.003 894.00 -2.026 0.003 
DL2* 452.5 -3.97 0.010 790.00 -2.493 0.010 
DL3 668.0 -2.29 0.010 894.00 -2.026 0.010 
DL4 498.0 -3.71 0.000 849.00 -2.518 0.000 
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Consequently, we tested these features as independent prognostic features using multivariate 
Cox regression analysis (Table 6.2). Only eight features shown to be independently associated 
with OS on the multivariate basis. Specifically, HL-4 NV (HR = 4.57, p = 0.001), HL-2 NV (HR = 
4.35, p = 0.003), HL2 NIV (HR= 3.80, p = 0.005 ), HL4 NIV (3.06, p = 0.042), PT-HL4-IMean (HR 
= 4.73, p = 0.002), CT-HL4-IMean (HR = 3.21, p = 0.020), DHL4 (HR = 3.84, p =0.019), DL2 (2.80, 
p = 0.036.  
Figure 6.2. (a) Kaplan-Meier plots of overall survival (OS) according to FIGO stage. (b) Kaplan-Meier 
plots of disease-free survival (DFS) according to FIGO stage. Each test was significant at the p-value < 
0.05 level. 
On the other hand, the homogeneity features showed opposite association trend, as opposed 
to the previous features, with both endpoints. For example, HL-3 local homogeneity (HR = 0.23, 
p = 0.008) remained to be independently associated with OS.  Patients with a higher tumor 
habitat values of level-2 and 4 also showed an increased risk of developing disease failure (residual 
or recurrence disease). HL-2 NV (HR = 2.29, p = 0.028),  HL-4 NIV (HR = 1.90, p = 0.027), PT-
HL4-IMean (HR = 2.67, p = 0.010), DHL2 (HR = 4.07, p = 0.001), and CT-HL4-IMean (HR = 3.20, p 
= 0.007) were the only features remained independently associated for DFS. 
(a) (b) 
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According to Harrel’s C-score (Table 6.4), HL-2 NV and HL-4 NV combined had the best 
association with overall survival and risk of disease progression. Based on the ROC based cut-offs, 
patients with higher values of HL-2 NV (< 631 voxels) and HL-4 NV (<508 voxels) showed a higher 
likelihood of survival (Figure 6.3.a and b) and response to treatment (Figure 6.4.a and b). 
Table 6.3. FIGO stage and habitat features with significant predictive ability based on univariate cox model 
and log-rank test. Features that showed an independent association with treatment endpoints are marked. 
Overall survival Disease-free survival 
HR Log-rank HR Log-rank 
Parameters Score 95%CI p-value Score 95%CI p-value LB UB LB UB 
 FIGO stage 1.39 1.09 1.77 0.005 1.33 1.08 1.65 0.008 
 HL1 NV 3.74 1.70 8.24 0.001 2.23 1.08 4.61 0.026 
 HL2 NV* 4.60 1.72 12.27 0.001 2.36 1.17 4.75 0.012 
 HL3 NV 2.69 1.59 10.24 0.001 2.36 1.17 4.75 0.012 
 HL4 NV* 4.36 1.63 11.64 0.001 2.11 1.02 4.37 0.048 
 HL2 NIV+ 4.39 1.75 11.01 0.001 1.89 1.45 3.78 0.045 
 HL4 NIV* 3.78 1.29 11.02 0.009 1.91 1.89 4.11 0.021 
 HL1 NMax 4.60 1.72 12.27 0.001 2.23 1.08 4.61 0.026 
 HL2 NMax 5.55 1.66 18.57 0.002 2.82 1.22 6.52 0.011 
 HL3 NMax 2.99 1.36 6.60 0.004 1.82 0.90 3.67 0.089 
 HL4 NMax 5.65 1.94 16.48 0.001 2.78 1.29 6.01 0.006 
 HL1 local homog. 0.40 0.18 0.88 0.018 0.65 0.33 1.30 0.021 
 HL2 local homog. 0.23 0.08 0.68 0.009 0.67 0.33 1.35 0.254 
 HL3 local homog. 0.30 0.12 0.74 0.006 0.48 0.22 1.03 0.051 
 HL4 local homog. 0.11 0.02 0.82 0.023 0.50 0.19 1.30 0.142 
 HL1 contrast 4.80 1.80 12.79 0.001 1.78 0.88 3.57 0.100 
 HL2 contrast 7.34 1.73 31.17 0.001 2.39 1.03 5.51 0.034 
 HL3 contrast 4.65 1.94 11.15 0.001 1.83 0.92 3.63 0.077 
 HL4 contrast 4.81 1.80 12.81 0.001 2.02 0.99 4.12 0.047 
  PT-HL4-IMean* 4.78 1.78 12.79 0.001 2.68 1.27 5.64 0.007 
  CT-HL4-IMean* 4.47 1.53 13.04 0.003 3.20 1.38 7.39 0.004 
  PT HL-4 SD 2nd VMax 3.34 1.47 7.57 0.007 2.13 1.06 4.29 0.029 
  CT HL-4  IMean 2nd  VMax 2.99 1.29 6.94 0.012 2.26 1.05 4.87 0.031 
  CT HL-4 SD 2nd  VMax 2.31 0.96 5.54 0.002 1.99 0.99 3.98 0.047 
  DL2+ 7.01 2.80 17.58 0.001 2.52 1.26 5.01 0.006 
  DL3 2.52 1.05 6.02 0.031 2.23 1.06 4.70 0.029 
  DL4* 7.23 3.00 17.46 0.001 2.88 1.44 5.73 0.002 
FIGO: International Federation of Gynecology and Obstetrics, HR: hazard ratio. 
*Habitat feature that remained independently associated with OS and DFS in multivariate analysis.
+Habitat feature that remained independently associated with OS only in multivariate analysis. 
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(a) (b) 
(c) (d) 
Figure 6.3. Kaplan-Meier plots of overall survival (OS) according to habitat features: (a) HL-2 NV: 
number of voxels within the volume of habitat level-2,(b) HL-4 NV: number of voxels within the volume 
of habitat level-4, (c) PT HL-4 IMean: PT mean intensity within the maximum (largest ) habitat volume of 
level 4, and (d) CT HL-4 IMean: CT Mean intensity within the maximum (largest ) habitat volume of level 
4. all features had log-rank test p-value < 0.05. 
Table 6.4. Harrell’s C-score for prognostic models of OS and DFS 
OS DFS 
Harrell’s C-score Harrell’s C-score 
Model score 95%CI LB 95%CI UB score 95%CI LB 95%CI UB 
Univariate 
   FIGO stage 0.669 0.619 0.720 0.646 0.572 0.720 
   HL-2 NV
   HL-4 NV 
0.733 0.667 0.799 0.620 0.529 0.711 
   HL2 NIV
   HL4 NIV 
0.642 0.555 0.730 0.611 0.509 0.813 
   PT-HL4-IMean
   CT-HL4-IMean 
0.616 0.546 0.687 0.619 0.522 0.716 
   DL2
   DL4 
0.705 0.644 0.768 0.645 0.523 0.729 
   DL4 0.750 0.633 0.835 0.650 0.547 0.753 
  HL3 local homog. 0.344 0.255 0.434 0.382 0.186 0.578 
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When evaluated using multiple logistic regression models, four MLRs consisting of the 
eight features predicted for OS, and one model predicted for DFS (Table 6.3).  As for the 
correlation with the dichotomized treatment outcomes of DM, SVM classifier with the top-5 
features consisting of HL-2 NV, PT-HL-4 IMEAN, CT-HL-4 IMEAN, HL-4 NIV, DHL4  scored the highest 
AUC, with SMOTE and No-SMOTE balancing, in comparison with MLR models (Table 6.4, Figure 
6.5) and SVM top-10 or top-20 classifiers high association with DM.  
Figure 6.4. Kaplan-Meier plots of disease free survival (DFS) according to habitat features: (a) HL-2 NV: 
number of voxels within the volume of habitat level-2,(b) HL-4 NV: number of voxels within the volume 
of habitat level-4, (c) PT HL-4 IMean: PT mean intensity within the maximum (largest ) habitat volume of 
level 4 , and (d) CT HL-4 IMean: CT Mean intensity within the maximum (largest ) habitat volume of level 
4. all features had log-rank test p-value < 0.05.
(a) (b) 
(c) (d) 
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Figure 6.5. Comparison between support vector machine (SVM) and multiple logistic regression modeling 
(MLR) regarding prediction of development of distant metastasis (DM) 
6.4 Discussion 
Although other research studies quantitatively investigated tumor volumes through 
radiomics, fewer studies have focused on the potential of tumor habitat features analysis [23]. 
After dividing the tumor into four habitats based on voxel intensity, we found that the majority of 
tumor volumes were characterized by large habitat subvolumes of level-2 (HL-2) and level-4 (HL-
4). These two habitat levels were located near the core of the tumor while being surrounded by 
level-1 (HL-1) and level-3 (HL-3)  at the tumors’ peripheries. 
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Table 6.5. Model evaluation using multiple logistic regressions with backward selection as part of 10-folds 
cross-validation. 
OS DFS 
MLR RC OR (95% CI) p-value
AUC 
(95%CI) RC 
OR 
(95% CI) p-value 
AUC
(95%CI) 
M
od
el
 1
 
HL-2 NV 1.93 6.91 (2.22-21.49) 
0.001 
0.004 
0.83 
(0.72-0.93) 1.224 
3.40
(1.42-8.12) 0.006
0.73 
(0.63-.86) 
HL-4 NV 1.65 5.21 (1.70-15.94) 
0.001 Constant -2.83 -1.224
M
od
el
 2
 
HL2 NIV 1.48 4.39 (1.54-12.55) 
0.006 
0.060 
0.74 
(0.62-0.86) 
HL4 NIV 1.16 3.18 (0.95-10.61) 
0.001 
0.165 1.18 
(1.00-1.39) 
0.048 
Constant -2.81 -1.23
M
od
el
 3
 
PT-HL4-IMEAN 1.71 5.55 (1.83-16.87) 0.002 
0.76 
(0.66-0.85) 
1.12 3.07 
(1.222-7.73) 
0.017 0.72 (0.62-0.82) 
CT-HL4-IMEAN 1.41 4.10 (1.33-12.63) 0.014 1.42 
4.15 
(1.55-11.13) 
0.005 
Constant -3.14 0.001 -2.29
M
od
el
 4
 
DHL2 1.16 
3.18 
(1.05-9.59) 
0.040 0.76 
(0.65-0.87) 
DHL4 1.45 4.28 (1.25-14.67) 0.021 0.079 
1.082 
(1.01-1.19) 
0.01 0.70 (0.61-0.90) 
Constant -2.76 0.001 -1.18
Our result highlights the significant association between the treatment endpoints, namely OS 
and DFS, with HL-2 NV (the number of voxels within HL-2), and HL-4 NV (the number of voxels 
within HL-4). We showed that the increase in the values of these features above the cut-off 
thresholds was associated with inferior outcomes. The intensity of SUV and HU in habitat level-4 
(PT-HL4-IMean and CT-HL4-IMean, respectively) were also independently associated with OS and 
DFS. The predictive importance of such features was confirmed by the outcome of the Harrel’s C-
statistic and multiple logistic regression validations where Model-1 ( HL-2 and HL-4 NV) scored 
the highest C-score and AUC. Such features support the concept that tumor heterogeneity may be 
a significant predictor of outcome in cervical cancer. Hence, these features could be considered as 
potential tools to evaluate the aggressiveness of the cervical tumors, i.e., imaging biomarkers.
The results of this study imply that habitat features with high-SUV intensity were superior 
to habitats with high-HU intensity in terms of predicting for patients’ OS and DFS. This finding 
might be due to the functional nature of PET, which is based on FDG uptake representing an 
inherent functional tumor trait as opposed to the anatomical nature of CT that represent
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variations in electron/mass density within tumor regions. 
Table 6.6. Comparison between the performance of the Support Vector Machine (SVM) top-5 features 
classifier with radial based kernel (RBF) and the multiple logistic regression models (MLR) as predictors of 
distant metastasis (DM). 
Method Radiomic features Sensitivity (%) Specificity (%) Accuracy (%) AUC 
SVM 
HL-2 NV 
PT-HL-4 IMean 
CT-HL-4 IMean 
HL-4 NIV
DHL4
72.5 21.9 72.5 0.75 
MLR HL-2 NV 
 PT-HL-4 IMean 
65.2 34.1 42.0 0.69 
Based on univariate analysis, FIGO stage was the only clinical parameter to be significantly 
associated with all treatment endpoints where late-stage patients were associated with poor 
survival and prone to disease recurrence or metastasis.  
Interestingly, we found FIGO staging to be a significant indicator for the studied endpoints 
although a high portion of the patient cohort had IIB (37.1%) and IIIB (25.0%) stages. This result 
is in accordance with the American Joint Committee on Cancer (AJCC) staging manual [24]. On 
the other hand, the fact that tumor histology showed insignificant association with both treatment 
outcomes might be due to the high percentage of squamous cell carcinoma type (82.3%) in 
comparison to the adenocarcinoma type (13.7%). The high predictive ability of tumor volume with 
treatment outcomes reported in this study and the others cited [25-27] encouraged us to 
investigate this promising biomarker thoroughly.
To further evaluate the potential of our approach, we used machine learning 
techniques to correlate the habitat features with distant metastasis. We compared the 
performance of multiple logistic modeling with support vector machine (Figure 6.5). The 
SVM classifier model consisting of top-5 features scored the highest AUC in comparison with 
both methods in comparison with top-1o and top-20 SVM classifiers. 
108 
Also, using SMOTE as part of SVM modeling increased the prediction power by 5%. The reason 
that these features showed significant correlations with DM but not for DFS might be due to the 
higher number of patients in the original cohort as opposed to the screened cohort for survival 
analysis. As for the better SVM predictive performance in comparison to MLR, the reason might 
be because nonlinear function better classifies patients with and without the development of 
distant metastasis, especially in such heterogeneous type of tumors [28, 29]. 
The radiomic analysis of habitat features complements the definition of habitat features. 
Subvolumes of low PET/CT intensities (HL-3) was characterized by high level of voxel intensity 
homogeneity, and low contrast whereas the opposite trend was noticed in regions of high 
intensities such as HL-2, and HL-4. Such distribution patterns of habitats in cervical cancer 
tumors enables us to identify tumor regions with aggressive progression from those that are less 
active [14]. 
 As part of our investigation, we derived a semantic (geographic) feature (Figure 6.6) that 
measures the distance between the two largest habitats of the same level within the tumor volume 
(DHL).  
Figure 6.6. Illustration of the definition of the distance between two habitat volumes of the same level 
(DHL). 
The distance between each of the two largest habitat levels (DHL-2 and DHL-4) showed 
acceptable correlation with overall tumor volume (Supplementary Table S.2) based on Pearson 
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correlation test and statistical significance association with FIGO stage based on Kruskal-Wallis 
test (Supplementary Table S.3). According to the outcome of the modeling validation analysis, a 
model consisting of DHL-2 and DHL-4 significantly predicted for the OS (AUC=0.76). However, only 
DHL-4 predicted for DFS and DM. Since we are the first to report these type of semantic features in 
habitat or radiomic studies, we suggest further investigation of these features predictive ability to 
take place on a larger dataset.   Moreover, the distance between HL-2 and HL-4 volumes were 
shorter in comparison to the larger distance between HL-1 and HL-3, which is understandable 
due to the peripheral location of the latter habitat levels. This finding could help to visualize the 
geometrical aspects of tumors as well as the direction of tumor growth. Also, integrating the 
semantic feature of DHL with the habitat features of NV and NIV could also serve as a guidance tool 
during the process of tumor segmentation. For example, the physician would be guided by the 
exact location of high and low intensities regions to avoid over or under segmenting the tumor 
volume.  
Another example of a promising clinical application of habitats is the ability to locate and 
quantify the tumoral spatial variation through mapping the tumor voxel distribution with high 
and low intensities into distinct habitat levels as well as tracking the distance between these levels 
before, during and after radiotherapy. Such approach has the potential to establish a scale for 
differentiating tumors based on heterogeneity levels, which could aid to personalize radiotherapy 
for cervical cancer patients. In other words, the use of the presented habitat features as a potential 
treatment outcome predictors may allow radiation oncologists to enhance their 
radiochemotherapy plans by selecting patient-specific dose escalation or treatment modality 
protocols.  
The presented tumor habitats are based on computational analysis of heterogeneous 
variations within tumors subregions. The linkage between our approach and the tumor cellular 
properties might lead to enhance our understanding about sophisticated cancerous cells 
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biological processes. From a radiological perspective, tumor exhibits variations in gray-level 
intensity heterogeneity, which can be used to aid clinicians to identify levels of tumor 
aggressiveness, density or necrosis. From a biological perspective, the spatial tumor variations 
may represent tissue and cellular properties such as proliferation, necrosis, and fibrosis. In this 
study, we showed that the four distinct habitat level features, based on gray-level intensity 
heterogeneity, have a significant association with OS and DFS, as in the case of  patients with a 
higher tumor habitat values of level-2 and 4 who showed an increased risk of developing disease 
failure (residual or recurrence disease). Furthermore, some of these features highly predicted for 
the development of DM. Accordingly, these results would permit the integration of habitat and 
biological biomarkers to present deeper understanding of tumor heterogeneity and biology. 
 A limitation of this study might be found in the retrospective nature, relatively short overall 
survival times and the limited number of patients. On the other hand, in this study, we focused 
on generating a patient database that is consistent regarding treatment modality, imaging 
techniques, and tumor segmentation method. 
6.5 Conclusion 
This study presents the first step to investigate the dynamics of intratumor heterogeneity 
using  PET/CT imaging habitats. The ability to generate robust non-invasive treatment outcome 
predictors would be a contribution of vital importance in the clinic of radiation oncology. We 
presented spatial heterogeneity descriptors as tools to provide new insights into cervical tumor 
functional and anatomical composition.  We also demonstrated the prognostic and predictive 
abilities of some habitat features for overall survival, disease-free survival, and distant metastasis 
for cervical cancer patients treated with radiochemotherapy. Therefore, PET/CT-radiologically 
defined habitats warrant further development for quantification of tumor volumes. 
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7 CHAPTER 7: CONCLUSIONS AND FUTURE DIRECTIONS 
7.1 Dissertation Conclusions 
         The ability to definitively cure cervical cancer patients is limited by the clinical ability to 
eradicate the disease both locally and regionally and to prevent locoregional and distant 
progression. Accordingly, clinicians face the problem of balancing proper treatment intensity 
and treatment-related toxicity. Some of the important applications of radiologic imaging in 
oncology include; to detect the primary disease, stage patients regarding the metastatic 
spread of tumors, assess response to treatments as well as surveillance for locoregional and 
distant disease recurrence. Therefore, having access to treatment outcome predictors could 
contribute to individualizing radiochemotherapy treatment plans by allowing for 
differential dosing, and customized multimodality regimens for each specific patient. In 
recent years, tumor heterogeneity descriptors based on separate analysis of PET and CT images 
have become increasingly valuable tools for predicting the outcomes of different 
treatments. While PET images provide functional information about the metabolic 
activity of tumors, CT images provide anatomical target definition and are necessary for 
radiotherapy dose calculations. 
      In this study, we primarily evaluated the ability of combined PET/CT radiomic features 
to develop predictive models based on different statistical modeling techniques. In the light 
of the results our studies, radiomic features might provide the physician with tools that 
go beyond the traditional biological descriptors for treatment outcome assessment. In 
the first chapter, we examined the reproducibility of several radiomic features extracted 
from 18F-FDG PET images of cervical cancer patients in response to the variation of 
segmentation methods and the number of gray intensity levels. According to our results, most 
of the radiomics within the scope of this study were highly dependent on the choice of imaging 
parameters such as segmentation method, gray level intensity discretization of metabolic
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cervical tumor volume as well as the PET reconstruction algorithm. This study shows that 
such testing is necessary before employing these features in clinical studies. Therefore, we 
suggest that testing the reproducibility of radiomic features should be performed before 
proceeding to employ them in clinical applications. 
        In conclusion, we found that tuning the parameters to the most reproducible setup and 
correcting the radiomic formulas to account for parameter variations can eliminate, or at least 
minimize such dependency.  In the second chapter, we presented radiomics as an emerging tool 
to extract more inherent information from FDG-PET images. We developed radiomic signature 
models that enhanced the predictive power for two treatment outcomes. Namely, four and 
two models significantly predicted for development of distant metastasis (DM) and loco-
regional recurrence (LRR), respectively, following standard of care chemoradiotherapy 
treatment. Based on the area under the receiver operator characteristic curves (AUC), these 
models had more predictive power in comparison to both radiomic univariate logistic models 
and the conventional SUV measurements such as SUVMAX and SUVPEAK. Among the best 
performing textural features, SZV and SAE (GLSZM features), second-order mean and 
different entropy (GLCM features) predicted for the loco-regionally recurrent disease.  On 
the other hand, NGTDM features such as texture strength and coarseness along with shape 
features such as metabolic tumor volume, surface area, asphericity and spherical disproportion 
were shown to be highly predictive features for the development of distant metastasis. Our 
results suggest that the proposed radiomic signature models might be used for correlation 
with clinical treatment outcomes for cervical cancer treated with definitive radiochemotherapy, 
and warrant further investigation. We also encourage inter-center studies, as larger patient 
cohorts are needed to validate the results. By identifying radiomic features that are insensitive 
of imaging parameters, this scope of research might lead to better assessment of therapy 
response, and provide a clearer understanding of the relation between radiomic features and 
tissue heterogeneity characteristics. 
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PET is a functional type of imaging, which reveals the physiologic or biochemical function of the 
organ of interest while CT is an anatomical type of imaging, which reveals the structure of the 
organ of interest. In the third chapter, we aimed to integrate image information from both 
modalities to generate radiomic predictive models with better tumor description. We also aimed 
to overcome the mathematical limitations of multiple logistic regression (MLR) modeling by using 
the more advanced support vector machine (SVM) classifiers. 
     Applying the latter approach increased the performance of radiomic features to predict 
the development of distant metastasis. In the fourth chapter, we took another direction by 
quantitatively analyze the tumor by dividing its gross volume into sub-regions (habitats) 
based on heterogeneity levels. Our investigative approach aimed to find a lead to better 
understanding of tumor heterogeneity characteristics. Equipped with the results from previous 
studies, we presented spatial heterogeneity descriptors as potential tools to provide new 
insights into cervical tumor functional and anatomical composition as well as to predict 
treatment outcomes in cervical cancer patients by analyzing the variation within the tumor 
habitats on pre-treatment PET/CT.  
       The clinical feasibility of this study lies in the fact that both the radiologists and the 
radiation oncologists would like to have a non-invasive confirmation tool, in contrast to 
pathological biopsies, which discriminates among high and low heterogeneous tumor regions. 
Therefore, introducing a robust tool with such potential might contribute to readjust the 
radiation therapy plan to accommodate for smaller irradiated volume, which will, in turn, could 
spare more healthy organs at risk.  As for study results, we found that the habitats of 
combined high-intensity PET/CT and high PET intensity showed a significant difference in 
survival times between the two studied groups. PET/CT-radiologically defined 
habitats may provide valuable predictive descriptors of cervical cancer tumors. Moreover, 
since each tumor site is characterized by variant heterogeneity, treatment protocol, and 
prognosis; site-specific studies are considered mandatory to understand the process and 
limitations of radiomics. 
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7.2 Future Directions 
       A primary future direction might be achieved through the combination of two –omics 
fields, radiomics, and genomic features, to form the field of radiogenomics, which is the 
mining of radiomic data to detect correlations with genomic patterns [1]. Complementing both 
fields, and research aim and strategies may provide a better understanding of the intratumor 
dynamics of cancer at the genetic level [2]. Such studies are much needed in PET since there is 
relatively fewer investigation of the role of radiogenomics in PET in comparison with CT and MR 
in oncology [3]. As we previously stated, the identification of features describing sub-
regional (habitats) characteristics could potentially provide clinically relevant information 
that aids in designing a more patient-specific radiation therapy plan. For example, a focus on 
the systematic integration of tumor habitats features with biological and pathological markers  [4] 
might lead to an enhanced understanding of areas of differing underlying physiology, 
morphology, metabolism, and behavior within a tumor.
      To our knowledge, there is still a lack of studies with the emphasis on quantitatively 
analyze the voxel distribution and heterogeneity patterns within the tumor volume based on the 
combined modalities of PET/CT or PET/MR [5, 6]. Accordingly, we highly recommend 
this scope of research. The evolution of research interests and innovations is guaranteed 
to have a stronger impact if accompanied by robust research methodology tools. The most 
important of these tools are the statistical and machine learning analysis tools.  There has been 
a remarkable advancement in the field of statistical modeling. In fact, the field of statistics is 
changing to face the challenges presented modern technologies. In the field of quantitative 
imaging, the primary challenge lies in the process of learning from the wealth of data that is 
inherent in medical images. Recruiting such tools and methods would allow for refining the design 
of quantitative imaging studies, aid the medical community to accept the new paradigm shift in 
the field, as well as cement its role as a new marker in the assessment of tumor response or stage.
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           On a similar note, generating an open-access imaging database would help to combine the 
effort for facilitating appropriate patient subsets for specific research purpose. Linkage of 
such database with clinical, genomic and phenotypic information will be of utmost importance. 
A key milestone has been reached in this field by the National Cancer Institute (NCI) intuitive 
for the Quantitative Imaging Network (QIN) [7, 8].  
        Although we presented promising findings, we also encourage inter-center studies with 
larger patient cohorts for validation. Preferably a cohort with high median time to event, 
outcome, which allows tracking patients’ radiobiological effect of treatment on an extended 
period post radiochemotherapy treatment, which will result in more reliable results regarding 
outcome prediction.  Regardless some technical challenges, PET/CT is progressively granted 
acceptance as a cornerstone functional imaging modality in oncology clinics. One major PET 
challenge is scanner’s low spatial resolution that often leads to poor anatomical localization of 
tumors [9]. High spatial resolution is critical to differentiate between regions with pathological 
from physiological radiotracer uptake to define the correct tumor diagnosis and stage. The lack 
of consensus on several scanning parameters such as reconstruction algorithm, slice parameters, 
and radiopharmaceutical administration protocols between cancer centers add difficulty for 
presenting radiomics as a decision support tool in the clinic [10, 11]. Therefore, efforts are 
needed to overcome these limitations. 
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1.1 APPENDIX A: SUPPLEMENTARY TABLES 
1. Supplementary Table S.1. Heatmap illustrating the Dice coefficient (DC) for manual and
semi-automatic methods. The volumes are sorted from small to large based on MTV1. A perfect
overlap between pairs of tumor volumes is indicated by a DC value of 1.0. Acceptance Criteria:
DC≥ 0.75 for all tumor pairs.
Case 
No. 
MTV1 MTV2 GBSV 
MTV1-
MTV2 
MTV1-
GBSV 
MTV2-
GBSV 
DC > 
0.75 
(y/n) 
1 8.90 8.70 27.48 0.91 0.48 0.45 n 
2 9.29 8.90 14.38 0.93 0.61 0.58 n 
3 9.98 11.64 16.63 0.73 0.65 0.69 n 
4 12.17 5.87 7.92 0.44 0.50 0.69 n 
5 12.62 31.78 14.17 0.53 0.69 0.54 n 
6 13.10 15.94 17.02 0.71 0.80 0.88 y 
7 14.47 8.12 9.88 0.68 0.60 0.74 n 
8 16.86 14.69 16.43 0.94 0.84 0.85 y 
9 17.99 24.74 22.88 0.75 0.79 0.91 y 
10 19.27 24.64 23.47 0.75 0.88 0.85 y 
11 20.53 20.24 22.08 0.97 0.95 0.92 y 
12 20.83 20.24 22.20 0.98 0.91 0.90 y 
13 21.71 22.49 17.51 0.92 0.72 0.76 y 
14 21.71 22.69 29.63 0.91 0.74 0.76 y 
15 22.00 19.95 17.33 0.91 0.78 0.88 y 
16 22.30 26.60 30.51 0.86 0.83 0.88 y 
17 24.84 25.72 22.69 0.96 0.75 0.84 y 
18 26.40 35.30 29.44 0.77 0.90 0.90 y 
19 30.12 33.64 31.89 0.85 0.89 0.80 y 
20 30.90 29.53 26.00 0.95 0.77 0.80 y 
21 31.49 55.16 79.70 0.62 0.70 0.69 n 
22 32.86 37.77 43.64 0.92 0.82 0.75 y 
23 33.25 35.00 41.76 0.92 0.76 0.80 y 
24 36.28 39.80 42.25 0.88 0.88 0.92 y 
25 38.04 39.41 33.15 0.94 0.88 0.85 y 
26 39.80 45.57 42.35 0.83 0.92 0.93 y 
27 41.86 55.16 55.35 0.87 0.83 0.92 y 
28 42.64 39.31 48.31 0.78 0.89 0.84 y 
29 43.00 47.04 55.65 0.88 0.86 0.86 y 
30 43.68 52.71 53.40 0.75 0.85 0.90 y 
31 44.73 51.29 51.85 0.85 0.91 0.93 y 
32 44.81 52.16 65.81 0.75 0.77 0.87 y 
33 45.28 53.89 63.76 0.79 0.83 0.88 y 
34 49.39 54.28 52.00 0.88 0.82 0.83 y 
35 54.24 66.89 71.06 0.75 0.86 0.92 y 
36 55.00 59.66 56.82 0.90 0.77 0.74 y 
37 55.16 66.50 56.00 0.78 0.91 0.83 y 
38 57.55 69.47 71.59 0.78 0.79 0.80 y 
39 60.24 66.00 70.00 0.89 0.87 0.82 y 
40 64.89 79.02 71.76 0.79 0.93 0.89 y 
41 66.01 54.28 56.72 0.79 0.83 0.85 y 
42 67.58 71.00 56.72 0.93 0.73 0.82 y 
43 69.00 66.70 68.75 0.93 0.92 0.87 y 
44 69.63 171.22 118.63 0.56 0.55 0.69 n 
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45 72.57 89.78 71.49 0.76 0.88 0.86 y 
46 74.33 94.12 90.69 0.76 0.88 0.91 y 
47 76.38 79.83 74.23 0.94 0.93 0.92 y 
48 78.15 82.54 98.80 0.87 0.81 0.90 y 
49 79.22 160.88 133.69 0.43 0.63 0.69 n 
50 83.10 81.06 95.40 0.96 0.88 0.90 y 
51 84.79 90.66 82.00 0.93 0.84 0.90 y 
52 87.63 106.01 95.84 0.79 0.82 0.81 y 
53 89.39 88.00 119.80 0.98 0.85 0.83 y 
54 92.12 102.00 93.00 0.88 0.87 0.87 y 
55 92.51 105.33 88.00 0.85 0.89 0.90 y 
56 98.18 116.63 109.00 0.76 0.92 0.83 y 
57 98.68 115.30 106.60 0.82 0.87 0.87 y 
58 101.06 82.84 121.92 0.80 0.78 0.76 y 
59 104.93 118.05 120.19 0.87 0.89 0.89 y 
60 107.00 112.00 120.88 0.94 0.82 0.93 y 
61 108.36 98.32 98.36 0.89 0.93 0.94 y 
62 109.92 136.52 131.48 0.75 0.89 0.90 y 
63 119.02 130.00 125.00 0.90 0.79 0.74 y 
64 124.10 149.53 130.00 0.80 0.85 0.80 y 
65 124.64 191.19 107.48 0.46 0.68 0.55 n 
66 128.61 151.57 149.63 0.82 0.80 0.79 y 
67 129.09 289.67 197.75 0.40 0.73 0.73 n 
68 130.36 147.18 145.52 0.86 0.83 0.86 y 
69 140.69 140.52 174.12 0.99 0.90 0.89 y 
70 143.27 169.57 160.68 0.82 0.84 0.83 y 
71 146.70 157.81 134.47 0.92 0.89 0.82 y 
72 151.29 188.17 161.07 0.75 0.93 0.83 y 
73 157.16 274.12 237.84 0.56 0.69 0.68 n 
74 162.00 153.64 154.91 0.85 0.79 0.82 y 
75 163.91 324.20 129.68 0.42 0.62 0.53 n 
76 165.08 199.80 183.27 0.78 0.93 0.92 y 
77 169.52 191.64 120.00 0.86 0.74 0.70 n 
78 178.87 187.48 166.04 0.95 0.80 0.77 y 
79 184.45 164.59 158.31 0.82 0.75 0.76 y 
80 248.40 383.26 131.05 0.45 0.59 0.50 n 
123 
 
2. Supplementary Table, S. 2 Descriptive Statistics for Mean Percentage Difference (d) 
measured for Segmentation Method (SM) pairs of: 1, ) MTV1-GBSV, and 2) MTV2-GBSV. 
MTV1: First Manually Segmented Metabolic Tumor Volume, Reference Volume. MTV2: Second 
Manually Segmented Metabolic Tumor Volume, Reference Volume. GBSV: Graphical-Based 
(Region-Based) Semi-automatic volume. 
Tables 1 -4 
information           
Sample size (n) = 65 patients          
Reproducibility 
criteria:           
1) Check if: d<=30% and SD(d) <=35         
2) Reproducibility Level (RL) as per the 
table below          
Color code           
Failed to meet criteria 
1           
Features meet criteria 1 and 2 with RL: 
High/Med/Low         
            
Reproducibility Level 
(RL)           
High RL <= 30         
Med 30< RL < =45         
Low 45 < RL <= 50         
NR* RL > 50         
            
NR: Not reproducible           
            
  High Med Low NR   
MTV1-GBSV 
15 4 3 65 
  
MTV2-GBSV   
64-32 7 3 1 0 
 
64-128 7 4 2 0 
 
64-256 4 4 2 1 
 
OSEM-FORIR 
21 1 4 13  
OSEM-FOREFBP 
 
OSEM-3DRP 0 9 4 26 
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Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
A) GLCM Features Statistic Statistic High/Med/Low/NR 
_autocorrelation_MTV1_GBSV 7.61 33.57 
NR 
_autocorrelation_MTV2_GBSV 12.11 35.34 
_Cluster_prominence_MTV1_GBSV -17.60 37.98   
_Cluster_prominence_MTV2_GBSV -3.98 38.81   
_Cluster_Shade_MTV1_GBSV 6.18 36.66   
_Cluster_Shade_MTV2_GBSV 2.73 39.87   
_Cluster_tendency_MTV1_GBSV -12.43 31.60 
NR 
_Cluster_tendency_MTV2_GBSV -2.35 31.07 
_Contrast_MTV1_GBSV 0.07 35.01 
NR 
_Contrast_MTV2_GBSV 19.45 31.37 
_Correlation_MTV1_GBSV -11.77 40.86   
_Correlation_MTV2_GBSV -16.01 41.69   
_Difference_Average_MTV1_GBSV 2.60 19.11 
High 
_Difference_Average_MTV2_GBSV 4.58 22.53 
_Difference_Entropy_MTV1_GBSV -2.16 17.76 
High 
_Difference_Entropy_MTV2_GBSV -2.38 13.68 
_Difference_Variance_MTV1_GBSV 1.52 18.94 
Low 
_Difference_Variance_MTV2_GBSV 1.60 25.08 
_dissimilarity_MTV1_GBSV 12.05 23.72 
Low 
_dissimilarity_MTV2_GBSV 10.94 31.69 
_energy_MTV1_GBSV -0.66 12.57 
NR 
_energy_MTV2_GBSV -10.37 10.50 
_Entropy_MTV1_GBSV -0.23 29.05 
High 
_Entropy_MTV2_GBSV 1.03 26.60 
_Gnorm_Entropy_MTV1_GBSV -0.03 18.43 
High 
_Gnorm_Entropy_MTV2_GBSV 0.79 15.01 
_Homogeneity1_MTV1_GBSV -0.80 23.49 
Med 
_Homogeneity1_MTV2_GBSV -8.37 20.05 
_Info_Correlation1_MTV1_GBSV -8.37 8.40 
NR 
_Info_Correlation1_MTV2_GBSV -3.02 8.49 
_Info_Correlation2_MTV1_GBSV -3.37 6.61 
High 
_Info_Correlation2_MTV2_GBSV -3.02 10.21 
_Inverse_difference_moment_MTV1_GBSV -0.03 2.11 
High 
_Inverse_difference_moment_MTV2_GBSV -1.20 2.18 
_Inverse_difference_MTV1_GBSV -0.10 1.61 
High 
_Inverse_difference_MTV2_GBSV -2.20 5.41 
_Inverse_variance_MTV1_GBSV -9.31 25.48 
NR 
_Inverse_variance_MTV2_GBSV -33.89 24.57 
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_Inverse_Variance_P_MTV1_GBSV -1.76 25.35 
NR 
_Inverse_Variance_P_MTV2_GBSV -12.97 21.68 
_Vnorm_Inverse_Variance_P_MTV1_GBSV -3.68 42.06 
NR 
_Vnorm_Inverse_Variance_P_MTV2_GBSV -16.64 32.97 
_Local_homogeneity_MTV1_GBSV -2.03 44.80 
NR 
_Local_homogeneity_MTV2_GBSV -12.64 47.61 
_Max_Probability_MTV1_GBSV -6.30 21.32 
NR 
_Max_Probability_MTV2_GBSV -11.47 19.87 
_Mean_MTV1_GBSV -7.07 12.28 
NR 
_Mean_MTV2_GBSV -25.43 9.97 
_Vnorm_Mean_MTV1_GBSV -1.11 31.14 
Med 
_Vnorm_Mean_MTV2_GBSV -5.66 19.87 
_VGnorm_Mean_MTV1_GBSV -2.08 3.57 
High 
_VGnorm_Mean_MTV2_GBSV -3.85 2.54 
_Sum_Average_MTV1_GBSV 4.61 33.43 
NR 
_Sum_Average_MTV2_GBSV 8.39 30.11 
_Gnorm_Sum_Average_MTV1_GBSV 5.45 58.89 
NR 
_Gnorm_Sum_Average_MTV2_GBSV 7.43 59.42 
_Sum_Entropy_MTV1_GBSV -0.54 25.15 
High 
_Sum_Entropy_MTV2_GBSV 1.08 14.52 
_Gnorm_Sum_Entropy_MTV1_GBSV -0.34 11.20 
High 
_Gnorm_Sum_Entropy_MTV2_GBSV 0.79 15.31 
_Sum_Variance_MTV1_GBSV -13.28 33.25 
NR 
_Sum_Variance_MTV2_GBSV -2.25 29.89 
_Gnorm_Sum_Variance_MTV1_GBSV -13.28 59.01 
NR 
_Gnorm_Sum_Variance_MTV2_GBSV -2.25 52.30 
_Variance_MTV1_GBSV 0.82 42.58   
_Variance_MTV2_GBSV -0.99 52.66   
_Vnorm_Variance_MTV1_GBSV 6.62 49.48   
_Vnorm_Variance_MTV2_GBSV 19.92 48.93   
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Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
B) GLRLM features Statistic Statistic High/Med/Low/NR 
_SRE_MTV1_GBSV 0.17 2.89 
High 
_SRE_MTV2_GBSV 0.42 2.24 
_SRHGE_MTV1_GBSV 8.31 7.64 
NR 
_SRHGE_MTV2_GBSV 12.30 8.51 
_SRLGE_MTV1_GBSV 7.41 7.10 
NR 
_SRLGE_MTV2_GBSV 24.90 7.59 
_RLNU_MTV1_GBSV -7.58 8.45 
NR 
_RLNU_MTV2_GBSV -19.36 7.48 
_Vnorm_RLNU_MTV1_GBSV -0.78 7.70 
NR 
_Vnorm_RLNU_MTV2_GBSV -0.84 8.10 
_GLNU_MTV1_GBSV -7.76 10.69 
NR 
_GLNU_MTV2_GBSV -24.47 10.18 
_Gnorm_GLNU_MTV1_GBSV -8.82 11.18 
NR 
_Gnorm_GLNU_MTV2_GBSV -14.26 11.89 
_Vnorm_GLNU_MTV1_GBSV -1.29 11.58 
NR 
_Vnorm_GLNU_MTV2_GBSV -16.55 10.71 
_VGnorm_GLNU_MTV1_GBSV -2.14 6.65 
NR 
_VGnorm_GLNU_MTV2_GBSV 5.12 7.29 
_HGRE_MTV1_GBSV 7.38 5.01 
NR 
_HGRE_MTV2_GBSV 12.10 4.42 
_Gnorm_HGRE_MTV1_GBSV 8.29 2.52 
NR 
_Gnorm_HGRE_MTV2_GBSV 24.85 2.55 
_LGRE_MTV1_GBSV -44.42 -39.15   
_LGRE_MTV2_GBSV 33.18 -34.51   
_LRE_MTV1_GBSV -0.79 7.39 
High 
_LRE_MTV2_GBSV 0.17 7.55 
_LRHGE_MTV1_GBSV 7.25 35.47 
NR 
_LRHGE_MTV2_GBSV 6.81 22.00 
_LRLGE_MTV1_GBSV -48.05 -9.69   
_LRLGE_MTV2_GBSV 58.16 -7.31   
_RPC_MTV1_GBSV -1.16 10.43 
High 
_RPC_MTV2_GBSV 0.92 8.09 
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Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
C) GLSZM features Statistic Statistic High/Med/Low/NR 
_HIE_MTV1_GBSV 3.15 33.56 
NR 
_HIE_MTV2_GBSV 1.00 47.59 
_Gnorm_HIE_MTV1_GBSV 4.30 19.57 
Med 
_Gnorm_HIE_MTV2_GBSV -0.87 19.86 
_HILAE_MTV1_GBSV -12.37 29.41 
NR 
_HILAE_MTV2_GBSV -32.13 23.79 
_HISAE_MTV1_GBSV 11.46 32.01 
NR 
_HISAE_MTV2_GBSV 15.64 23.64 
_IV_MTV1_GBSV 9.33 32.27 
NR 
_IV_MTV2_GBSV -22.94 23.91 
_LAE_MTV1_GBSV -11.91 28.84 
NR 
_LAE_MTV2_GBSV -35.06 29.62 
_LIE_MTV1_GBSV 12.25 27.56 
NR 
_LIE_MTV2_GBSV -1.08 20.47 
_LILAE_MTV1_GBSV -2.49 23.10 
NR 
_LILAE_MTV2_GBSV -30.23 9.83 
_LISAE_MTV1_GBSV 9.76 22.27 
NR 
_LISAE_MTV2_GBSV 5.27 5.84 
_SAE_MTV1_GBSV 7.96 36.52 
NR 
_SAE_MTV2_GBSV 10.26 32.49 
_SZV_MTV1_GBSV 13.12 35.45 
NR 
_SZV_MTV2_GBSV -3.26 22.83 
_ZP_MTV1_GBSV 3.31 30.19 
Med 
_ZP_MTV2_GBSV 7.35 25.21 
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Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
D) NTGTM features Statistic Statistic High/Med/Low/NR 
_Busyness_MTV1_GBSV 1.73 1.55 
NR 
_Busyness_MTV2_GBSV -7.53 2.28 
_Coarseness_MTV1_GBSV 3.42 0.08 NR 
_Coarseness_MTV2_GBSV 20.79 0.13   
_Vnorm_Coarseness_MTV1_GBSV 3.42 2.68 
NR 
_Vnorm_Coarseness_MTV2_GBSV 0.51 0.08 
_Complexity_MTV1_GBSV -24.51 1.30 NR 
_Complexity_MTV2_GBSV -26.19 3.68   
_Gnorm_Complexity_MTV1_GBSV -24.51 0.11 NR 
_Gnorm_Complexity_MTV2_GBSV -26.19 0.24   
_Contrast_MTV1_GBSV 7.61 3.99 NR 
_Contrast_MTV2_GBSV 19.72 0.74   
_Gnorm_Contrast_MTV1_GBSV 4.05 0.22 NR 
_Gnorm_Contrast_MTV2_GBSV 20.28 1.32   
_Texture Strength_MTV1_GBSV -30.94 0.08 NR 
_Texture Strength_MTV2_GBSV -11.06 0.28   
_Vnorm_Texture Strength_MTV1_GBSV -34.18 3.01 NR 
_Vnorm_Texture Strength_MTV2_GBSV -29.37 0.24   
_VGnorm_Texture Strength_MTV1_GBSV -28.16 0.79 
NR 
_VGnorm_Texture Strength_MTV2_GBSV -33.24 3.99 
 
   
Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
E) Shape-Based Features Statistic Statistic High/Med/Low/NR 
_sph_disprop_MTV1_GBSV 6.31 3.89 
High 
_sph_disprop_MTV2_GBSV 5.01 3.50 
_Asphericity_MTV1_GBSV -5.63 6.85 
High 
_Asphericity_MTV2_GBSV -4.97 6.91 
_Surf_Acm2_MTV1_GBSV -1.15 5.25 
High 
_Surf_Acm2_MTV2_GBSV -9.45 5.18 
_surf_ovr_vol_MTV1_GBSV 8.95 4.79 
Low 
_surf_ovr_vol_MTV2_GBSV 12.16 5.27 
_convexity_MTV1_GBSV -5.53 3.87 
High 
_convexity_MTV2_GBSV -4.93 3.47 
_compactness_MTV1_GBSV -9.23 6.86 
NR 
_compactness_MTV2_GBSV -15.15 6.96 
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Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
F) IVH Features Statistic Statistic High/Med/Low/NR 
_Intensity_contrast_MTV1_GBSV -3.94 3.97 
NR 
_Intensity_contrast_MTV2_GBSV -9.14 3.53 
_Intensity_energy_MTV1_GBSV 8.17 3.85 
NR 
_Intensity_energy_MTV2_GBSV 16.61 2.48 
_Intensity_entropy_MTV1_GBSV -1.67 3.28 
High 
_Intensity_entropy_MTV2_GBSV -3.04 2.74 
_Intensity_hist_entropy2_MTV1_GBSV -0.13 4.38 
High 
_Intensity_hist_entropy2_MTV2_GBSV -0.18 4.01 
_Intensity_locall_homog_MTV1_GBSV -2.48 5.53 
NR 
_Intensity_locall_homog_MTV2_GBSV 4.28 4.78 
_Intensity_uniformity_MTV1_GBSV -1.42 5.34 
NR 
_Intensity_uniformity__MTV2_GBSV -0.48 5.04 
_V10_V90_MTV1_GBSV 9.84 3.65 
NR 
_V10_V90_MTV2_GBSV 3.96 3.00 
_V40_MTV1_GBSV 11.84 2.13 
NR 
_V40_MTV2_GBSV 13.04 2.16 
_V70_MTV1_GBSV 11.32 3.20 
NR 
_V70_MTV2_GBSV 15.81 2.59 
_V80_MTV1_GBSV 10.64 3.48 
NR 
_V80_MTV2_GBSV 15.23 2.57 
_Maximum_Intensity_MTV1_GBSV 2.60 3.51 
NR 
_Maximum_Intensity_MTV2_GBSV 1.89 2.60 
_Mean_Intensity_MTV1_GBSV 8.50 3.13 
NR 
_Mean_Intensity_MTV2_GBSV 14.60 3.22 
_Peak_Intensity_MTV1_GBSV 5.57 3.00 
NR 
_Peak_Intensity_MTV2_GBSV 6.16 2.23 
_I10_I90_MTV1_GBSV -0.03 3.50 
NR 
_I10_I90_MTV2_GBSV -2.02 2.34 
_I30_MTV1_GBSV 6.70 3.64 
NR 
_I30_MTV2_GBSV 12.41 3.22 
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Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
G) First order statistical Features Statistic Statistic High/Med/Low/NR 
_SD_MTV1_GBSV -0.60 10.46 
NR 
_SD_MTV2_GBSV -2.70 11.12 
_Skewness_MTV1_GBSV -76.66 10.83 
NR 
_Skewness_MTV2_GBSV -31.95 10.01 
_Kurtosis_MTV1_GBSV 27.09 6.22 
NR 
_Kurtosis_MTV2_GBSV -249.16 6.82 
_RMS_MTV1_GBSV 7.04 4.68 
NR 
_RMS_MTV2_GBSV 11.76 4.14 
_Coeff_Vari_MTV1_GBSV -8.00 2.36 
NR 
_Coeff_Vari_MTV2_GBSV -15.27 2.38 
V90 (volume percentage having at least intensity of 90%) and I90 (minimum intensity 
 of 90% of the highest intensity volume). 
Supplementary Table S. 2 Descriptive Statistics for Mean Percentage Difference (d) measured 
for Gray Intensity Levels (GL) pairs of 1) 64-32, 2) 64-128, and 3) 64-256 
Radiomic features calc. method d% 
SD 
Reproducibility Level 
(RL) 
A) GLCM Features Statistic Statistic High/Med/Low/NR 
_autocorrelation_32_64 -101.26 0.18 
_autocorrelation_64_128 -98.07 3.18 
_autocorrelation_64_256 -144.93 0.11 
_Cluster_prominence_32_64 -145.37 0.06 
_Cluster_prominence_64_128 -120.99 9.33 
_Cluster_prominence_64_256 -162.28 0.01 
_Cluster_Shade_32_64 -130.90 1.77 
_Cluster_Shade_64_128 -97.68 2.61 
_Cluster_Shade_64_256 -158.60 0.09 
_Cluster_tendency_32_64 -99.46 0.15 
_Cluster_tendency_64_128 -53.06 3.06 
_Cluster_tendency_64_256 -144.54 0.09 
_Contrast_32_64 42.56 1.49 
_Contrast_64_128 -95.51 4.21 
_Contrast_64_256 -144.02 0.12 
_Correlation_32_64 102.16 0.28 
_Correlation_64_128 69.27 4.57 
_Correlation_64_256 -142.07 0.84 
_Difference_Average_32_64 -55.01 0.31 
_Difference_Average_64_128 -54.19 1.65 
_Difference_Average_64_256 -98.00 0.16 
_Difference_Entropy_32_64 -14.70 0.67 High 
_Difference_Entropy_64_128 10.61 0.98 High 
131 
 
_Difference_Entropy_64_256 -17.38 1.36 Med 
_Difference_Variance_32_64 -98.52 0.25   
_Difference_Variance_64_128 -97.33 1.51   
_Difference_Variance_64_256 -144.14 0.09   
_dissimilarity_32_64 -11.22 0.32 
Low _dissimilarity_64_128 15.30 3.44 
_dissimilarity_64_256 -17.01 0.28 
_energy_32_64 29.82 0.90   
_energy_64_128 69.27 4.57   
_energy_64_256 -105.07 4.26   
_Entropy_32_64 -15.25 0.56 High 
_Entropy_64_128 -10.90 0.93 High 
_Entropy_64_256 -17.78 1.19 Med 
_Homogeneity1_32_64 0.00 3.33   
_Homogeneity1_64_128 32.58 2.33   
_Homogeneity1_64_256 64.72 1.80   
_Info_Correlation1_32_64 -15.79 2.88   
_Info_Correlation1_64_128 -25.54 3.16   
_Info_Correlation1_64_256 52.25 4.63   
_Info_Correlation2_32_64 -11.41 1.10 
Med _Info_Correlation2_64_128 -11.64 0.97 
_Info_Correlation2_64_256 -19.74 1.52 
_Inverse_difference_32_64 -0.04 0.05 
High _Inverse_difference_64_128 0.12 0.29 
_Inverse_difference_64_256 0.08 0.02 
_Inverse_difference_moment_32_64 0.01 0.04 
High _Inverse_difference_moment_64_128 0.20 0.14 
_Inverse_difference_moment_64_256 0.15 0.01 
_Inverse_variance_32_64 38.28 3.17   
_Inverse_variance_64_128 40.59 5.01   
_Inverse_variance_64_256 80.30 4.40   
_Inverse_Variance_P_32_64 41.39 2.84   
_Inverse_Variance_P_64_128 43.27 3.98   
_Inverse_Variance_P_64_256 82.55 4.03   
_Local_homogeneity_64_32 0.00     
_Local_homogeneity_64_128 44.11 3.23   
_Local_homogeneity_64_256 83.13 2.67   
_max_Probability_32_64 67.63 3.04   
_max_Probability_64_128 55.55 4.75   
_max_Probability_64_256 94.39 4.19   
_Mean_32_64 35.95 7.45   
_Mean_64_128 -44.25 8.91   
_Mean_64_256 83.63 15.12   
_Vgnorm_Mean_32_64 0.93 15.35 Med 
_Vgnorm_Mean_64_128 3.58 6.50 Med 
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_Vgnorm_Mean_64_256 6.08 10.73 Med 
_Sum_Average_32_64 -55.74 0.49   
_Sum_Average_64_128 54.82 2.16   
_Sum_Average_64_256 98.37 0.60   
_Sum_Entropy_32_64 -15.07 0.49 High 
_Sum_Entropy_64_128 -10.85 2.16 High 
_Sum_Entropy_64_256 -17.64 0.60 Med 
_Sum_Variance_32_64 -98.77 0.62   
_Sum_Variance_64_128 -97.82 0.95   
_Sum_Variance_64_256 -144.33 1.20   
_Variance_32_64 -69.06 5.60   
_Variance_64_128 110.61 5.68   
_Variance_64_256 149.35 6.61   
  
    
  
 
 
Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
B) GLRLM features Statistic Statistic High/Med/Low/NR 
_LRE_32_64 7.89 1.63 
Med _LRE_64_128 12.88 2.10 
_LRE_64_256 12.85 2.12 
_LRHGE_32_64 -91.75 3.78   
_LRHGE_64_128 -91.92 4.57   
_LRHGE_64_256 -139.71 4.07   
_LRLGE_32_64 79.57 6.90   
_LRLGE_64_128 82.00 6.57   
_LRLGE_64_256 126.19 6.28   
_RLNU_32_64 -11.53 1.56 
Med _RLNU_64_128 -11.91 1.92 
_RLNU_64_256 7.58 2.97 
_RPC_32_64 -4.84 0.77 
High _RPC_64_128 -3.17 0.76 
_RPC_64_256 5.06 1.10 
_LGRE_32_64 72.09 6.48   
_LGRE_64_128 66.33 10.01   
_LGRE_64_256 121.00 6.29   
_GLNU_32_64 39.23 2.84   
_GLNU_64_128 38.01 4.36   
_GLNU_64_256 73.58 3.52   
_HGRE_32_64 -96.89 3.85   
_HGRE_64_128 94.27 4.76   
_HGRE_64_256 -141.06 4.10   
_SRE_32_64 -2.88 0.44 
High _SRE_64_128 -1.84 0.36 
_SRE_64_256 -2.99 0.48 
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_SRHGE_32_64 -98.07 3.87   
_SRHGE_64_128 -94.84 4.80   
_SRHGE_64_256 -141.37 4.11   
_SRLGE_32_64 72.46 6.65   
_SRLGE_64_128 77.08 5.55   
_SRLGE_64_256 -119.06 6.36   
  
Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
C) GLSZM features Statistic Statistic High/Med/Low/NR 
_HIE_32_64 -89.74 4.49   
_HIE_64_128 -89.70 3.96   
_HIE_64_256 -135.10 4.19   
_HILAE_32_64 -5.08 9.10   
_HILAE_64_128 -15.73 8.43   
_HILAE_64_256 -43.61 10.48   
_HISAE_32_64 -118.94 6.89   
_HISAE_64_128 114.04 6.29   
_HISAE_64_256 147.91 4.49   
_IV_32_64 5.24 6.47   
_IV_64_128 33.39 7.05   
_IV_64_256 63.59 7.40   
_LAE_32_64 82.58 7.79   
_LAE_64_128 74.45 8.26   
_LAE_64_256 107.55 7.06   
_LIE_32_64 40.25 10.29   
_LIE_64_128 48.00 10.27   
_LIE_64_256 89.39 9.99   
_LILAE_32_64 95.79 10.03   
_LILAE_64_128 85.68 10.62   
_LILAE_64_256 133.79 7.20   
_LISAE_32_64 -23.65 12.96   
_LISAE_64_128 -10.08 13.40   
_LISAE_64_256 36.42 13.99   
_SAE_32_64 -31.34 12.19   
_SAE_64_128 -46.76 8.04   
_SAE_64_256 -60.28 7.91   
_SZV_32_64 -48.53 0.64   
_SZV_64_128 -36.63 2.22   
_SZV_64_256 -56.21 0.25   
_ZP_32_64 -34.88 12.14   
_ZP_64_128 -19.91 2.25   
_ZP_64_256 -32.17 0.40   
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Radiomic features calc. method d% SD 
Reproducibility 
Level (RL) 
D) NTGTM features Statistic Statistic High/Med/Low/NR 
        
_Busyness_32_64 138.17 222.81   
_Busyness_64_128 175.45 253.40   
_Busyness_64_256 220.36 1052.94   
_Coarseness_32_64 -45.38 -177.81   
_Coarseness_64_128 -34.25 -147.99   
_Coarseness_64_256 -52.56 -198.50   
_Vnorm_Coarseness_32_64 -39.68 -160.10   
_Vnorm_Coarseness_64_128 -29.94 -119.48   
_Vnorm_Coarseness_64_256 -45.96 -193.99   
_Complexity_32_64 -30.49 -121.65   
_Complexity_64_128 -17.41 -64.90   
_Complexity_64_256 -28.12 -176.79   
_Gnorm_Complexity_32_64 -91.70 52.06   
_Gnorm_Complexity_64_128 -88.68 -116.82   
_Gnorm_Complexity_64_256 -132.19 -176.16   
_Contrast_32_64 67.75 124.95   
_Contrast_64_128 72.07 84.73   
_Contrast_64_256 -111.33 -173.77   
_Gnorm_Contrast_32_64 -52.12 -67.28   
_Gnorm_Contrast_64_128 51.26 -66.28   
_Gnorm_Contrast_64_256 91.98 -119.86   
_Texture Strength_32_64 74.41 -17.98   
_Texture Strength_64_128 76.67 12.98   
_Texture Strength_64_256 118.00 -21.25   
_Vnorm_Texture Strength_32_64 63.24 -120.50   
_Vnorm_Texture Strength_64_128 51.95 -119.05   
_Vnorm_Texture Strength_64_256 88.26 -176.31   
_VGnorm_Texture Strength_32_64 89.72 -65.09   
_VGnorm_Texture Strength_64_128 -134.88 120.24   
_VGnorm_Texture Strength_64_256 134.30 -118.66   
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Supplementary Table S. 3. Descriptive Statistics for Mean Percentage Difference (d) measured for 
Gray Intensity Levels (GL) pairs of: (1) 64-32, (2) 64-128, and (3) 64-256 
Radiomic features calc. method 
(d) 
over n 
= 8 
SD Reproducibility Level (RL) 
A) GLCM features
Statist
ic 
Statisti
c 
High/Med/Low/NR 
_autocorrelation_OSEM_FOREIR 
-
25.92 
3.70 
NR _autocorrelation_OSEM_FOREFBP -31.79 4.06 
_autocorrelation_OSEM_3DRP -17.71 5.96 
_Cluster_prominence_OSEM_FOREIR 
-
118.8
5 
39.41 
_Cluster_prominence_OSEM_FOREFBP 
-
98.92 
41.25 
_Cluster_prominence_OSEM_3DRP 
-
132.6
8 
91.95 
_Cluster_Shade_OSEM_FOREIR 
-
107.0
2 
40.07 
_Cluster_Shade_OSEM_FOREFBP 
-
79.86 
67.37 
_Cluster_Shade_OSEM_3DRP 
-
129.6
7 
80.02 
_Cluster_tendency_OSEM_FOREIR -81.31 60.05 
_Cluster_tendency_OSEM_FOREFBP 
-
43.38
39.18 
_Cluster_tendency_OSEM_3DRP 
-
118.17 
48.01 
_Contrast_OSEM_FOREIR 0.29 4.07 High 
_Contrast_OSEM_FOREFBP 8.27 6.44 High 
_Contrast_OSEM_3DRP 39.39 5.65 NR 
_Correlation_OSEM_FOREIR -5.94 3.65 
NR _Correlation_OSEM_FOREFBP 31.26 5.12 
_Correlation_OSEM_3DRP 38.09 5.18 
_Difference_Average_OSEM_FOREIR -1.39 8.32 High 
_Difference_Average_OSEM_FOREFB
P 0.90 
9.06 High 
_Difference_Average_OSEM_3DRP 2.75 9.52 Med 
_Difference_Entropy_OSEM_FOREIR 5.31 10.01 High 
_Difference_Entropy_OSEM_FOREF
BP 8.93 
10.62 High 
_Difference_Entropy_OSEM_3DRP 10.72 19.07 Med 
_Difference_Variance_OSEM_FOREI
R 0.57 
8.34 High 
_Difference_Variance_OSEM_FOREF
BP -0.21
12.87 High 
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_Difference_Variance_OSEM_3DRP 1.54 8.08 Med 
_dissimilarity_OSEM_FOREIR -0.95 13.23 High 
_dissimilarity_OSEM_FOREFBP -0.21 13.21 High 
_dissimilarity_OSEM_3DRP -16.01 12.85 NR 
_energy_OSEM_FOREIR 19.15 12.90 
NR _energy_OSEM_FOREFBP 7.96 13.65 
_energy_OSEM_3DRP -9.93 9.25 
_Entropy_OSEM_FOREIR -1.44 16.66 High 
_Entropy_OSEM_FOREFBP -0.39 17.22 High 
_Entropy_OSEM_3DRP 29.47 17.99 NR 
_Mean_OSEM_FOREIR -0.34 0.00 High 
_Mean_OSEM_FOREFBP -0.12 4.15 High 
_Mean_OSEM_3DRP 29.00 3.44 NR 
_Vnorm_Mean_OSEM_FOREIR -0.29 2.10 High 
_Vnorm_Mean_OSEM_FOREFBP -4.91 2.70 High 
_Vnorm_Mean_OSEM_3DRP 2.22 2.73 Med 
_Gnorm_Mean_OSEM_FOREIR -0.34 4.85 High 
_Gnorm_Mean_OSEM_FOREFBP -0.12 5.87 High 
_Gnorm_Mean_OSEM_3DRP 4.87 5.23 Med 
_Vgnorm_Mean_OSEM_FOREIR -0.29 8.87 High 
_Vgnorm_Mean_OSEM_FOREFBP -4.92 8.45 High 
_Vgnorm_Mean_OSEM_3DRP 1.96 8.08 Med 
_Homogeneity1_OSEM_FOREIR 4.26 3.91 High 
_Homogeneity1_OSEM_FOREFBP 0.64 6.11 High 
_Homogeneity1_OSEM_3DRP 28.57 5.38 NR 
_Info_Correlation1_OSEM_FOREIR -2.27 0.57 High 
_Info_Correlation1_OSEM_FOREFBP -3.07 1.17 High 
_Info_Correlation1_OSEM_3DRP 5.06 0.15 Med 
_Info_Correlation2_OSEM_FOREIR -1.41 2.01 High 
_Info_Correlation2_OSEM_FOREFBP -1.29 2.47 High 
_Info_Correlation2_OSEM_3DRP 4.96 3.82 Med 
_Inverse_difference_OSEM_FOREIR 0.15 0.99 High 
_Inverse_difference_OSEM_FOREFB
P -0.28
0.97 High 
_Inverse_difference_OSEM_3DRP 4.33 1.42 Med 
_Inverse_difference_moment_OSEM
_FOREIR -0.04
15.67 High 
_Inverse_difference_moment_OSEM
_FOREFBP -0.31
10.34 High 
_Inverse_difference_moment_OSEM
_3DRP -1.02
10.17 Med 
_Inverse_variance_OSEM_FOREIR 8.91 0.56 High 
_Inverse_variance_OSEM_FOREFBP 2.44 0.46 High 
_Inverse_variance_OSEM_3DRP 31.46 6.61 NR 
_Inverse_Variance_P_OSEM_FOREI
R 
-
30.49 
4.98 High 
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_Inverse_Variance_P_OSEM_FOREF
BP 
-17.41 6.17 High 
_Inverse_Variance_P_OSEM_3DRP -28.12 5.29 NR 
_Local_homogeneity_64_32 -91.70 8.55 High 
_Local_homogeneity_OSEM_FOREFB
P 
-
88.68
7.13 High 
_Local_homogeneity_OSEM_3DRP 
-
132.19 
8.18 NR 
_max_Probability_OSEM_FOREIR 77.88 0.63 
NR 
_max_Probability_OSEM_FOREFBP 82.45 2.77 
_max_Probability_OSEM_3DRP 
-
101.3
3 
0.77 
_Mean_OSEM_FOREIR -52.12 0.79 High 
_Mean_OSEM_FOREFBP 51.26 1.22 High 
_Mean_OSEM_3DRP 91.98 1.54 NR 
_Sum_Average_OSEM_FOREIR 
-
48.53 
12.41 
_Sum_Average_OSEM_FOREFBP 
-
36.63 
20.26 
_Sum_Average_OSEM_3DRP -56.21 20.20 
_Sum_Entropy_OSEM_FOREIR -9.06 -14.29 High 
_Sum_Entropy_OSEM_FOREFBP 10.61 -14.55 High 
_Sum_Entropy_OSEM_3DRP 19.35 -29.70 Med 
_Sum_Variance_OSEM_FOREIR 
-
34.88 
125.14 
_Sum_Variance_OSEM_FOREFBP -19.91 128.95 
_Sum_Variance_OSEM_3DRP -32.17 198.45 
_Variance_OSEM_FOREIR -2.88 106.36 
_Variance_OSEM_FOREFBP -1.84 87.36 
_Variance_OSEM_3DRP -2.99 148.44 
Radiomic features calc. method 
d% 
SD 
Reproducibility 
Level (RL) 
B) GLRLM features
Statisti
c 
Statist
ic 
High/Med/Low/N
R 
_LRE_OSEM_FOREIR 1.21 0.48 High 
_LRE_OSEM_FOREFBP 0.83 3.37 High 
_LRE_OSEM_3DRP -23.04 8.18 NR 
_SRE_OSEM_FOREIR -0.09 0.98 High 
_SRE_OSEM_FOREFBP -0.20 6.69 High 
_SRE_OSEM_3DRP 24.62 0.27 NR 
_SRHGE_OSEM_FOREIR -23.62 14.73 NR 
_SRHGE_OSEM_FOREFBP -27.95 5.27 NR 
_SRHGE_OSEM_3DRP -38.06 6.20 
_SRLGE_OSEM_FOREIR -48.53 25.64 
_SRLGE_OSEM_FOREFBP -36.63 12.47 
_SRLGE_OSEM_3DRP -56.21 17.43 
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_LRHGE_OSEM_FOREIR -69.06 36.84 
_LRHGE_OSEM_FOREFBP 110.61 4.10 
_LRHGE_OSEM_3DRP 149.35 -1.50
_LRLGE_OSEM_FOREIR -34.88 37.85 
_LRLGE_OSEM_FOREFBP -19.91 4.41 
_LRLGE_OSEM_3DRP -32.17 -1.03
_LGRE_OSEM_FOREIR -98.77 38.65 
_LGRE_OSEM_FOREFBP -97.82 5.68 
_LGRE_OSEM_3DRP -
144.33
3.54 
_RLNU_OSEM_FOREIR -2.58 24.77 
High _RLNU_OSEM_FOREFBP -0.40 25.35 
_RLNU_OSEM_3DRP 1.37 57.21 
_GLNU_OSEM_FOREIR -13.57 -3.06
NR _GLNU_OSEM_FOREFBP 6.59 -5.26
_GLNU_OSEM_3DRP 14.43 -8.37
_Gnorm_GLNU_OSEM_FOREIR 35.94 -19.89
NR _Gnorm_GLNU_OSEM_FOREFBP 6.59 -24.71
_Gnorm_GLNU_OSEM_3DRP -2.23 -25.20
_HGRE_OSEM_FOREIR 1.48 -27.22 NR 
_HGRE_OSEM_FOREFBP -28.37 -29.78 NR 
_HGRE_OSEM_3DRP -38.27 -31.04
_Gnorm_HGRE_OSEM_FOREIR 0.93 -33.27
NR _Gnorm_HGRE_OSEM_FOREFBP -28.37 -37.20
_Gnorm_HGRE_OSEM_3DRP -9.22 -37.38
_RPC_OSEM_FOREIR -0.30 -8.24
High 
_RPC_OSEM_FOREFBP -0.22 -20.25
_RPC_OSEM_3DRP -25.61 -31.16 Med 
Radiomic features calc. method 
d% 
SD 
Reproducibility 
Level (RL) 
C) GLSZM features
Statisti
c 
Statist
ic 
High/Med/Low/N
R 
_SAE_OSEM_FOREIR -12.37 -0.44
NR _SAE_OSEM_FOREFBP -32.13 -3.36
_SAE_OSEM_3DRP 11.46 -0.18
_IV_OSEM_FOREIR 15.64 -0.57
NR _IV_OSEM_FOREFBP 9.33 -6.89
_IV_OSEM_3DRP -22.94 -0.63
_LAE_OSEM_FOREIR -11.91 -5.46
NR _LAE_OSEM_FOREFBP -35.06 -11.26
_LAE_OSEM_3DRP 12.25 -15.97
_HIE_OSEM_FOREIR -1.08 -10.13
_HIE_OSEM_FOREFBP -2.49 -22.85
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_HIE_OSEM_3DRP -30.23 -34.01
_HILAE_OSEM_FOREIR 9.76 11.44 
_HILAE_OSEM_FOREFBP 5.27 -38.93
_HILAE_OSEM_3DRP 7.96 -55.35
_HISAE_OSEM_FOREIR 10.26 10.08 
_HISAE_OSEM_FOREFBP 13.12 -39.14
_HISAE_OSEM_3DRP -3.26 -55.49
_LIE_OSEM_FOREIR 3.42 7.71 
NR _LIE_OSEM_FOREFBP 0.51 -39.50
_LIE_OSEM_3DRP -24.51 -58.94
_LILAE_OSEM_FOREIR -26.19 -17.79
_LILAE_OSEM_FOREFBP -24.51 -64.16
_LILAE_OSEM_3DRP -26.19 -81.90
_LISAE_OSEM_FOREIR 7.61 -6.99
_LISAE_OSEM_FOREFBP 19.72 -41.12
_LISAE_OSEM_3DRP 4.05 -66.69
_SZV_OSEM_FOREIR 20.28 -69.67
NR _SZV_OSEM_FOREFBP -3.94 -25.10
_SZV_OSEM_3DRP -9.14 -28.30
_ZP_OSEM_FOREIR 8.17 -55.49
_ZP_OSEM_FOREFBP 16.61 -28.30 NR 
_ZP_OSEM_3DRP 29.49 -28.30
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_Contrast_OSEM_FOREFBP 6.53 -2.89 Low 
_Contrast_3DRP -19.61 -17.08 NR 
_Gnorm_Contrast_OSEM_FOREIR -6.73 -2.89 Med 
_Gnorm_Contrast_OSEM_FOREFBP 4.47 1.05 Med 
_Gnorm_Contrast_3DRP -19.01 -1.28 NR 
_Texture Strength_OSEM_FOREIR 9.93 8.51 
NR _Texture Strength_OSEM_FOREFBP 31.55 25.62 
_Texture Strength_3DRP 38.91 0.22 
_VGnorm_Texture Strength_OSEM_FOREIR 15.27 -2.89
NR _VGnorm_Texture Strength_OSEM_FOREFBP 19.66 -17.08
_VGnorm_Texture Strength_3DRP 23.81 -2.89
Radiomic features calc. method 
d% 
SD 
Reproducibility 
Level (RL) 
D) NTGTM features
Statistic 
Statisti
c 
High/Med/Low
/NR 
_Busyness_OSEM_FOREIR 
-828.74
-
532.70 
_Busyness_OSEM_FOREFBP 
1427.29 
-
198.42 
_Busyness_3DRP 
1601.65 
-
741.28 
_Coarseness_OSEM_FOREIR 5.82 -11.18
Low _Coarseness_OSEM_FOREFBP 18.62 -30.09
_Coarseness_3DRP 24.84 -2.68
_Vnorm_Coarseness_OSEM_FOREIR 10.62 -4.95
Low _Vnorm_Coarseness_OSEM_FOREFBP 18.58 5.92 
_Vnorm_Coarseness_3DRP 29.48 10.78 
2.71 7.00 Low 
1.59 9.55 Low 
_Complexity_OSEM_FOREIR 
_Complexity_OSEM_FOREFBP 
_Complexity_3DRP -6.97 -0.70 NR 
_Gnorm_Complexity_OSEM_FOREIR -2.66 1.38 
NR _Gnorm_Complexity_OSEM_FOREFBP -4.60 -0.44
_Gnorm_Complexity_3DRP 17.62 1.02 
_Contrast_OSEM_FOREIR -4.95 -17.08 Low 
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Supplementary Table S. 4. Mann-Whitney U test and ranks generated using Ranker search method 
for top 20 radiomic features 
Radiomic feature Class N 
Mean 
Rank 
Sum of 
Ranks 
U-score
Z-
score 
Ranks using 
Ranker search 
RF101 
No 
DM 
93 52.32 4866.00 
495.00 -4.96 0.091 
DM 28 89.82 2515.00 
RF12 
No 
DM 
93 53.27 4954.00 
583.00 -4.42 0.082 
DM 28 86.68 2427.00 
RF40 
No 
DM 
93 58.35 5427.00 
1056.00 -1.51 0.068 
DM 28 69.79 1954.00 
RF66 
No 
DM 
93 58.77 5466.00 
1095.00 -1.27 0.062 
DM 28 68.39 1915.00 
RF49 
No 
DM 
93 57.96 5390.00 
1019.00 -1.74 0.061 
DM 28 71.11 1991.00 
RF6 
No 
DM 
93 55.89 5198.00 
827.00 -2.92 0.059 
DM 28 77.96 2183.00 
RF8 
No 
DM 
93 54.89 5105.00 
734.00 -3.49 0.055 
DM 28 81.29 2276.00 
RF64 
No 
DM 
93 56.46 5251.00 
880.00 -2.59 0.054 
DM 28 76.07 2130.00 
RF10 
No 
DM 
93 55.03 5118.00 
747.00 -3.41 0.053 
DM 28 80.82 2263.00 
RF90 
No 
DM 
93 56.68 5271.00 
900.00 -2.47 0.052 
DM 28 75.36 2110.00 
RF9 
No 
DM 
93 54.40 5059.00 
688.00 -3.77 0.052 
DM 28 82.93 2322.00 
RF21 
No 
DM 
93 55.00 5115.00 
744.00 -3.43 0.051 
DM 28 80.93 2266.00 
RF74 
No 
DM 
93 58.69 5458.00 
1087.00 -1.32 0.051 
DM 28 68.68 1923.00 
RF7 
No 
DM 
93 54.54 5072.00 
701.00 -3.69 0.048 
DM 28 82.46 2309.00 
RF70 
No 
DM 
93 58.14 5407.00 
1036.00 -1.63 0.047 
DM 28 70.50 1974.00 
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RF82 
No 
DM 
93 63.54 5909.00 
1066.00 -1.45 0.045 
DM 28 52.57 1472.00 
RF85 
No 
DM 
93 56.84 5286.00 
915.00 -2.38 0.043 
DM 28 74.82 2095.00 
RF50 
No 
DM 
93 57.15 5315.00 
944.00 -2.20 0.042 
DM 28 73.79 2066.00 
RF69 
No 
DM 
93 58.17 5410.00 
1039.00 -1.62 0.042 
DM 28 70.39 1971.00 
RF51 
No 
DM 
93 57.56 5353.00 
982.00 -1.97 0.041 
DM 28 72.43 2028.00 
RF101: TS, NGTDM (PT) 
RF63: RPC, GLRLM 
(PT) 
RF18: IDM, GLCM (PT) 
RF02: Contrast, GLCM 
(PT) 
RF50: DE, GLCM (CT) 
RF154: 
Compactness, SF 
RF100: Complexity, 
NGTDM (PT) 
RF155: SP, SF 
RF97: Coarseness, 
NGTDM (PT) 
RF151: Surface Area, 
SF 
RF62: RLNU, GLRLM, 
(PT) 
RF106: TS, NGTDM 
(CT) 
RF12: 2nd Mean, GLCM 
(CT) 
RF150: Tumor 
Volume, SF 
RF28: Contrast, GLCM 
(CT) 
RF12: 2nd Mean, GLCM 
(PT), 
RF153: Asphericity, SF 
RF95: SZV, GLSZM, 
(CT) 
RF24:  DE, GLCM (PT) 
RF105: Complexity, 
NGTDM (CT) 
Supplementary Table S. 5. Pearson correlation coefficients presenting the association of the distances 
between maximum and second maximum with the overall tumor volume. Test is considered significant at 
P-value <0.05 (two-sided).
Tumor vol. DHL1 DHL2 DHL3 DHL4 
Tumor vol. 
1 
DHL1 
0.509 1 
DHL2 
0.546 0.408 1 
DHL3 
0.395 0.457 0.345 1 
DHL4 0.536 0.401 0.396 0.426 1 
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Supplementary Table S. 6. Kruskal-Wallis test, representing the association presenting the 
association of the distances between maximum and second maximum with the FIGO stage. In this 
analysis, we test the distribution similarity of each habitat feature across different FIGO stage types. Test 
is considered significant at P-value <0.05 (two-sided). 
Feature Χ2 df p-value
DHL1 11.46 6 0.07 
DHL2 16.07 6 0.01 
DHL3 10.17 6 0.10 
DHL4 12.26 6 0.04 
Supplementary Table S. 7. The numbers of positive and negative samples of the training set before 
and after using the synthetic minority oversampling technique (SMOTE). SMOTE was applied using a 
random seed = 1 and nearest neighbor = 5. 
Distant Metastasis cases 
Sample DM No-DM Total 
Original training set 20 67 86 
After SMOTE 66 67 133 
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